<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD003817.pub3" GROUP_ID="ENDOC" ID="231801090609004514" MERGED_FROM="" MODIFIED="2008-11-12 09:14:49 +0100" MODIFIED_BY="Gudrun Paletta" REVIEW_NO="SK" REVMAN_SUB_VERSION="5.0.16" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="5.2">
<COVER_SHEET MODIFIED="2008-11-12 09:13:16 +0100" MODIFIED_BY="Gudrun Paletta">
<TITLE>Exercise for overweight or obesity</TITLE>
<CONTACT>
<PERSON ID="14744" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Kelly</FIRST_NAME>
<MIDDLE_INITIALS>A</MIDDLE_INITIALS>
<LAST_NAME>Shaw</LAST_NAME>
<SUFFIX/>
<POSITION>Honorary Associate</POSITION>
<EMAIL_1>kelly.shaw@dhhs.tas.gov.au</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Menzies Research Institute</DEPARTMENT>
<ORGANISATION>Public Health Unit</ORGANISATION>
<ADDRESS_1>2/152 Macquarie Street</ADDRESS_1>
<ADDRESS_2/>
<CITY>Hobart</CITY>
<ZIP>7000</ZIP>
<REGION>Tasmania</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>+61 3 6222 7678</PHONE_1>
<PHONE_2/>
<FAX_1>+61 3 6222 7407</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2008-11-12 09:12:45 +0100" MODIFIED_BY="Gudrun Paletta">
<PERSON ID="14744" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Kelly</FIRST_NAME>
<MIDDLE_INITIALS>A</MIDDLE_INITIALS>
<LAST_NAME>Shaw</LAST_NAME>
<SUFFIX/>
<POSITION>Honorary Associate</POSITION>
<EMAIL_1>kelly.shaw@dhhs.tas.gov.au</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Menzies Research Institute</DEPARTMENT>
<ORGANISATION>Public Health Unit</ORGANISATION>
<ADDRESS_1>2/152 Macquarie Street</ADDRESS_1>
<ADDRESS_2/>
<CITY>Hobart</CITY>
<ZIP>7000</ZIP>
<REGION>Tasmania</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>+61 3 6222 7678</PHONE_1>
<PHONE_2/>
<FAX_1>+61 3 6222 7407</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="3D797E5182E26AA2017531FD273C9115" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Hanni</FIRST_NAME>
<MIDDLE_INITIALS>C</MIDDLE_INITIALS>
<LAST_NAME>Gennat</LAST_NAME>
<SUFFIX/>
<POSITION>Postdoctoral Research Fellow</POSITION>
<EMAIL_1>hanni.gennat@utas.edu.au</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Menzies Research Institute</DEPARTMENT>
<ORGANISATION>University of Tasmania</ORGANISATION>
<ADDRESS_1>Campbell Street</ADDRESS_1>
<ADDRESS_2/>
<CITY>Hobart</CITY>
<ZIP>7000</ZIP>
<REGION>Tasmania</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="14723" ROLE="AUTHOR">
<PREFIX>Assoc Prof</PREFIX>
<FIRST_NAME>Peter</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>O'Rourke</LAST_NAME>
<SUFFIX/>
<POSITION>Reader in Biostatistics</POSITION>
<EMAIL_1>p.orourke@sph.uq.edu.au</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>School of Population Health</DEPARTMENT>
<ORGANISATION>University of Queensland</ORGANISATION>
<ADDRESS_1>School of Population Health</ADDRESS_1>
<ADDRESS_2>University of Queensland Medical School</ADDRESS_2>
<CITY>Herston</CITY>
<ZIP>4006</ZIP>
<REGION>Queensland</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="12249" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Chris</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Del Mar</LAST_NAME>
<SUFFIX>MA MB BChir MD FRACGP FAFPHM</SUFFIX>
<POSITION>Dean</POSITION>
<EMAIL_1>cdelmar@bond.edu.au</EMAIL_1>
<EMAIL_2/>
<URL>http://ari.cochrane.org/en/about.html</URL>
<MOBILE_PHONE>+61 403 220080</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>Faculty of Health Sciences and Medicine</DEPARTMENT>
<ORGANISATION>Bond University</ORGANISATION>
<ADDRESS_1>University Pde</ADDRESS_1>
<ADDRESS_2>Robina</ADDRESS_2>
<CITY>Gold Coast</CITY>
<ZIP>4229</ZIP>
<REGION>Queensland</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>+61 7 5595 5499</PHONE_1>
<PHONE_2/>
<FAX_1>+61 7 5595 4122</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2008-11-12 09:13:16 +0100" MODIFIED_BY="Gudrun Paletta">
<UP_TO_DATE>
<DATE DAY="31" MONTH="12" YEAR="2005"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="31" MONTH="12" YEAR="2005"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="30" MONTH="5" YEAR="2009"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2002"/>
<REVIEW_PUBLISHED ISSUE="4" YEAR="2006"/>
<LAST_CITATION_ISSUE ISSUE="4" YEAR="2006"/>
</DATES>
<WHATS_NEW MODIFIED="2008-10-23 13:16:44 +0200" MODIFIED_BY="Gudrun Paletta">
<WHATS_NEW_ENTRY EVENT="AMENDMENT">
<DATE DAY="3" MONTH="10" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2008-10-23 13:16:28 +0200" MODIFIED_BY="Gudrun Paletta">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2008-10-23 13:16:28 +0200" MODIFIED_BY="Gudrun Paletta">
<DATE DAY="23" MONTH="10" YEAR="2008"/>
<DESCRIPTION>
<P>An editorial decision was made by the Cochrane Metabolic and Endocrine Disorders Review Group to exclude data from Thong 2000 in this review as the standard deviation data, calculated from standard error data, for Thong 2000 is not consistent with data recorded from any other study included in this review and does not appear to be reliable. Data from Thong 2000 were re-assessed and the study was re-classified from 'exercise versus no treatment control' and 'exercise versus diet' to 'exercise + diet versus diet alone'.<BR/>
<BR/>As a consequence of the above, the following amendments have been made:<BR/>- The above was noted in the notes section for Thong 2000 of 'Characteristics of Included Studies' table<BR/>- Data in the 'comparisons and data' table were changed to reflect the re-classification of the study<BR/>- Meta-analyses were repeated for affected comparisons: 'exercise versus no treatment control', 'exercise versus diet' and 'exercise+ diet versus diet alone'. Data for Thong 2000 were de-selected before meta-analyses were repeated.<BR/>- The abstract, synopsis and text of the review were modified to reflect the new numbers and characteristics of studies for each affected comparison group<BR/>- The 'summary of main findings' table in the additional tables was modified to reflect the new summary of main findings for each affected comparison group</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Royal Australian College of General Practitioners</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>National Health and Medical Research Council</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-10-23 13:27:50 +0200" MODIFIED_BY="Gudrun Paletta">
<SUMMARY MODIFIED="2008-10-23 13:17:12 +0200" MODIFIED_BY="Gudrun Paletta">
<TITLE MODIFIED="2008-10-19 16:07:33 +0200" MODIFIED_BY="Gudrun Paletta">Exercise for overweight or obesity</TITLE>
<SUMMARY_BODY MODIFIED="2008-10-23 13:17:12 +0200" MODIFIED_BY="Gudrun Paletta">
<P>Overweight and obesity are important public health problems and are associated with many serious health conditions. The risk of developing overweight and obesity depends on lifestyle factors such as food intake and physical activity levels. Treatment for overweight and obesity therefore commonly involves diet and exercise. We found that exercise has a positive effect on body weight and cardiovascular disease risk factors in people with overweight or obesity, particularly when combined with diet, and that exercise improves health even if no weight is lost. No data were identified on adverse events, quality of life, morbidity, costs or mortality.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT>
<ABS_BACKGROUND>
<P>Clinical trials have shown that exercise in adults with overweight or obesity can reduce bodyweight. There has been no quantitative systematic review of this in <I>The Cochrane Library</I>.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To assess exercise as a means of achieving weight loss in people with overweight or obesity, using randomised controlled clinical trials.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY>
<P>Studies were obtained from computerised searches of multiple electronic bibliographic databases.<BR/> </P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Studies were included if they were randomised controlled trials that examined body weight change using one or more physical activity intervention in adults with overweight or obesity at baseline and loss to follow-up of participants of less than 15%. </P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>Two authors independently assessed trial quality and extracted data. </P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS>
<P>The 43 studies included 3476 participants. Although significant heterogeneity in some of the main effects' analyses limited ability to pool effect sizes across some studies, a number of pooled effect sizes were calculated. When compared with no treatment, exercise resulted in small weight losses across studies. Exercise combined with diet resulted in a greater weight reduction than diet alone (WMD - 1.0 kg; 95% confidence interval (CI) -1.3 to -0.7). Increasing exercise intensity increased the magnitude of weight loss (WMD - 1.5 kg; 95% CI -2.3 to -0.7). There were significant differences in other outcome measures such as serum lipids, blood pressure and fasting plasma glucose. Exercise as a sole weight loss intervention resulted in significant reductions in diastolic blood pressure (WMD - 2 mmHg; 95% CI -4 to -1), triglycerides (WMD - 0.2 mmol/L; 95% CI -0.3 to -0.1) and fasting glucose (WMD - 0.2 mmol/L; 95% CI -0.3 to -0.1). Higher intensity exercise resulted in greater reduction in fasting serum glucose than lower intensity exercise (WMD - 0.3 mmol/L; 95% CI -0.5 to -0.2). No data were identified on adverse events, quality of life, morbidity, costs or on mortality. </P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>The results of this review support the use of exercise as a weight loss intervention, particularly when combined with dietary change. Exercise is associated with improved cardiovascular disease risk factors even if no weight is lost. </P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-10-23 13:27:50 +0200" MODIFIED_BY="Gudrun Paletta">
<BACKGROUND MODIFIED="2008-10-03 12:21:13 +0200" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2008-10-03 11:50:31 +0200" MODIFIED_BY="[Empty name]">
<P>Overweight and obesity are conditions of excess body fat (<LINK REF="REF-NHMRC-1997" TYPE="REFERENCE">NHMRC 1997</LINK>). The World Health Organisation (WHO) defines weight status according to body mass index (BMI), the ratio of weight (in kilograms) divided by height (in metres squared). A BMI of 20 to 25.9 defines normal weight, 25 to 29.9 defines overweight and equal to or greater than 30 defines obesity (<LINK REF="REF-WHO-2003" TYPE="REFERENCE">WHO 2003</LINK>). Overweight and obesity are a major public health problem with more than one billion adults overweight globally, 300 million of which have obesity (<LINK REF="REF-WHO-2006" TYPE="REFERENCE">WHO 2006</LINK>). Increased consumption of more energy-dense, nutrient-poor foods with high levels of sugar and saturated fats, combined with reduced physical activity, have led to the increase in prevalence (<LINK REF="REF-WHO-2003" TYPE="REFERENCE">WHO 2003</LINK>). Overweight and obesity pose a major risk for serious chronic diseases, including type 2 diabetes, cardiovascular disease, hypertension and stroke, and certain forms of cancer. Effective weight management for individuals and groups with overweight and obesity involves a range of strategies including reducing energy intake through dietary change and increasing energy expenditure by increasing physical activity levels (<LINK REF="REF-WHO-2003" TYPE="REFERENCE">WHO 2003</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2008-10-03 11:50:58 +0200" MODIFIED_BY="[Empty name]">
<P>Although evidence supporting the efficacy of exercise to achieve weight loss is disappointing, studies do support the efficacy of exercise to prevent weight gain. A number of large studies, including the Reno diet-heart study, the "First National Health Nutrition and Examination Survey" (NHANES-1) and the Canada Fitness survey have found a negative association between physical activity and weight gain (<LINK REF="REF-Foreyt-1995" TYPE="REFERENCE">Foreyt 1995</LINK>; <LINK REF="REF-Williamson-1993" TYPE="REFERENCE">Williamson 1993</LINK>; <LINK REF="REF-Tremblay-1986" TYPE="REFERENCE">Tremblay 1986</LINK>; <LINK REF="REF-Tremblay-1990" TYPE="REFERENCE">Tremblay 1990</LINK>). These studies were large-scale cross-sectional and longitudinal studies. The impact of a number of vigorous and non-vigorous leisure activities on weight was examined. People who were habitually more active were found to be less obese. Therefore increasing physical activity, both exercise and habitual activity, may have a role in preventing obesity, preventing worsening of already established obesity, and reducing body mass in obese people.</P>
</INTERVENTION>
<THEORY MODIFIED="2008-10-03 12:21:13 +0200" MODIFIED_BY="[Empty name]">
<P>Even if exercise does not result in weight loss, it confers significant health benefits to people with overweight and obesity. Blood lipid profiles associated with increased risk of coronary heart disease are a common metabolic feature of obesity. Since the early 1980s there has been increasing evidence that central fat accumulation has an adverse action on lipids, resulting in elevated triglycerides and very-low-density lipoproteins and low levels of high-density lipoproteins (<LINK REF="REF-Despres-1994" TYPE="REFERENCE">Despres 1994</LINK>). Exercise, with or without weight loss, improves plasma lipoprotein status, in particular, increasing high-density lipoproteins therefore may be of particular benefit to people who are abdominally obese even if no weight is lost by exercising. Similarly, large cross-sectional studies demonstrate reduction in blood pressure in those who regularly exercise, compared with sedentary persons, irrespective of weight (<LINK REF="REF-Montoye-1972" TYPE="REFERENCE">Montoye 1972</LINK>; <LINK REF="REF-Sandvik-1993" TYPE="REFERENCE">Sandvik 1993</LINK>). The large cohort Harvard alumni study, showed that those who engaged in regular vigorous leisure activities had a 33 percent lower risk (relative risk reduction) of developing hypertension and 41 percent reduction (relative risk reduction) in mortality from coronary heart disease over 20 years (<LINK REF="REF-Paffenbarger-1983" TYPE="REFERENCE">Paffenbarger 1983</LINK>).</P>
<P>Exercise interventions ideally should be used in the context of a multi-component weight loss program to gain their maximum benefit. Diet and exercise combined with psychological interventions comprise an intuitively powerful weight loss program (<LINK REF="REF-NHLBI-1998" TYPE="REFERENCE">NHLBI 1998</LINK>). However, in spite of the increased comprehensiveness of weight loss programs and improvements in patient education, understanding of the role of diet and exercise in weight loss, psychological interventions, and improved pharmacotherapies for weight reduction, results of weight loss trials have continued to remain disappointing (<LINK REF="REF-Liao-2000" TYPE="REFERENCE">Liao 2000</LINK>). There are still major gaps in our understanding of the roles of diet, exercise, and psychological therapies in weight reduction. Also, achieving long-term modification of food intake and food type by the obese individual without creating decreases in energy expenditure associated with dieting, and dealing with relapse to pre-intervention diet and exercise behaviours are ongoing challenges (<LINK REF="REF-Brownell-1986" TYPE="REFERENCE">Brownell 1986</LINK>).</P>
<P>Studies examining the magnitude of weight loss achievable with exercise have shown disappointing results. Garrow and Summerbell, in a meta-analysis of 28 studies of exercise and weight loss, concluded that weight lost in exercise programs without caloric restriction is small and usually ranges from 2 to 7 kg (<LINK REF="REF-Garrow-1995" TYPE="REFERENCE">Garrow 1995</LINK>). Ballor and Keesey, in an earlier meta-analysis, also found that weight loss associated with exercise was modest (<LINK REF="REF-Ballor-1991" TYPE="REFERENCE">Ballor 1991</LINK>). However, considerable research has been performed in the area since these meta-analyses were performed. This review aimed to clarify the effect of exercise on body weight and health in people with overweight and obesity, using high quality criteria to assess and summarise the evidence.</P>
</THEORY>
</BACKGROUND>
<OBJECTIVES>
<P>To assess the efficacy of exercise as a means of achieving weight loss in people with overweight and obesity.</P>
</OBJECTIVES>
<METHODS MODIFIED="2008-10-23 13:24:58 +0200" MODIFIED_BY="Gudrun Paletta">
<SELECTION_CRITERIA MODIFIED="2008-10-03 12:21:16 +0200" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES>
<P>All randomised controlled clinical trials of exercise in people with overweight or obesity, with a duration of at least three months and loss to follow-up of less than 15%, were considered for inclusion. </P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Studies were limited to adult participants (aged over 18 years). Studies included adults with overweight or obesity according to body mass index, waist circumference or waist-to-hip ratio, irrespective of health status. </P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2008-10-03 12:21:16 +0200" MODIFIED_BY="[Empty name]">
<P>The studies included had an exercise prescription. Exercise is defined as any form of physical activity performed on a repeated basis for an defined period of time (exercise training). Exercise prescriptions include specific recommendations for the type, intensity, frequency and duration of any physical activity with a specific objective (e.g. increase fitness, lose weight) (<LINK REF="REF-Bouchard-1994" TYPE="REFERENCE">Bouchard 1994</LINK>). Studies stating that they simply recommended increasing physical activity were not included within the analyses unless it was possible to quantify the exercise stimulus by some means. Studies that combined exercise and medication associated with weight loss as an intervention were excluded.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2008-10-03 11:52:41 +0200" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2008-10-03 11:52:27 +0200" MODIFIED_BY="[Empty name]">
<UL>
<LI>weight or another indicator of body mass (e.g. body mass index, waist measurement, waist-to-hip ratio);</LI>
<LI>morbidity and mortality;</LI>
<LI>well-being and quality of life.</LI>
</UL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2008-10-03 11:52:41 +0200" MODIFIED_BY="[Empty name]">
<UL>
<LI>serum lipids;</LI>
<LI>serum glucose;</LI>
<LI>systolic and diastolic blood pressure;</LI>
<LI>adverse effects.</LI>
</UL>
<P>
<BR/>We planned on examining the following effect modifiers if there were sufficient data: sex, age, adherence to treatment, initial weight and co-morbidities.</P>
<SUBSECTION>
<HEADING LEVEL="5">Timing of outcome assessment</HEADING>
<P>Studies with a duration including follow-up period of three months or greater were included in this review.</P>
</SUBSECTION>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-10-23 13:24:58 +0200" MODIFIED_BY="Gudrun Paletta">
<ELECTRONIC_SEARCHES MODIFIED="2008-10-23 13:24:58 +0200" MODIFIED_BY="Gudrun Paletta">
<P>We use the following sources for the identification of trials:<BR/>
</P>
<UL>
<LI>
<I>The Cochrane Library;</I>
</LI>
<LI>MEDLINE (until 2005);</LI>
<LI>SPORT Discus (until 2005);</LI>
<LI>EMBASE (until 2005).</LI>
</UL>
<P>
<BR/>We also searched databases of ongoing trials: Current Controlled Trials (www.controlled-trials.com - with links to other databases of ongoing trials).<BR/>The reference lists of review articles and of all included studies were searched in order to find other potentially eligible studies.<BR/>Potential missing, unpublished or ongoing studies were planned to be sought by contacting experts in the field. This was not necessary.<BR/>Publications in all languages were sought.</P>
<P>Please see <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> for a detailed search strategy.</P>
<P>Additional key words of relevance were sought during the electronic or other searches. None were identified.</P>
</ELECTRONIC_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2008-10-03 12:16:35 +0200" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2008-10-03 11:57:42 +0200" MODIFIED_BY="[Empty name]">
<P>Assessment of quality and results data was undertaken by two reviewers (KS and HCG). Full articles were retrieved for further assessment if the information given in the abstract obtained from the searches suggested that the study: 1. included people who were overweight or obese, 2. compared exercise with placebo or another non-pharmacological weight loss intervention, 3. assessed one or more relevant clinical outcome measures, 4. used random allocation to the comparison groups. When a title or abstract could not be rejected with certainty, the full text of the article was obtained for further evaluation. Interrater agreement for study selection was measured using the kappa statistic (<LINK REF="REF-Cohen-1960" TYPE="REFERENCE">Cohen 1960</LINK>). Where differences in opinion existed, these were resolved by a third party (POR). Where duplicate publications and companion papers were located, information was maximised by using all versions of the study.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2008-10-03 12:16:35 +0200" MODIFIED_BY="[Empty name]">
<P>Data extracted included the following:</P>
<UL>
<LI>general information: Published/unpublished, title, authors, source, contact address, country, language of publication, year of publication, duplicate publications;</LI>
<LI>trial characteristics: Design, duration, randomisation (and method), allocation concealment (and method), blinding (outcome assessors), check of blinding;</LI>
<LI>intervention: Exercise prescription, comparison interventions (method, timing);</LI>
<LI>patients: Sampling (random/convenience), exclusion criteria, total number and number in comparison groups, gender, age, diagnostic criteria of overweight or obesity, similarity of groups at baseline, assessment of compliance or relapse, withdrawals or losses to follow-up (reasons or description), subgroups;</LI>
<LI>outcomes: Outcomes specified above, what was the main outcome assessed in the study, other events, length of follow-up;</LI>
<LI>results: For outcomes and times of assessment, intention-to-treat analysis.</LI>
</UL>
<P>A template data extraction form was developed and sent to the Metabolic and Endocrine Disorders Group Editorial Base for approval. Study authors were not contacted for further information.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2008-10-03 11:58:08 +0200" MODIFIED_BY="[Empty name]">
<P>The quality of reporting each trial was assessed based largely on the quality criteria specified by Schulz and by Jadad (<LINK REF="REF-Schulz-1995" TYPE="REFERENCE">Schulz 1995</LINK>; <LINK REF="REF-Jadad-1996" TYPE="REFERENCE">Jadad 1996</LINK>). In particular, the following factors were studied:<BR/>(1) Minimisation of selection bias - a) was the randomisation procedure adequate? b) was the allocation concealment adequate?<BR/>(2) Minimisation of attrition bias - a) were withdrawals and dropouts completely described? b) was analysis by intention-to-treat?<BR/>(3) Minimisation of detection bias - were outcome assessors blind to the intervention?</P>
<P>Based on these criteria, studies were subdivided into the following three categories (see Cochrane Handbook):<BR/>A - all quality criteria met: low risk of bias.<BR/>B - one or more of the quality criteria only partly met: moderate risk of bias.<BR/>C - one or more criteria not met: high risk of bias.<BR/>This classification was planned to be used as the basis of a sensitivity analysis.</P>
<P>Each trial was assessed for quality assessment independently by two reviewers (KS, HCG). Interrater agreement was calculated using the kappa statistic (<LINK REF="REF-Cohen-1960" TYPE="REFERENCE">Cohen 1960</LINK>).</P>
</QUALITY_ASSESSMENT>
<HETEROGENEITY_ASSESSMENT MODIFIED="2008-10-03 11:58:23 +0200" MODIFIED_BY="[Empty name]">
<P>Where heterogeneity existed a random effects model was used to explore results. Effect sized are presented as weighted mean differences with 95% confidence intervals. The chi-square method was used to assess heterogeneity with the significance set at P &lt; 0.1. Heterogeneity was also examined with I<SUP>2</SUP>. Where I<SUP>2</SUP> values of greater than 50% were present, meta-analytic pooling was not performed (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>).</P>
</HETEROGENEITY_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2008-10-03 11:58:41 +0200" MODIFIED_BY="[Empty name]">
<P>Where data were available which were sufficiently similar with respect to interventions and outcomes, pooled estimates of effect were obtained using Review Manager (RevMan) 4.2. Data were entered into RevMan and analysed using RevMan Analyses, the statistical component of RevMan. Fixed-effect models were used to pool data where appropriate.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2008-10-03 11:58:55 +0200" MODIFIED_BY="[Empty name]">
<P>Should the quantity of data have permitted, we planned to examine subgroups based on the following factors:<BR/>
</P>
<UL>
<LI>type, intensity and duration of the exercise intervention;</LI>
<LI>age;</LI>
<LI>gender;</LI>
<LI>smoking status;</LI>
<LI>different comparison interventions;</LI>
<LI>co-morbidities.</LI>
</UL>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2008-10-03 11:59:15 +0200" MODIFIED_BY="[Empty name]">
<P>We compared the results of fixed- and random-effects models. We also planned to perform sensitivity analyses in order to explore the influence of the following factors on effect size:<BR/>
</P>
<UL>
<LI>repeating the analysis excluding unpublished studies (if there were any);</LI>
<LI>repeating the analysis taking account of study quality, as specified above;</LI>
<LI>repeating the analysis excluding any very long or large studies to establish how much they dominate the results;</LI>
<LI>repeating the analysis excluding studies using the following filters: diagnostic criteria, language of publication, source of funding (industry versus other), country.</LI>
</UL>
<P>
<BR/>Funnel plots were performed for assessment of small study bias.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2008-10-23 13:27:50 +0200" MODIFIED_BY="Gudrun Paletta">
<STUDY_DESCRIPTION MODIFIED="2008-10-23 13:26:48 +0200" MODIFIED_BY="Gudrun Paletta">
<SEARCH_RESULTS MODIFIED="2008-10-23 13:25:23 +0200" MODIFIED_BY="Gudrun Paletta">
<P>The search strategy, last performed in January 2006, identified 4040 abstracts for perusal. On review of the abstracts, 271 articles were retrieved for perusal. Of these, 89 potentially relevant studies were located.</P>
<P>
<B>
<I>QUOROM (quality of reporting of meta-analyses) statement </I>
</B>(<LINK REF="REF-Moher-1999" TYPE="REFERENCE">Moher 1999</LINK>
<U>)<BR/>
</U>
</P>
<UL>
<LI>potentially relevant abstracts identified and screened for retrieval (n = 4040);</LI>
<LI>abstracts excluded (n = 3769);</LI>
<LI>studies retrieved for more detailed evaluation (n = 271);</LI>
<LI>studies excluded (n = 182);</LI>
<LI>potentially appropriate studies to be included in the systematic review (n = 89);</LI>
<LI>studies excluded from the systematic review, with reasons in <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> (n = 46);</LI>
<LI>studies included in the systematic review (n = 43);</LI>
<LI>duplicate publications (n = 2);</LI>
<LI>RCTs included in the systematic review (n = 41).</LI>
</UL>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2008-10-23 13:26:23 +0200" MODIFIED_BY="Gudrun Paletta">
<P>A total of 43 studies, reporting the results from 41 trials, met the inclusion criteria and were included in the review. The kappa statistic for trial selection was 0.73; 95% confidence interval (CI) 0.64 to 0.82. The details of these studies are described in <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>. Two studies were duplicate publications of other studies included in the review. Data from these studies were included and were used to maximise available information about the primary studies (<LINK REF="STD-Pritchard-1997" TYPE="STUDY">Pritchard 1997</LINK>; <LINK REF="STD-Svendsen-1993" TYPE="STUDY">Svendsen 1993</LINK>). Two studies compared exercise and behaviour therapy with behaviour therapy alone (<LINK REF="STD-Jeffery-1998" TYPE="STUDY">Jeffery 1998</LINK>; <LINK REF="STD-Jeffery-2003" TYPE="STUDY">Jeffery 2003</LINK>). A number of trials did not present results in a manner that enabled variance data for change in outcome measures to be extracted and the variance data for one study was not consistent with the data recorded from any other study (<LINK REF="STD-Thong-2000" TYPE="STUDY">Thong 2000</LINK>). Data from all of these studies, identified in the 'Notes' section of <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>, are included in the results but are reported narratively (<LINK REF="STD-Aggel_x002d_Leijssen-2001b" TYPE="STUDY">Aggel-Leijssen 2001b</LINK>; <LINK REF="STD-Aggel_x002d_Leijssen-2002" TYPE="STUDY">Aggel-Leijssen 2002</LINK>; <LINK REF="STD-Balkestein-1999" TYPE="STUDY">Balkestein 1999</LINK>; <LINK REF="STD-Gillett-1987" TYPE="STUDY">Gillett 1987</LINK>; <LINK REF="STD-Manning-1991" TYPE="STUDY">Manning 1991</LINK>; Raz 1994; <LINK REF="STD-Stensel-1994" TYPE="STUDY">Stensel 1994</LINK>; <LINK REF="STD-Thong-2000" TYPE="STUDY">Thong 2000</LINK>; <LINK REF="STD-Utter-2000" TYPE="STUDY">Utter 2000</LINK>; <LINK REF="STD-Wing-1988" TYPE="STUDY">Wing 1988</LINK>; <LINK REF="STD-Wirth-1985" TYPE="STUDY">Wirth 1985</LINK>). The data from these studies are not included in the analyses.</P>
<P>
<B>Studies</B>
<BR/>All included trials were randomised controlled clinical trials. Eight trials were factorial in design (<LINK REF="STD-Aggel_x002d_Leijssen-2001" TYPE="STUDY">Aggel-Leijssen 2001</LINK>; <LINK REF="STD-Anderssen-1996" TYPE="STUDY">Anderssen 1996</LINK>; <LINK REF="STD-Cox-2004" TYPE="STUDY">Cox 2004</LINK>; <LINK REF="STD-Jeffery-1998" TYPE="STUDY">Jeffery 1998</LINK>; <LINK REF="STD-Neumark-1995" TYPE="STUDY">Neumark 1995</LINK>; <LINK REF="STD-Nieman-1998" TYPE="STUDY">Nieman 1998</LINK>; <LINK REF="STD-Stefanick-1998" TYPE="STUDY">Stefanick 1998</LINK>; <LINK REF="STD-Wood-1991" TYPE="STUDY">Wood 1991</LINK>). The remaining 33 were parallel in design.</P>
<SUBSECTION>
<HEADING LEVEL="4">Participants and settings</HEADING>
<P>There were a total of 3476 participants in the 41 trials. All trials were conducted in adults. The weighted mean age of participants was 42.4 years for the 32 trials that reported age as a mean value. The remaining nine trials, which reported age as a range, included participants aged between 20 and 75 years. Of the 39 trials that reported gender distribution of participants, 17 included men only, 15 included women only, and 10 included both men and women. The duration of the included studies ranged from 3 to 12 months, including follow-up.</P>
<P>Twenty-four trials were conducted in the United States of America, four were conducted in The Netherlands (<LINK REF="STD-Aggel_x002d_Leijssen-2001" TYPE="STUDY">Aggel-Leijssen 2001</LINK>; <LINK REF="STD-Aggel_x002d_Leijssen-2001b" TYPE="STUDY">Aggel-Leijssen 2001b</LINK>; <LINK REF="STD-Aggel_x002d_Leijssen-2002" TYPE="STUDY">Aggel-Leijssen 2002</LINK>; <LINK REF="STD-Balkestein-1999" TYPE="STUDY">Balkestein 1999</LINK>), three in Canada (<LINK REF="STD-Janssen-2002" TYPE="STUDY">Janssen 2002</LINK>; <LINK REF="STD-Ross-1996" TYPE="STUDY">Ross 1996</LINK>; <LINK REF="STD-Thong-2000" TYPE="STUDY">Thong 2000</LINK>) and Australia (<LINK REF="STD-Cox-2004" TYPE="STUDY">Cox 2004</LINK>; <LINK REF="STD-Cox-1996" TYPE="STUDY">Cox 1996</LINK>; <LINK REF="STD-Pritchard-1997" TYPE="STUDY">Pritchard 1997</LINK>), two in Israel (Raz 1994; <LINK REF="STD-Neumark-1995" TYPE="STUDY">Neumark 1995</LINK>) and one in Norway (<LINK REF="STD-Anderssen-1996" TYPE="STUDY">Anderssen 1996</LINK>), the United Kingdom (<LINK REF="STD-Stensel-1994" TYPE="STUDY">Stensel 1994</LINK>), Denmark (<LINK REF="STD-Svendsen-1993" TYPE="STUDY">Svendsen 1993</LINK>) and Germany (<LINK REF="STD-Wirth-1985" TYPE="STUDY">Wirth 1985</LINK>), respectively. All trials were outpatient community studies. None were inpatient hospital studies. The range of outpatient settings in which trials were conducted included general medical clinics, hospital obesity outpatient clinics, primary care, university campuses and workplace settings. Most participants were recruited by local news media (e.g. local newspaper, radio announcements, bulletin boards). One study recruited their participants from a database of participants of a cohort study (<LINK REF="STD-Anderssen-1996" TYPE="STUDY">Anderssen 1996</LINK>), one from a group of people newly registered to participate in a concurrent lifestyle intervention trial (<LINK REF="STD-Hellenius-1993" TYPE="STUDY">Hellenius 1993</LINK>), one from a database of respondents to a community survey questionnaire (<LINK REF="STD-Svendsen-1993" TYPE="STUDY">Svendsen 1993</LINK>), and one from the staff of a national business corporation (<LINK REF="STD-Pritchard-1997" TYPE="STUDY">Pritchard 1997</LINK>).</P>
<P>The exercise interventions that were evaluated are listed below. Eighteen trials evaluated multiple exercise interventions within their design, and 23 trials evaluated a single exercise intervention. Twenty-one trials evaluated a walking intervention, 10 evaluated cycle ergometry (exercise bicycle), eight evaluated jogging, eight evaluated weights training, five evaluated commercial aerobics, five evaluated treadmill exercise, two evaluated stair stepping, and one evaluated each of dancing, ball games, calisthenics, rowing, and aqua jogging, respectively. No trials evaluated swimming or water aerobics as weight loss interventions.</P>
<P>Twelve trials contained groups that compared exercise with no treatment as a weight loss intervention in people with overweight or obesity. Seven trials evaluated walking / jogging, three evaluated cycle ergometry (<LINK REF="STD-Aggel_x002d_Leijssen-2001b" TYPE="STUDY">Aggel-Leijssen 2001b</LINK>; <LINK REF="STD-Cox-2004" TYPE="STUDY">Cox 2004</LINK>; <LINK REF="STD-Irwin-2003" TYPE="STUDY">Irwin 2003</LINK>), two evaluated weights training (<LINK REF="STD-Irwin-2003" TYPE="STUDY">Irwin 2003</LINK>; <LINK REF="STD-Manning-1991" TYPE="STUDY">Manning 1991</LINK>), and one each evaluated aerobics (<LINK REF="STD-Pritchard-1997" TYPE="STUDY">Pritchard 1997</LINK>) and ball games / calisthenics (<LINK REF="STD-Wirth-1985" TYPE="STUDY">Wirth 1985</LINK>). The exercise intensity was high (greater than 60% maximal oxygen uptake (VO2 max) / maximum heart rate) for eight trials, low (less than 60% VO2 max / maximum heart rate) for one trial (<LINK REF="STD-Aggel_x002d_Leijssen-2001b" TYPE="STUDY">Aggel-Leijssen 2001b</LINK>), and not specified for two trials (<LINK REF="STD-Stensel-1994" TYPE="STUDY">Stensel 1994</LINK>; <LINK REF="STD-Wing-1998" TYPE="STUDY">Wing 1998</LINK>). The exercise frequency was 3 to 5 days a week for all trials. Exercise duration ranged from 15 to 60 minutes with the median exercise duration per session of 45 minutes.</P>
<P>Ten trials contained groups that compared exercise to diet as weight loss interventions in people with overweight or obesity. Six trials evaluated walking or jogging, two evaluated aerobic exercise of the participants choice equivalent to brisk walking or jogging (<LINK REF="STD-Stefanick-1998" TYPE="STUDY">Stefanick 1998</LINK>; <LINK REF="STD-Pritchard-1997" TYPE="STUDY">Pritchard 1997</LINK>), one evaluated cycle ergometry (<LINK REF="STD-Cox-2004" TYPE="STUDY">Cox 2004</LINK>) and one evaluated aerobic exercise consisting of either walking, jogging, aerobics or circuit training (<LINK REF="STD-Anderssen-1996" TYPE="STUDY">Anderssen 1996</LINK>). The exercise intensity was high (greater than 60% VO2 max / maximum heart rate) for nine trials and not specified for one trial (<LINK REF="STD-Wing-1998" TYPE="STUDY">Wing 1998</LINK>). The exercise frequency was 3 to 5 days a week for nine trials and 2 to 3 days a week for one trial (<LINK REF="STD-Hellenius-1993" TYPE="STUDY">Hellenius 1993</LINK>). Exercise duration ranged from 30 to 60 minutes with the median exercise duration per session of 40 minutes. Three studies compared exercise with a low calorie diet (<LINK REF="STD-Cox-2004" TYPE="STUDY">Cox 2004</LINK>; <LINK REF="STD-Schwartz-1987" TYPE="STUDY">Schwartz 1987</LINK>; <LINK REF="STD-Schwartz-1990" TYPE="STUDY">Schwartz 1990</LINK>), three compared exercise with a low fat diet (<LINK REF="STD-Stefanick-1998" TYPE="STUDY">Stefanick 1998</LINK>; <LINK REF="STD-Anderssen-1996" TYPE="STUDY">Anderssen 1996</LINK>; <LINK REF="STD-Pritchard-1997" TYPE="STUDY">Pritchard 1997</LINK>), and four compared exercise with a low fat or low calorie diet (<LINK REF="STD-Gordon-1997" TYPE="STUDY">Gordon 1997</LINK>; <LINK REF="STD-Hellenius-1993" TYPE="STUDY">Hellenius 1993</LINK>; <LINK REF="STD-Wing-1998" TYPE="STUDY">Wing 1998</LINK>; <LINK REF="STD-Wood-1988" TYPE="STUDY">Wood 1988</LINK>).</P>
<P>Seventeen trials contained groups that compared exercise in combination with diet to diet alone as weight loss interventions in people with overweight or obesity. Eight trials evaluated walking or jogging, two evaluated cycle ergometry (<LINK REF="STD-Cox-2004" TYPE="STUDY">Cox 2004</LINK>; <LINK REF="STD-Hays-2004" TYPE="STUDY">Hays 2004</LINK>), one evaluated step aerobics (<LINK REF="STD-Wadden-1997" TYPE="STUDY">Wadden 1997</LINK>), one cycling/walking/stair stepping (<LINK REF="STD-Ross-1996" TYPE="STUDY">Ross 1996</LINK>), one cycling or walking or aqua jogging (<LINK REF="STD-Janssen-2002" TYPE="STUDY">Janssen 2002</LINK>), one treadmill exercise or cycling or stair stepping (<LINK REF="STD-Aggel_x002d_Leijssen-2001" TYPE="STUDY">Aggel-Leijssen 2001</LINK>), one walking in combination with weights training (<LINK REF="STD-Whatley-1994" TYPE="STUDY">Whatley 1994</LINK>), one walking or jogging or aerobics (<LINK REF="STD-Neumark-1995" TYPE="STUDY">Neumark 1995</LINK>), one aerobic exercise in combination with weights training (<LINK REF="STD-Svendsen-1993" TYPE="STUDY">Svendsen 1993</LINK>) and one of exercise of the participants choice equivalent to brisk walking or jogging (<LINK REF="STD-Stefanick-1998" TYPE="STUDY">Stefanick 1998</LINK>). The exercise intensity was high (greater than 60% VO2 max / maximum heart rate) for 13 trials, low (lower than 60% VO2 max / maximum heart rate) for one trial (<LINK REF="STD-Janssen-2002" TYPE="STUDY">Janssen 2002</LINK>) and not specified for three trials (<LINK REF="STD-Wing-1998" TYPE="STUDY">Wing 1998</LINK>; <LINK REF="STD-Wood-1991" TYPE="STUDY">Wood 1991</LINK>; <LINK REF="STD-Stefanick-1998" TYPE="STUDY">Stefanick 1998</LINK>). The exercise frequency was greater than five days a week for two trials (<LINK REF="STD-Neumark-1995" TYPE="STUDY">Neumark 1995</LINK>; <LINK REF="STD-Thong-2000" TYPE="STUDY">Thong 2000</LINK>) and 3 to 5 days a week for 15 trials. Exercise duration ranged from 30 to 90 minutes with the median exercise duration per session of 50 minutes. A low calorie diet was used for 11 trials, a low fat diet for three trials (<LINK REF="STD-Hays-2004" TYPE="STUDY">Hays 2004</LINK>; <LINK REF="STD-Kiernan-2001" TYPE="STUDY">Kiernan 2001</LINK>; <LINK REF="STD-Stefanick-1998" TYPE="STUDY">Stefanick 1998</LINK>) and a low fat or low calorie diet for three trials (<LINK REF="STD-Gordon-1997" TYPE="STUDY">Gordon 1997</LINK>; <LINK REF="STD-Wood-1991" TYPE="STUDY">Wood 1991</LINK>; <LINK REF="STD-Wing-1998" TYPE="STUDY">Wing 1998</LINK>).</P>
<P>Eight trials contained groups that compared high with low intensity exercise stimuli as weight loss interventions in people with overweight or obesity. In seven of the eight trials subgroups of participants were also on low fat or low calorie diets. Exercise stimuli investigated included high versus low intensity walking (<LINK REF="STD-Jakicic-2003" TYPE="STUDY">Jakicic 2003</LINK>; <LINK REF="STD-Leutholtz-1995" TYPE="STUDY">Leutholtz 1995</LINK>), step aerobics versus increasing incidental physical activity (<LINK REF="STD-Anderson-1999" TYPE="STUDY">Anderson 1999</LINK>), cycling plus treadmill exercise plus weights training versus cycling plus treadmill exercise alone (<LINK REF="STD-Wallace-1997" TYPE="STUDY">Wallace 1997</LINK>), high versus low intensity walking plus weights training (<LINK REF="STD-Whatley-1994" TYPE="STUDY">Whatley 1994</LINK>), and treadmill exercise plus cycling plus stair stepping versus weights training (<LINK REF="STD-Janssen-2002" TYPE="STUDY">Janssen 2002</LINK>; <LINK REF="STD-Ross-1996" TYPE="STUDY">Ross 1996</LINK>). The exercise frequency was 3 to 5 days a week for all trials. Exercise duration ranged from 20 to 60 minutes in the high intensity group and 10 to 60 minutes in the low intensity group.</P>
<P>Overall, trials did not differ markedly in the degree of overweight in the patient groups. Most reported weight change as kilograms lost. Only two trials reported weight change as change in BMI alone (<LINK REF="STD-Anderssen-1996" TYPE="STUDY">Anderssen 1996</LINK>; <LINK REF="STD-Hellenius-1993" TYPE="STUDY">Hellenius 1993</LINK>). Weight entry criteria for most trials included participants with overweight as well as participants with obesity. Twenty-two trials specified weight entry criteria according to BMI (in excess of 25 for all studies except <LINK REF="STD-Anderssen-1996" TYPE="STUDY">Anderssen 1996</LINK> and <LINK REF="STD-Irwin-2003" TYPE="STUDY">Irwin 2003</LINK> which specified BMI equal or greater than 24 for inclusion). Eight trials specified weight entry criteria according to percentage overweight (all between 110% to 200% according to Metropolitan Life Insurance Tables) and five trials according to percentage body fat (all in excess of 24%). The remainder specified weight entry criteria according to waist-to-hip ratio (<LINK REF="STD-Stefanick-1998" TYPE="STUDY">Stefanick 1998</LINK>; <LINK REF="STD-Wallace-1997" TYPE="STUDY">Wallace 1997</LINK>) and kilograms overweight (<LINK REF="STD-Anderson-1999" TYPE="STUDY">Anderson 1999</LINK>; <LINK REF="STD-Jeffery-1998" TYPE="STUDY">Jeffery 1998</LINK>;<LINK REF="STD-Jeffery-2003" TYPE="STUDY">Jeffery 2003</LINK>).</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2008-10-23 13:26:48 +0200" MODIFIED_BY="Gudrun Paletta">
<P>Following an evaluation of the methods and results section of the trials, 46 were excluded from the review. These studies and their reasons for exclusion are presented in <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2008-10-23 13:27:07 +0200" MODIFIED_BY="Gudrun Paletta">
<P>The methodological quality of included studies is described in <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>. All 43 included studies had some methodological weaknesses according to the quality criteria applied. Only four studies (<LINK REF="STD-Irwin-2003" TYPE="STUDY">Irwin 2003</LINK>;<LINK REF="STD-Gillett-1987" TYPE="STUDY">Gillett 1987</LINK>; <LINK REF="STD-Stefanick-1998" TYPE="STUDY">Stefanick 1998</LINK>; <LINK REF="STD-Wood-1988" TYPE="STUDY">Wood 1988</LINK>) reported the method of randomisation. For the remaining studies it was not possible to tell whether allocation to groups was concealed. All included studies had a loss to follow-up of less than 15% as specified in the inclusion criteria for the review. Blinded outcome assessment was carried out in three studies (<LINK REF="STD-Irwin-2003" TYPE="STUDY">Irwin 2003</LINK>;<LINK REF="STD-Anderson-1999" TYPE="STUDY">Anderson 1999</LINK>; <LINK REF="STD-Wing-1988" TYPE="STUDY">Wing 1988</LINK>), the others were not clear or not done. The duration of all included studies, including follow-up, was three months or more, as specified in the inclusion criteria for the review. Twenty-five of the 41 trials were four months or less in duration.</P>
<P>Four trials suffered from potential selection bias due to the population from which the sample was selected being biased in some way. <LINK REF="STD-Anderssen-1996" TYPE="STUDY">Anderssen 1996</LINK> recruited the sample from a database of participants of a cohort study, <LINK REF="STD-Hellenius-1993" TYPE="STUDY">Hellenius 1993</LINK> recruited from a group of people newly registered to participate in a concurrent lifestyle intervention trial, the details of which were not specified, <LINK REF="STD-Svendsen-1993" TYPE="STUDY">Svendsen 1993</LINK> recruited from a database of respondents to a community survey questionnaire, the generalizability of which is unknown, and <LINK REF="STD-Pritchard-1997" TYPE="STUDY">Pritchard 1997</LINK> recruited from the staff of a national business corporation, the nature of which is unknown.</P>
<P>Many trials had small sample sizes, meaning that it would have been difficult to detect small but potentially significant differences across groups. Two trials performed intention-to-treat analyses (<LINK REF="STD-Irwin-2003" TYPE="STUDY">Irwin 2003</LINK>; <LINK REF="STD-Jakicic-2003" TYPE="STUDY">Jakicic 2003</LINK>). Allocation concealment for all trials was categorised as 'B', indicating that one or more criteria were not met.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2008-10-23 13:27:50 +0200" MODIFIED_BY="Gudrun Paletta">
<P>A summary table 'Summary of main findings from comparisons for each outcome', outlining the changes in outcome measures within each of the comparison groups, is provided in <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>, original data for all outcomes in <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="3">Primary outcomes</HEADING>
<P>No data were identified on mortality, morbidity, adverse events or quality of life among the trials included in this review.</P>
<P>
<B>
<I>Weight</I>
</B>
<BR/>The effects of interventions on between-group change in weight and body mass index (BMI) are shown in 'Comparisons 01 and 02'. Due to heterogeneity of interventions and comparisons, we believed it appropriate to obtain pooled estimates for only two groups of trials assessing weight: exercise and diet versus diet alone, and high versus low intensity exercise without dietary change; and one group of trials assessing BMI: exercise and diet versus diet alone.</P>
<P>In the group exercise plus diet versus diet alone fourteen trials involving 1049 participants included data regarding weight loss that were suitable for meta-analysis. Participants in both groups lost weight across trials. The pooled effect for interventions with a follow-up between 3 and 12 months was a reduction in weight of 1.1 kg (95% confidence interval (CI), 0.6 to 1.5) in the exercise and diet group compared with the diet alone group. Five trials involving 452 participants included data regarding change in BMI that were suitable for meta-analysis. Participants in both groups reduced BMI. The pooled effect for interventions was a reduction in BMI of 0.4 kg/m<SUP>2</SUP> (95% CI, 0.1 to 0.7) in the exercise and diet group compared with the diet alone group.</P>
<P>In the high versus low intensity exercise without dietary change group weight loss data from four trials involving 317 participants were pooled. All trials favoured high intensity exercise for weight loss. The pooled effect for interventions with a follow-up between 3.5 and 12 months was a reduction in weight of 1.5 kg (95% CI, 0.7 to 2.3) in the high intensity exercise group compared with the low intensity exercise group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Secondary outcomes</HEADING>
<P>
<B>
<I>Systolic blood pressure</I>
</B>
<BR/>Pooled estimates of between-group changes in systolic blood pressure could be estimated for two groups of trials: exercise versus diet and exercise and diet versus diet alone (Comparisons 02.03 and 03.03). Four trials involving 361 participants compared change in systolic blood pressure with exercise versus diet. All trials favoured diet over exercise for reduction in systolic blood pressure. Participants who dieted reduced systolic blood pressure 2 mmHg (95% CI, 0.3 to 4) more than participants who exercised (P = 0.02). Six trials involving 615 participants compared change in systolic blood pressure with exercise and diet versus diet alone. Both groups reduced systolic blood pressure and no statistically significant difference between groups was demonstrated (P = 0.87).</P>
<P>
<B>
<I>Diastolic blood pressure</I>
</B>
<BR/>Pooled estimates of between-group changes in diastolic blood pressure could be estimated for two groups of trials: exercise versus no treatment, and exercise versus diet (Comparisons 01.04 and 02.04). In the two trials that involved 259 participants and compared change in diastolic blood pressure with exercise versus no treatment, participants who exercised reduced diastolic blood pressure 2 mmHg (95% CI, 1 to 4) more than no treatment (P = 0.01). In the four trials that involved 361 participants and compared diet and exercise for reducing diastolic blood pressure, there was no significant difference between interventions (P = 0.19). Both interventions resulted in clinically significant reductions in diastolic blood pressure.</P>
<P>
<B>
<I>Serum cholesterol</I>
</B>
<BR/>There was one group of trials where pooled estimates of between-group changes in serum cholesterol could be estimated: exercise versus no treatment (Comparison 01.05). Participants who exercised did not reduce their serum cholesterol significantly more than those with no treatment in the three trials, involving 348 participants, that compared the two groups (P = 0.65).</P>
<P>
<B>
<I>Serum triglycerides</I>
</B>
<BR/>There were three groups of trials where pooled estimates of between-group changes in triglycerides could be estimated: exercise and diet versus diet alone, high versus low intensity exercise with dietary change, and exercise versus no treatment (Comparisons 01.06, 03.06 and 04.06). No statistically significant difference between interventions was observed for exercise and diet versus diet alone (six trials, 619 participants) (P = 0.12) or high versus low intensity exercise with dietary change (two trials, 65 participants) (P = 0.98). Serum triglycerides were reduced by each intervention and across trials. In the third group of three trials involving 348 participants, people who exercised reduced serum triglycerides by 0.2 mmol/L (95% CI, 0.1 to 0.3) more than those with no treatment (P &lt; 0.01).</P>
<P>
<B>
<I>Serum high-density lipoprotein (HDL)</I>
</B>
<BR/>There was one group of trials where pooled estimates of between-group changes in serum HDL were able to be estimated: high versus low intensity exercise with dietary change (Comparison 4.7: Comparisons and Data). Rather than increasing HDL, both high and low intensity exercise were associated with reduced HDL across trials. Low intensity exercise was associated with a greater reduction than high intensity exercise however this difference was not statistically significant (two trials, 65 participants) (P = 0.48).</P>
<P>
<B>
<I>Fasting serum glucose</I>
</B>
<BR/>There were four groups of trials where pooled estimates of between-group changes in fasting serum glucose could be estimated: exercise and diet versus diet alone, high versus low intensity exercise without dietary change, exercise versus no treatment, and exercise versus diet (Comparisons 01.08, 02.08, 03.08 and 05.06). Exercise reduced fasting serum glucose by 0.2 mmol/L (95% CI, 0.1 to 0.3) compared with no treatment (two trials, 273 participants) (P = 0.006). High intensity exercise reduced fasting serum glucose by 0.3 mmol/L (95% CI, 0.2 to 0.5) more than low intensity exercise (two trials, 46 participants) (P &lt; 0.01). When diet and exercise were compared, diet resulted in an 0.1 mmol/L (95% CI, 0.0 to 0.2) greater reduction in fasting serum glucose than exercise (three trials, 354 participants). However, there was no statistically significant difference between diet and exercise versus diet in reducing fasting serum glucose (P = 0.82). Both interventions resulted in reduced fasting serum glucose.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Subgroup analyses</HEADING>
<P>The number of trials available for subgroup analysis was limited for most outcomes except for weight loss in the exercise and diet versus diet only group of trials. The pooled results from this group of trials demonstrated a small but statistically significant effect when the results of a large number of trials were pooled. Subgroup analysis by sex and age could performed. Analysis by sex did no show relevant changes in pooled estimates. Analysis by age demonstrated that the pooled effect for studies with a mean age of participants of less than 45 years was a reduction in weight of 1.6 kg (95% CI, 0.6 to 2.6) in the exercise and diet group compared with the diet alone group, and the pooled effect for studies with a mean age of participants of greater than 45 years was a reduction in weight of 1.0 kg (95%CI, 1.3 to 0.7) in the exercise and diet group compared with the diet alone group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Sensitivity analyses</HEADING>
<P>Because most trials reported similar components of quality that were assessed (method of randomisation, allocation concealment, and blinding of the assessor), we could not examine the effects of these variables on outcomes.<BR/>
<B>
<BR/>Publication and small study bias</B>
<BR/>Publication bias was examined with the use of a funnel plot. The funnel plot for weight change (14 studies) did not suggest the presence of small study bias (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>).</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2008-10-19 16:22:39 +0200" MODIFIED_BY="Gudrun Paletta">
<SUMMARY_OF_RESULTS MODIFIED="2008-10-19 16:22:39 +0200" MODIFIED_BY="Gudrun Paletta">
<P>The findings of this study demonstrate that exercise has a positive effect on body weight in people with overweight and obesity. Although exercise alone improved weight loss only marginally compared with no treatment in this study, when combined with dietary interventions, the amount of weight loss achieved with exercise increased substantially. These findings are consistent with previous reviews (<LINK REF="REF-Miller-1997" TYPE="REFERENCE">Miller 1997</LINK>; <LINK REF="REF-McTigue-2003" TYPE="REFERENCE">McTigue 2003</LINK>; <LINK REF="REF-Douketis-2005" TYPE="REFERENCE">Douketis 2005</LINK>) that demonstrate only modest (less than five kg) weight loss with exercise alone as a weight loss intervention, and improved weight loss with diet and exercise compared with exercise alone.</P>
<P>An assessment of the effect of exercise intensity on weight loss was an important part of this study. Numerous trials have shown that an inverse association between body weight and physical activity exists (<LINK REF="REF-Coakley-1998" TYPE="REFERENCE">Coakley 1998</LINK>; <LINK REF="REF-DiPietro-1998" TYPE="REFERENCE">DiPietro 1998</LINK>; <LINK REF="REF-King-2001" TYPE="REFERENCE">King 2001</LINK>; <LINK REF="REF-Swinburn-2004" TYPE="REFERENCE">Swinburn 2004</LINK>). However, most of these trials have assessed the effect of vigorous activity on body weight. The benefits of moderate and light intensity activity on body weight have been less extensively evaluated (<LINK REF="REF-Stewart-1997" TYPE="REFERENCE">Stewart 1997</LINK>; <LINK REF="REF-Westerterp-2001" TYPE="REFERENCE">Westerterp 2001</LINK>; <LINK REF="REF-Dionne-2003" TYPE="REFERENCE">Dionne 2003</LINK>). There is some evidence that moderate exercise such as walking, is no more effective than light exercise, such as calisthenics and stretching, as part of a weight loss programme (<LINK REF="STD-Jakicic-1995" TYPE="STUDY">Jakicic 1995</LINK>; <LINK REF="STD-Ross-1996" TYPE="STUDY">Ross 1996</LINK>). The results of this study support the hypothesis that vigorous activity is more effective than moderate or light intensity exercise in inducing weight loss. In this study high and low intensity exercise were associated with weight loss, both when combined with dietary weight loss methods and when undertaken without dietary change.</P>
<P>However, high intensity exercise was only significantly better than low intensity exercise at inducing weight loss when undertaken without dietary change. When diet was also modified, exercise intensity did not significantly affect the degree of weight loss. It is possible that this occurred because when exercise is combined with diet, the effect of exercise intensity on the magnitude of weight loss is outweighed by the effects of the dietary intervention.</P>
<P>Diet was demonstrated to be significantly more effective at facilitating weight loss than exercise in this meta-analysis. Both low calorie and low fat diets were used as comparison dietary interventions across clinical trials. Each was more effective at facilitating weight loss than exercise alone. This is consistent with the findings of other studies that also demonstrate dietary modification is superior to exercise in attaining weight loss in overweight and obese adults (<LINK REF="REF-Curioni-2005" TYPE="REFERENCE">Curioni 2005</LINK>; <LINK REF="REF-Hansen-2005" TYPE="REFERENCE">Hansen 2005</LINK>). It thus appears that dietary interventions are a more potent method for creating an energy imbalance than physical activity interventions.</P>
<P>A strength of this study compared with other systematic reviews and meta-analyses of exercise and weight loss is the inclusion of cardiovascular disease (CVD) risk factors as outcome measures for analyses (<LINK REF="REF-Miller-1997" TYPE="REFERENCE">Miller 1997</LINK>; <LINK REF="REF-McTigue-2003" TYPE="REFERENCE">McTigue 2003</LINK>; <LINK REF="REF-Douketis-2005" TYPE="REFERENCE">Douketis 2005</LINK>). Positive effects on CVD risk factors were demonstrated with exercise interventions in overweight and obese adults in this study. Those who participated in exercise interventions alone reduced systolic and diastolic blood pressure, cholesterol, triglycerides and fasting serum glucose. They also increased HDL levels. The changes that were statistically significant compared with no treatment were changes in diastolic blood pressure, triglycerides, HDL and glucose.</P>
<P>These changes were independent of significant weight loss. Weight loss does not appear to uniformly improve cardiovascular risk factors, particularly if 5% or less body weight reduction (<LINK REF="REF-Douketis-2005" TYPE="REFERENCE">Douketis 2005</LINK>). However, RCTs have demonstrated that exercise improves risk factors for CVD in adult populations (<LINK REF="REF-Campbell-1997" TYPE="REFERENCE">Campbell 1997</LINK>; <LINK REF="REF-Hu-1999" TYPE="REFERENCE">Hu 1999</LINK>; <LINK REF="REF-Hu-2000" TYPE="REFERENCE">Hu 2000</LINK>). The findings of this study indicate that the benefit of exercise on cardiovascular risk factors extends to adults with overweight and obesity.</P>
<P>Exercise combined with diet also has a positive effect on cardiovascular risk factors. Consistent with previous research, participants in this study who combined exercise with diet reduced systolic and diastolic blood pressure, serum cholesterol and triglycerides, and fasting serum glucose. However, when directly compared, exercise combined with diet was no more effective in reducing the above cardiovascular risk factors than diet alone.</P>
<P>The reason for this finding is uncertain. Both diet and physical activity are known to improve risk factors for CVD in adults (<LINK REF="REF-Rossner-2001" TYPE="REFERENCE">Rossner 2001</LINK>; <LINK REF="REF-Schubert-2006" TYPE="REFERENCE">Schubert 2006</LINK>). It was therefore hypothesized that the effects of each on CVD risk would be additive and that a combination of both interventions would have greater efficacy than diet alone. It is possible that participants in the diet only group also increased physical activity levels as a result of study participation. Alternatively, the study may have had insufficient power to demonstrate an additive effect. The effect of diet was greater than the effect of exercise on numerous CVD risk factors. Diet may have therefore masked the effect of exercise on CVD risk factors between comparison groups.</P>
<P>Both high and low intensity exercise resulted in reduced systolic blood pressure and serum triglycerides. However, high intensity exercise had a greater positive effect on fasting serum glucose than low intensity exercise, suggesting that exercise intensity affects the magnitude of the health benefit of the exercise undertaken. It has previously been proposed that a threshold of vigorous activity volume exists which has to be reached to affect CVD risk in adults (<LINK REF="STD-Cox-2003" TYPE="STUDY">Cox 2003</LINK>). Results of this study support this hypothesis and suggest that this threshold may also exist in overweight and obese adults.</P>
<SUBSECTION>
<HEADING LEVEL="3">Limitations of the review</HEADING>
<P>A limitation of this systematic review is the paucity of long-term trials available for inclusion in the analyses. Most people lose weight initially and then regain it over time (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>). Thus, without longer term trials, the true effect of exercise on body weight is difficult to determine. Also, without long-term trials, the effects of exercise on mortality are difficult to determine. The results of this study demonstrated that exercise was associated with improvement in CVD risk factors. However, the effect of exercise on disease endpoints such as myocardial infarction, cerebro-vascular accident and type 2 diabetes could not be demonstrated. Without long-term trials it is assumed, but not definite, that exercise will also have positive impacts on these end-points.</P>
<P>Also, a large number of studies were excluded from analysis due to the relatively large losses to follow-up. This was done because if studies with large losses to follow-up were included in the analyses, valid conclusions about the relative efficacy of exercise interventions could not be drawn. Although this is a valid justification to exclude studies with large losses to follow-up, the negative effect of doing so is to reduce the power of meta-analyses.</P>
</SUBSECTION>
</SUMMARY_OF_RESULTS>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE>
<P>This review suggests that exercise is an effective weight loss intervention, particularly when combined with dietary interventions. Exercise is also an effective intervention for improving a range of secondary outcomes even when weight loss does not occur. While this review did not show any long-term morbidity and mortality benefits associated with exercise, exercise was shown to positively impact the intermediate outcomes that are commonly associated with cardiovascular disease.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>A large amount of research has been undertaken to assess the effects of exercise on weight loss in people who are overweight or obese. Exercise stimuli that have been studied include walking, jogging, weights training, stationary cycling, aerobics, ball games, calisthenics and stair stepping. Further studies could assess alternative exercise stimuli such as increased incidental physical activity and water based activities. Every effort should be made to maintain high retention rates in trials, and reasons for withdrawal should be ascertained so that factors affecting exercise adherence can be further explored. Studies with longer duration of follow-up would provide further information regarding the long-term health effects of regular physical activity in people who are overweight or obese. </P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>The authors gratefully acknowledge the contribution of Ms Fiona Tito from the Cochrane Consumer Review Group for her invaluable assistance in preparation of the protocol of this review. We also wish to acknowledge the assistance of Dr Sandi Pirozzo and Professor Paul Glasziou in providing advice regarding analysis of results.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS>
<P>KELLY SHAW: Protocol development, literature search, assessment of trials and data extraction. Was also the principal reviewer performing the analysis and interpretation of data, as well as the development of the final review.</P>
<P>HANNI GENNAT: Assessment of trials, data extraction, data entry, quality scoring of trials.</P>
<P>PETER O'ROURKE: Resolution of differences of opinion between reviewers, statistical analysis, assistance in interpretation of data and development of the final review.</P>
<P>CHRISTOPHER DEL MAR: Assessment of trials and data extraction, assistance in development of the final review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2008-10-23 13:20:01 +0200" MODIFIED_BY="Gudrun Paletta">
<P>OBJECTIVE: Changed from 'regular physical activity' to 'exercise'; add 'overweight' to 'obesity'</P>
<P>TYPES OF STUDIES: Add 'loss to follow-up of less than 15%'; delete 'quasi-randomised trials'</P>
<P>TYPES OF OUTCOME MEASURES: Delete from additional outcome measures 'VO2max' and 'cost'; delete 'relapse'; timing of outcome assessment changed to 'duration including follow-up of three months or more were included'</P>
<P>METHODS OF THE REVIEW: Change second reviewer from CDM to HCG for quality assessment of trials, data extraction, data entry; change third reviewer from FT to POR for resolving differences of opinion</P>
<P>DATA ANALYSIS: Dichotomous data not identified therefore relative risk omitted; heterogeneity explored using I-squared in addition to chi-squared</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2008-10-23 13:19:42 +0200" MODIFIED_BY="Gudrun Paletta"/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2008-10-03 12:20:11 +0200" MODIFIED_BY="[Empty name]">
<STUDIES>
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Aggel_x002d_Leijssen-2001" NAME="Aggel-Leijssen 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van Aggel-Leijssen D, Saris W, Hul G, van Baak M</AU>
<TI>Short-term effects of weight loss with or without low-intensity exercise training on fat metabolism in obese men</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2001</YR>
<VL>73</VL>
<PG>523-531</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Aggel_x002d_Leijssen-2001b" NAME="Aggel-Leijssen 2001b" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van Aggel-Leijssen D, Saris W, Wagenmakers A, Jul G, van Baak M</AU>
<TI>The effect of low-intensity exercise training on fat metabolism of obese women</TI>
<SO>Obesity Research</SO>
<YR>2001</YR>
<VL>9</VL>
<NO>2</NO>
<PG>86-96</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Aggel_x002d_Leijssen-2002" NAME="Aggel-Leijssen 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aggel-Leijssen D, Saris W, Wagenmakers A, Senden J, Van Baak M</AU>
<TI>Effect of exercise training at different intensities on fat metabolism of obese men</TI>
<SO>Journal of Applied Physiology</SO>
<YR>2002</YR>
<VL>92</VL>
<PG>1300-1309</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Anderson-1999" NAME="Anderson 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Anderson R, Wadden T, Bartlett S, Zemel B et al</AU>
<TI>Effects of lifestyle activity vs structured aerobic exercise in obese women: A randomized trial</TI>
<SO>Journal of the American Medical Association</SO>
<YR>1999</YR>
<VL>281</VL>
<NO>4</NO>
<PG>335-340</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Anderssen-1996" NAME="Anderssen 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Anderssen S, Hjermann I, Urdal P, Torjesen P, Holme I</AU>
<TI>Improved carbohydrate metabolism after physical training and dietary intervention in individuals with the 'atherothrombogenic syndrome'. Oslo Diet and Exercise Study (ODES). A randomized trial</TI>
<SO>Journal of Internal Medicine</SO>
<YR>1996</YR>
<VL>240</VL>
<PG>203-209</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Balkestein-1999" NAME="Balkestein 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Balkestein E, van Aggel-Leijssen D, van Baak M, Struijker-Boudier H, van Bortel L</AU>
<TI>The effect of weight loss with or without exercise training on large artery compliance in health obese men</TI>
<SO>Journal of Hypertension</SO>
<YR>1999</YR>
<VL>17</VL>
<PG>1831-1835</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cox-1996" NAME="Cox 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cox K, Puddey I, Morton A, Burke V, Beilin L, McAleer M</AU>
<TI>Exercise and weight control in sedentary overweight men: effects on clinic and ambulatory blood pressure</TI>
<SO>Journal of Hypertension</SO>
<YR>1996</YR>
<VL>14</VL>
<PG>779-790</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cox-2004" NAME="Cox 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cox K, Burke V, Morton A, Beilin L, Puddey I</AU>
<TI>Independent and additive effects of energy restriction and exercise on glucose and insulin concentrations in sedentary overweight men</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2004</YR>
<VL>80</VL>
<PG>308-316</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gillett-1987" NAME="Gillett 1987" YEAR="1987">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gillett P, Eisenman P</AU>
<TI>The effect of intensity controlled aerobic dance exercise on aerobic capacity of middle-aged, overweight women</TI>
<SO>Research in Nursing and Health</SO>
<YR>1987</YR>
<VL>10</VL>
<PG>383-390</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gordon-1997" NAME="Gordon 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gordon N, Scott C, Levine B</AU>
<TI>Comparison of single versus multiple lifestyle interventions: are the antihypertensive effects of exercise training and diet-induced weight loss additive?</TI>
<SO>American Journal of Cardiology</SO>
<YR>1997</YR>
<VL>79</VL>
<PG>763-767</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hays-2004" NAME="Hays 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hays N, Starling R, Liu X, Sullivan D, Trappe T, Fluckey J, Evans W</AU>
<TI>Effects of an ad libitum low-fat, high-carbohydrate diet on body weight, body composition, and fat distribution in older men and women</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2004</YR>
<VL>164</VL>
<PG>210-217</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hellenius-1993" NAME="Hellenius 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hellenius M, Faire U, Berglund B, Hamsten A, Krakau I</AU>
<TI>Diet and exercise are equally effective in reducing risk for cardiovascular disease. Results of a randomized controlled study in men with slightly to moderately raised cardiovascular risk factors</TI>
<SO>Atherosclerosis</SO>
<YR>1993</YR>
<VL>103</VL>
<PG>81-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Irwin-2003" NAME="Irwin 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Irwin M, Yasui Y, Ulrich C, Bowen D, Rudolph R, Schwartz R, Yukawa M, Aiello E, Potter J, McTiernan A</AU>
<TI>Effect of exercise on total and intra-abdominal body fat in postmenopausal women: a randomized controlled trial</TI>
<SO>Journal of the American Medical Association</SO>
<YR>2003</YR>
<VL>289</VL>
<NO>3</NO>
<PG>323-330</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jakicic-1995" NAME="Jakicic 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jakicic J, Wing R, Butler B, Robertson R</AU>
<TI>Prescribing exercise in multiple short bouts versus one continuous bout: effects on adherence, cardiorespiratory fitness, and weight loss in overweight women</TI>
<SO>International Journal of Obesity</SO>
<YR>1995</YR>
<VL>19</VL>
<PG>893-901</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jakicic-2003" NAME="Jakicic 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jakicic J, Marcus B, Gallagher K, Napolitano M, Lang W</AU>
<TI>Effect of exercise duration and intensity on weight loss in overweight, sedentary women: a randomized trial</TI>
<SO>Journal of the American Medical Association</SO>
<YR>2003</YR>
<VL>290</VL>
<NO>10</NO>
<PG>1323-1330</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Janssen-2002" NAME="Janssen 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Janssen I, Fortier A, Hudson R, Ross R</AU>
<TI>Effects of an energy-restrictive diet with or without exercise on abdominal fat, intermuscular fat, and metabolic risk factors in obese women</TI>
<SO>Diabetes Care</SO>
<YR>2002</YR>
<VL>25</VL>
<NO>3</NO>
<PG>431-438</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jeffery-1998" NAME="Jeffery 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jeffery R, Thorson C, Wing R, Burton L</AU>
<TI>Use of personal trainers and financial incentives to increase exercise in a behavioral weight-loss program</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>1998</YR>
<VL>66</VL>
<NO>5</NO>
<PG>777-783</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jeffery-2003" NAME="Jeffery 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jeffery R, Wing R, Sherwood N, Tate D</AU>
<TI>Physical activity and weight loss: does prescribing higher physical activity goals improve outcome?</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2003</YR>
<VL>78</VL>
<PG>684-689</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kiernan-2001" NAME="Kiernan 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kiernan M, King A, Stefanick M, Killen J</AU>
<TI>Men gain additional psychological benefits by adding exercise to a weight loss program</TI>
<SO>Obesity Research</SO>
<YR>2001</YR>
<VL>9</VL>
<NO>12</NO>
<PG>770-777</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Leutholtz-1995" NAME="Leutholtz 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leutholtz B, Keyser R, Heusner W, Wendt V, Rosen L</AU>
<TI>Exercise training and severe caloric restriction: Effect on lean body mass in the obese</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>1995</YR>
<VL>76</VL>
<PG>65-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Manning-1991" NAME="Manning 1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Manning J, Dooly-Manning C, White K, Kampa I, Silas S, Kesselhaut M, Ruoff M</AU>
<TI>Effects of a resistive training program on lipoprotein-lipid levels in obese women</TI>
<SO>Medicine and Science in Sports and Exercise</SO>
<YR>1991</YR>
<VL>23</VL>
<NO>11</NO>
<PG>1222-1226</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Neumark-1995" NAME="Neumark 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Neumark-Sztainer D, Kaufmann N, Berry E</AU>
<TI>Physical activity within a community-based weight control program: Program evaluation and predictors of success</TI>
<SO>Public Health Reviews</SO>
<YR>1995</YR>
<VL>23</VL>
<PG>237-251</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nieman-1998" NAME="Nieman 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nieman D, Nehlsen-Cannarella S, Henson D, Koch A, Butterworth D, Fagoaga O, Utter A</AU>
<TI>Immune response to exercise training and / or energy restriction in obese women</TI>
<SO>Medicine and Science in Sports and Exercise</SO>
<YR>1998</YR>
<VL>30</VL>
<NO>5</NO>
<PG>679-686</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pritchard-1997" NAME="Pritchard 1997" YEAR="1997">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Pritchard J, Nowson C, Wark J</AU>
<TI>A worksite program for overweight middle-aged men achieves lesser weight loss with exercise than with dietary change</TI>
<SO>Journal of the American Dietetic Association</SO>
<YR>1997</YR>
<VL>97</VL>
<NO>1</NO>
<PG>37-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pritchard J, Nowson C, Wark J</AU>
<TI>Bone loss accompanying diet-induced or exercise-induced weight loss: a randomised controlled study</TI>
<SO>International Journal of Obesity</SO>
<YR>1996</YR>
<VL>20</VL>
<PG>513-520</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Raz--1994" NAME="Raz  1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Raz I, Hauser E, Bursztyn M</AU>
<TI>Moderate exercise improves glucose metabolism in uncontrolled elderly patients with non-insulin-dependent diabetes mellitus</TI>
<SO>Israel Journal of Medical Science</SO>
<YR>1994</YR>
<VL>30</VL>
<PG>766-770</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ross-1996" NAME="Ross 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ross R, Rissanen J, Pedwell H, Clifford J, Shragge P</AU>
<TI>Influence of diet and exercise on skeletal muscle and visceral adipose tissue in men</TI>
<SO>Journal of Applied Physiology</SO>
<YR>1996</YR>
<VL>81</VL>
<NO>6</NO>
<PG>2445-2455</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schwartz-1987" NAME="Schwartz 1987" YEAR="1987">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schwartz R</AU>
<TI>The independent effects of dietary weight loss and aerobic training on high density lipoproteins and apolipoprotein A-I concentrations in obese men</TI>
<SO>Metabolism</SO>
<YR>1987</YR>
<VL>36</VL>
<NO>2</NO>
<PG>165-171</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schwartz-1990" NAME="Schwartz 1990" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schwartz R, Jaeger L, Veith R, Lakshminarayan S</AU>
<TI>The effect of diet or exercise on plasma norepinephrine kinetics in moderately obese young men</TI>
<SO>International Journal of Obesity</SO>
<YR>1990</YR>
<VL>14</VL>
<PG>1-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stefanick-1998" NAME="Stefanick 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stefanick M, Mackey S, Sheehan M, Ellsworth N, Haskell W, Wood P</AU>
<TI>Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol</TI>
<SO>The New England Journal of Medicine</SO>
<YR>1998</YR>
<VL>339</VL>
<NO>1</NO>
<PG>12-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stensel-1994" NAME="Stensel 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stensel D, Brooke-Wavell K, Hardman A, Jones P, Norgan N</AU>
<TI>The influence of a 1-year programme of brisk walking on endurance fitness and body composition in previously sedentary men aged 42-59 years</TI>
<SO>European Journal of Applied Physiology</SO>
<YR>1994</YR>
<VL>68</VL>
<PG>531-537</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Svendsen-1993" NAME="Svendsen 1993" YEAR="1993">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Svendsen O, Hassager C, Christiansen C</AU>
<TI>Effect of an energy-restrictive diet, with or without exercise, on lean tissue mass, resting metabolic rate, cardiovascular risk factors, and bone in overweight postmenopausal women</TI>
<SO>The American Journal of Medicine</SO>
<YR>1993</YR>
<VL>95</VL>
<PG>131-140</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Svendsen O, Krotkiewski M, Hassager C, Christiansen C</AU>
<TI>Effects on muscles of dieting with or without exercise in overweight postmenopausal women</TI>
<SO>Journal of Applied Physiology</SO>
<YR>1996</YR>
<VL>80</VL>
<PG>1365-1370</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Thong-2000" NAME="Thong 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Thong F, Hudson R, Ross R, Janssen I, Graham T</AU>
<TI>Plasma leptin in moderately obese men: independent effects of weight loss and aerobic exercise</TI>
<SO>American Journal of Physiology, Endocrinology and Metabolism</SO>
<YR>2000</YR>
<VL>279</VL>
<PG>307-313</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Utter-2000" NAME="Utter 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Utter A, Whitcomb D, Nieman D, Butterworth D, Vermillion S</AU>
<TI>Effects of exercise training on gallbladder function in an obese female population</TI>
<SO>Medicine and Science in Sports and Exercise</SO>
<YR>2000</YR>
<VL>32</VL>
<NO>1</NO>
<PG>41-49</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wadden-1997" NAME="Wadden 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wadden T, Vogt R, Andersen R, Bartlett S, Foster G, Wilk J, Kuehnel R, Weinstock R, Buckenmeyer P, Berkowitz R, Steen S</AU>
<TI>Exercise in the treatment of obesity: effects of four interventions on body composition, resting energy expenditure, appetite and mood</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>1997</YR>
<VL>65</VL>
<NO>2</NO>
<PG>269-277</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wallace-1997" NAME="Wallace 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wallace M, Mills B, Browning C</AU>
<TI>Effects of cross-training on markers of insulin resistance / hyperinsulinemia</TI>
<SO>Medicine and Science in Sports and Exercise</SO>
<YR>1997</YR>
<VL>29</VL>
<NO>9</NO>
<PG>1170-1175</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Whatley-1994" NAME="Whatley 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Whatley J, Gillespie W, Honig J, Walsh M, Blackburn A, Blackburn G</AU>
<TI>Does the amount of endurance exercise in combination with weight training and a very-low-energy diet affect resting metabolic rate and body composition?</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1994</YR>
<VL>59</VL>
<PG>1088-1092</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wing-1988" NAME="Wing 1988" YEAR="1988">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wing R, Epstein L, Paternostro-Bayles M, Kriska A, Nowalk M, Gooding W</AU>
<TI>Exercise in a behavioural weight control programme for obese patients with Type 2 (non-insulin-dependent) diabetes</TI>
<SO>Diabetologia</SO>
<YR>1988</YR>
<VL>31</VL>
<PG>902-909</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wing-1998" NAME="Wing 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wing R, Venditti E, Jakicic J, Polley B, Lang W</AU>
<TI>Lifestyle intervention in overweight individuals with a family history of diabetes</TI>
<SO>Diabetes Care</SO>
<YR>1998</YR>
<VL>21</VL>
<NO>3</NO>
<PG>350-360</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wirth-1985" NAME="Wirth 1985" YEAR="1985">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wirth A, Diehm C, Hanel W, Welte J, Vogel I</AU>
<TI>Training-induced changes in serum lipids, fat tolerance, and adipose tissue metabolism in patients with hypertriglyceridemia</TI>
<SO>Atherosclerosis</SO>
<YR>1985</YR>
<VL>54</VL>
<PG>263-271</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wood-1988" NAME="Wood 1988" YEAR="1988">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wood P, Stefanick M, Dreon D, Frey-Hewitt B, Garay S, Williams P, Superko R, Fortmann S, Albers J, Vranizan K, Ellsworth N, Terry R, Haskell W</AU>
<TI>Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise</TI>
<SO>The New England Journal of Medicine</SO>
<YR>1988</YR>
<VL>319</VL>
<NO>18</NO>
<PG>1173-1179</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wood-1991" NAME="Wood 1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wood P, Stefanick M, Williams P, Haskell W</AU>
<TI>The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women</TI>
<SO>The New England Journal of Medicine</SO>
<YR>1991</YR>
<VL>325</VL>
<NO>7</NO>
<PG>461-466</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Ades-2003" NAME="Ades 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ades P, Savage P, Cress E, Brochu M, Lee M, Poehlman E</AU>
<TI>Resistance training on physical performance in disables older female cardiac patients</TI>
<SO>Medicine and Science in Sports and Exercise</SO>
<YR>2003</YR>
<VL>35</VL>
<NO>8</NO>
<PG>1265-1270</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Aiello-2004" NAME="Aiello 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aiello E, Yutaka Y, Tworoger S, Ulrich C, Irwin M, Bowen D, Schwartz R, Kumai C, Potter J, McTiernan A</AU>
<TI>Effect of a year long, moderate-intensity exercise intervention on the occurrence and severity of menopause symptoms in postmenopausal women</TI>
<SO>Menopause</SO>
<YR>2004</YR>
<VL>11</VL>
<NO>4</NO>
<PG>382-388</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Aldred-1995" NAME="Aldred 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aldred H, Hardman A, Taylor S</AU>
<TI>Influence of 12 weeks of training by brisk walking on postprandial lipemia and insulinemia in sedentary middle-aged women</TI>
<SO>Metabolism</SO>
<YR>1995</YR>
<VL>44</VL>
<NO>3</NO>
<PG>390-397</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Asikainen-2002" NAME="Asikainen 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Asikainen T, Miilunpalo S, Oja P, Rinne M, Pasanen M, Vuori I</AU>
<TI>Walking trials in postmenopausal women: effect of one vs two daily bouts on aerobic fitness</TI>
<SO>Scandinavian Journal of Medicine and Science in Sports</SO>
<YR>2002</YR>
<VL>12(2)</VL>
<PG>99-105</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Blumenthal-2000" NAME="Blumenthal 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Blumenthal J, Sherwood A, Gullette E, Babyak M, Waugh R, Georgiades A, Craighead L et al</AU>
<TI>Exercise and weight loss reduce blood pressure in men and women with mild hypertension</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2000</YR>
<VL>160</VL>
<PG>1947-1958</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cox-2003" NAME="Cox 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cox K, Burke V, Morton A, Beilin L, Puddey I</AU>
<TI>The independent and combined effects of 16 weeks of vigorous exercise and energy restriction on men - a randomized controlled trial</TI>
<SO>Metabolism</SO>
<YR>2003</YR>
<VL>52</VL>
<NO>1</NO>
<PG>107-115</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cuff-2003" NAME="Cuff 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cuff D, Meneilly G, Martin A, Ignaszewski A, Tildesley H, Frohlich J</AU>
<TI>Effective exercise modality to reduce insulin resistance in women with type 2 diabetes</TI>
<SO>Diabetes Care</SO>
<YR>2003</YR>
<VL>26</VL>
<NO>11</NO>
<PG>2977-2982</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Donnelly-2003" NAME="Donnelly 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Donnelly J, Kirk E, Jacobsen D, Hill J, Sullivan D, Johnson S</AU>
<TI>Effects of 16 months of verified, supervised aerobic exercise on macronutrient intake in overweight men and women: the Midwest Exercise Trial</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2003</YR>
<VL>78</VL>
<PG>950-956</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dunn-1999" NAME="Dunn 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dunn A, Marcus B, Kampert J, Garcia M, et al</AU>
<TI>Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness: a randomized trial</TI>
<SO>Journal of the American Medical Association</SO>
<YR>1999</YR>
<VL>281</VL>
<PG>327-334</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dzator-2004" NAME="Dzator 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dzator J, Hendrie D, Burke V, Gianguilio N, Gillam H, Beilin L, Houghton S</AU>
<TI>A randomized trial of interactive group sessions achieved greater improvements in nutrition and physical activity at a tiny increase in cost</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2004</YR>
<VL>57</VL>
<PG>610-619</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Esposito-2003" NAME="Esposito 2003" YEAR="2003">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D</AU>
<TI>Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women</TI>
<SO>Journal of the American Medical Association</SO>
<YR>2003</YR>
<VL>289</VL>
<NO>14</NO>
<PG>1799-1804</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Esposito-2004" NAME="Esposito 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Esposito K, Giugliano F, DiPalo C, Giugliano G, Marfella R, D'Andrea F, D'Armiento M, Giugliano D</AU>
<TI>Effect of lifestyle changes on erectile dysfunction in obese men: A randomized controlled trial</TI>
<SO>Journal of the American Medical Association</SO>
<YR>2004</YR>
<VL>291</VL>
<NO>24</NO>
<PG>2978-2984</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Figueroa-2003" NAME="Figueroa 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Figueroa A, Going S, Milliken L, Blew R, Sharp S, Teixeira P, Lohman T</AU>
<TI>Effects of exercise training and hormone replacement therapy on lean and fat mass in postmenopausal women</TI>
<SO>The Journals of Gerontology</SO>
<YR>2003</YR>
<VL>58A</VL>
<NO>3</NO>
<PG>266-270</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fogelholm-2001" NAME="Fogelholm 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fogelholm G, Sievanen H, Kukkonen-Harjula T, Pasanen M</AU>
<TI>Bone mineral density during reduction, maintenance and regain of body weight in premenopausal, obese women</TI>
<SO>Osteoporosis International</SO>
<YR>2001</YR>
<VL>12</VL>
<PG>199-206</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grant-2004" NAME="Grant 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grant S, Todd K, Aitchison T, Kelly P, Stoddart D</AU>
<TI>The effects of a 12-week group exercise programme on physiological and psychological variables and function in overweight women</TI>
<SO>Public Health</SO>
<YR>2004</YR>
<VL>118</VL>
<PG>31-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hartwell-1986" NAME="Hartwell 1986" YEAR="1986">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hartwell S, Kaplan R, Wallace J</AU>
<TI>Comparison of behavioral interventions for control of type II diabetes mellitus</TI>
<SO>Behavior Therapy</SO>
<YR>1986</YR>
<VL>17</VL>
<PG>447-461</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hinderliter-2002" NAME="Hinderliter 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hinderliter A, Sherwood A, Gullette E, Babyak M et al.</AU>
<TI>Reduction of left ventricular hypertrophy after exercise and weight loss in overweight patients with mild hypertension</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2002</YR>
<VL>162</VL>
<NO>12</NO>
<PG>1333-1340</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Houmard-2003" NAME="Houmard 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Houmard J, Tanner C, Slentz C, Duscha B, McCartney J, Kraus W</AU>
<TI>Effect of the volume and intensity of exercise training on insulin sensitivity</TI>
<SO>Journal of Applied Physiology</SO>
<YR>2004</YR>
<VL>96</VL>
<PG>101-106</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Huttunen-1979" NAME="Huttunen 1979" YEAR="1979">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Huttunen J, Lansimies E, Voutilainen E, Ehnholm C, Hietanen E, Penttila I et al</AU>
<TI>Effect of moderate physical exercise on serum lipoproteins</TI>
<SO>Circulation</SO>
<YR>1979</YR>
<VL>60</VL>
<NO>6</NO>
<PG>1220-1229</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jakicic-1998" NAME="Jakicic 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jakicic J, Polley B, Wing R</AU>
<TI>Accuracy of self-reported exercise and the relationship with weight loss in overweight women</TI>
<SO>Medicine and Science in Sports and Exercise</SO>
<YR>1998</YR>
<VL>30</VL>
<NO>4</NO>
<PG>634-638</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kirk-2003" NAME="Kirk 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kirk E, Jacobsen D, Gibson C, Hill J, Donnelly J</AU>
<TI>Time course for changes in aerobic capacity and body composition in overweight men and women in response to long-term exercise: the Midwest Exercise Trial</TI>
<SO>International Journal of Obesity</SO>
<YR>2003</YR>
<VL>27</VL>
<PG>912-919</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kraemer-1997" NAME="Kraemer 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kraemer W, Volek J, Clark K, Gordon S, Incledon T, Puhl S et al</AU>
<TI>Physiological adaptations to a weight-loss dietary regimen and exercise programs in women</TI>
<SO>Journal of Applied Physiology</SO>
<YR>1997</YR>
<VL>83</VL>
<PG>270-279</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kraemer-1999" NAME="Kraemer 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kraemer W, Jeff V, Clark K, Scott G, Puhl S, Koziris P et al</AU>
<TI>Influence of exercise training on physiological and performance changes with weight loss in men</TI>
<SO>Medicine and Science in Sports and Exercise</SO>
<YR>1999</YR>
<VL>31</VL>
<NO>9</NO>
<PG>1320-1329</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lehmann-1995" NAME="Lehmann 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lehmann R, Vokac A, Miedermann K, Agosti K, Spinas G</AU>
<TI>Loss of abdominal fat and improvement of the cardiovascular risk profile by regular moderate exercise training in patients with NIDDM</TI>
<SO>Diabetologia</SO>
<YR>1995</YR>
<VL>38</VL>
<PG>1313-1319</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lejeune-2003" NAME="Lejeune 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lejeune M, van Aggel-Leijssen D, van Baak M, Westerterp-Plantenga M</AU>
<TI>Effects of dietary restraint vs exercise during weight maintenance in obese men</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>2003</YR>
<VL>57</VL>
<PG>1338-1344</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Levesque-1997" NAME="Levesque 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Levesque M, Boulay M, Bouchard C, Simoneau J</AU>
<TI>Time course of training-induced changes in maximal exercise of short duration in men and women</TI>
<SO>International Journal of Sports Medicine</SO>
<YR>1997</YR>
<VL>18</VL>
<PG>464-469</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lindstrom-2003" NAME="Lindstrom 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lindstrom J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, Uusitupa M, Tuomilehto J</AU>
<TI>The Finnish diabetes prevention study: Lifestyle intervention and 3-year results on diet and physical activity</TI>
<SO>Diabetes Care</SO>
<YR>2003</YR>
<VL>26</VL>
<NO>12</NO>
<PG>3230-3236</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Loreto-2003" NAME="Loreto 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Loreto C, Fanelli C, Lucidi P, Murdolo G, de Cicco A, Parlanti N, Santeusanio F, Brunetti P, de Feo P</AU>
<TI>Validation of a counseling stategy to promote the adoption and the maintenance of physical activity by type 2 diabetic subjects</TI>
<SO>Diabetes Care</SO>
<YR>2003</YR>
<VL>26</VL>
<NO>2</NO>
<PG>404-408</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mensink-2003" NAME="Mensink 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mensink M, Blaak E, Corpeleijn E, Saris W, deBruin T, Feskens E</AU>
<TI>Lifestyle intervention according to general recommendations improves glucose tolerance</TI>
<SO>Obesity Research</SO>
<YR>2003</YR>
<VL>11</VL>
<NO>12</NO>
<PG>1588-1596</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Messier-2000" NAME="Messier 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Messier S, Loeser R, Mitchell M, Valle G, Morgan T, Rejeski W et al</AU>
<TI>Exercise and weight loss in obese older adults with knee osteoarthritis: a preliminary study</TI>
<SO>Journal of the American Geriatric Society</SO>
<YR>2000</YR>
<VL>48</VL>
<PG>1062-1072</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nicklas-2004" NAME="Nicklas 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nicklas B, Ambrosius W, Messier S, Miller G, Penninx B, Loeser R, Palla S, Bleecker E, Pahor M</AU>
<TI>Diet-induced weight loss, exercise and chronic inflammation in older, obese adults: a randomized controlled clinical trial</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2004</YR>
<VL>79</VL>
<PG>544-551</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Okura-2003" NAME="Okura 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Okura T, Nakata Y, Tanaka K</AU>
<TI>Effects of exercise intensity on physical fitness and risk factors for coronary heart disease</TI>
<SO>Obesity Research</SO>
<YR>2003</YR>
<VL>11</VL>
<NO>9</NO>
<PG>1131-1139</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Potteiger-2003" NAME="Potteiger 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Potteiger J, Jacobsen D, Donnelly J, Hill J</AU>
<TI>Glucose and insulin responses following 16 months of exercise training in overweight adults: The Midwest Exercise Trial</TI>
<SO>Metabolism</SO>
<YR>2003</YR>
<VL>52</VL>
<NO>9</NO>
<PG>1175-1181</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Probart-1991" NAME="Probart 1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Probart C, Notelovitz M, Martin D, Khan F, Fields C</AU>
<TI>The effect of moderate aerobic exercise on physical fitness among women 70 years and older</TI>
<SO>Maturitas</SO>
<YR>1991</YR>
<VL>14</VL>
<PG>49-56</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Proper-2003" NAME="Proper 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Proper K, Hildebrandt V, Ban der Beek A, Twisk J, Van Mechelen W</AU>
<TI>Effect of individual counseling on physical activity fitness and health: A randomized controlled trial in a workplace setting</TI>
<SO>American Journal of Preventive Medicine</SO>
<YR>2003</YR>
<VL>24</VL>
<NO>3</NO>
<PG>218-226</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Racette-1995" NAME="Racette 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Racette S, Schoeller D, Kushner R, Neil K, Herling-Iaffaldano K</AU>
<TI>Effects of aerobic exercise and dietary carbohydrate on energy expenditure and body composition during weight reduction in obese women</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1995</YR>
<VL>61</VL>
<PG>486-494</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ribeiro-1984" NAME="Ribeiro 1984" YEAR="1984">
<REFERENCE NOTES="&lt;p&gt;Am Heart J. 1984 Nov;108(5):1183-9. &lt;br&gt;&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ribeiro G, Hartley H, Sherwood J, Herd J</AU>
<TI>The effectiveness of a low lipid diet and exercise in the management of coronary artery disease</TI>
<SO>American Heart Journal</SO>
<YR>1984</YR>
<VL>108 (5)</VL>
<PG>1183-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Samaras-1997" NAME="Samaras 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Samaras K, Ashwell S, Mackintosh A, Fleury A, Campbell L, Chisholm D</AU>
<TI>Will older sedentary people with non-insulin-dependent diabetes mellitus start exercising? A health promotion model</TI>
<SO>Diabetes Research and Clinical Practice</SO>
<YR>1997</YR>
<VL>37</VL>
<PG>121-128</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schmitz-2003" NAME="Schmitz 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schmitz K, Jensen M, Kugler K, Jeffery R, Leon A</AU>
<TI>Strength training for obesity prevention in midlife women</TI>
<SO>International Journal of Obesity</SO>
<YR>2003</YR>
<VL>27</VL>
<PG>326-333</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schuler-1991" NAME="Schuler 1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schuler G, Hambrecht R, Schlierf G, Niebauer J, Hauer K, Neumann J et al</AU>
<TI>Regular physical exercise and low-fat diet</TI>
<SO>Circulation</SO>
<YR>1991</YR>
<VL>86</VL>
<NO>1</NO>
<PG>1-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Slentz-2004" NAME="Slentz 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Slentz C, Duscha B, Johnson J, Ketchum K, Aiken L, Samsa G, Houmard J, Bales C, Kraus W</AU>
<TI>Effects of the amount of exercise on body weight, body composition and measures of central obesity</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2004</YR>
<VL>164</VL>
<NO>1</NO>
<PG>31-39</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stahle-2000" NAME="Stahle 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stahle A, Lindquist I, Mattsson E</AU>
<TI>Important factors for physical activity among elderly patients one year after an acute myocardial infarction</TI>
<SO>Scandanavian Journal of Rehabilitation Medicine</SO>
<YR>2000</YR>
<VL>32</VL>
<PG>111-116</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Teixeira-2003" NAME="Teixeira 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Teixeira P, Going S, Houtkooper L, Metcalfe L, Blew R, Flint-Wagner H, Cussler E, Sardinha L, Lohman T</AU>
<TI>Resistance training in postmenopausal women with and without hormone therapy</TI>
<SO>Medicine and Science in Sports and Exercise</SO>
<YR>2003</YR>
<VL>35</VL>
<NO>4</NO>
<PG>555-562</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Watkins-2003" NAME="Watkins 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Watkins L, Sherwood A, Feinglos M, Hinderliter A, Babyak M, Gullette E, Waugh R, Blumenthal J</AU>
<TI>Effects of exercise and weight loss on cardiac risk factors associated with syndrome X</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2003</YR>
<VL>163</VL>
<NO>16</NO>
<PG>1889-1895</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weinstock-1998" NAME="Weinstock 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Weinstock R, Dai H, Wadden T</AU>
<TI>Diet and exercise in the treatment of obesity: effects of 3 interventions on insulin resistance</TI>
<SO>Archives of Internal Medicine</SO>
<YR>1998</YR>
<VL>158</VL>
<NO>22</NO>
<PG>2477-2485</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yamanouchi-1995" NAME="Yamanouchi 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yamanouchi K, Shinozaki T, Chikada K, Nishikawa T, Ito K, Shimizu S et al</AU>
<TI>Daily walking combined with diet therapy is a useful means for obese NIDDM patients not only to reduce body weight but also to improve insulin sensitivity</TI>
<SO>Diabetes Care</SO>
<YR>1995</YR>
<VL>18</VL>
<NO>6</NO>
<PG>775-778</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2008-10-03 12:20:11 +0200" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2008-10-03 12:20:11 +0200" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Ballor-1991" NAME="Ballor 1991" TYPE="JOURNAL_ARTICLE">
<AU>Ballor D, Keesey R</AU>
<TI>A meta-analysis of the factors affecting exercise-induced changes in body mass, fat mass and fat-free mass in males and females</TI>
<SO>International Journal of Obesity</SO>
<YR>1991</YR>
<VL>15</VL>
<PG>717-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bouchard-1994" NAME="Bouchard 1994" TYPE="BOOK">
<AU>Bouchard C, Shephard RJ, Stephens TE</AU>
<SO>Physical activity fitness, and health: international proceedings and consensus statement</SO>
<YR>1994</YR>
<PB>Champaign, Ill, Human Kinetics Publishers</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Brownell-1986" NAME="Brownell 1986" TYPE="JOURNAL_ARTICLE">
<AU>Brownell K, Marlatt G, Lichtenstein E, Wilson G</AU>
<TI>Understanding and preventing relapse</TI>
<SO>American Psychologist</SO>
<YR>1986</YR>
<VL>41</VL>
<NO>7</NO>
<PG>765-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Campbell-1997" NAME="Campbell 1997" TYPE="JOURNAL_ARTICLE">
<AU>Campbell A, Robertson M, Gardner M, Norton R, Tilyard M, Buchner D</AU>
<TI>Randomised controlled trial of a general practice programme of home-based exercise to prevent falls in elderly women</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<PG>1065-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Coakley-1998" NAME="Coakley 1998" TYPE="JOURNAL_ARTICLE">
<AU>Coakley E, Kawachi I, Manson J, Speizer F, Willet W, Colditz G</AU>
<TI>Lower levels of physical functioning are associated with higher body weight among middle-aged and older women</TI>
<SO>International Journal of Obesity and Related Metabolic Disorders</SO>
<YR>1998</YR>
<VL>22</VL>
<PG>958-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cohen-1960" NAME="Cohen 1960" TYPE="JOURNAL_ARTICLE">
<AU>Cohen J</AU>
<TI>A coefficient of agreement for nominal scales</TI>
<SO>Educational and Psychological Measurement</SO>
<YR>1960</YR>
<VL>20</VL>
<PG>37-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cox-2003" MODIFIED="2008-10-03 12:20:02 +0200" MODIFIED_BY="[Empty name]" NAME="Cox 2003" TYPE="JOURNAL_ARTICLE">
<AU>Cox K, Burke V, Morton A, Beilin L, Puddey I</AU>
<TI>The independent and combined effects of 16 weeks of vigorous exercise and energy restriction on body mass and composition in free-living overweight men--a randomized controlled trial</TI>
<SO>Metabolism: clinical and experimental</SO>
<YR>2003</YR>
<VL>52</VL>
<PG>107-15</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Curioni-2005" NAME="Curioni 2005" TYPE="JOURNAL_ARTICLE">
<AU>Curioni C, Lourenco P</AU>
<TI>Long-term weight loss after diet and exercise: a systematic review</TI>
<SO>International Journal of Obesity</SO>
<YR>2005</YR>
<VL>29</VL>
<PG>1168-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Despres-1994" NAME="Despres 1994" TYPE="JOURNAL_ARTICLE">
<AU>Despres J</AU>
<TI>Dyslipidaemia and obesity</TI>
<SO>Ballieres Clinical Endocrinology and Metabolism</SO>
<YR>1994</YR>
<VL>8</VL>
<PG>629-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dionne-2003" NAME="Dionne 2003" TYPE="JOURNAL_ARTICLE">
<AU>Dionne I, Ades P, Poehlman E</AU>
<TI>Impact of cardiovascular fitness and physical activity level on health outcomes in older persons</TI>
<SO>Mechanisms of Ageing and Development</SO>
<YR>2003</YR>
<VL>124</VL>
<PG>259-67</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-DiPietro-1998" NAME="DiPietro 1998" TYPE="JOURNAL_ARTICLE">
<AU>DiPietro L, Kohl H, Barlow C, Blair S</AU>
<TI>Improvements in cardiorespiratory fitness attenuate age-related weight gain in healthy men and women: The Aerobics Center Longitudinal Study</TI>
<SO>International Journal of Obesity</SO>
<YR>1998</YR>
<VL>22</VL>
<PG>55-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Douketis-2005" NAME="Douketis 2005" TYPE="JOURNAL_ARTICLE">
<AU>Douketis J, Macie C, Thabane L, Williamson D</AU>
<TI>Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice</TI>
<SO>International Journal of Obesity</SO>
<YR>2005</YR>
<VL>29</VL>
<PG>1153-67</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger G, Swinburne B</AU>
<TI>An "ecological" approach to the obesity pandemic</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<NO>7106</NO>
<PG>477-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Foreyt-1995" NAME="Foreyt 1995" TYPE="JOURNAL_ARTICLE">
<AU>Foreyt J, Brunner R, Goodrich G, St Jeor S, Miller G</AU>
<TI>Psychological correlates of reported physical activity in normal-weight and obese adults: the Reno diet-heart study</TI>
<SO>International Journal of Obesity and Related Metabolic Disorders</SO>
<YR>1995</YR>
<VL>19 (suppl 4)</VL>
<PG>S69-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Garrow-1995" NAME="Garrow 1995" TYPE="JOURNAL_ARTICLE">
<AU>Garrow J, Summerbell C</AU>
<TI>Meta-analysis: effect of exercise, with or without dieting, on the body composition of overweight subjects</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>1995</YR>
<VL>49</VL>
<PG>1-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hansen-2005" NAME="Hansen 2005" TYPE="JOURNAL_ARTICLE">
<AU>Hansen K, Shriver T, Schoeller D</AU>
<TI>The effects of exercise on the storage and oxidation of dietary fat</TI>
<SO>Sports Medicine</SO>
<YR>2005</YR>
<VL>35</VL>
<PG>363-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>Higgins J, Thompson S, Deeks J, Altman D</AU>
<TI>Measuring inconsistency in meta-analysis</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<PG>556-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hu-1999" NAME="Hu 1999" TYPE="JOURNAL_ARTICLE">
<AU>Hu F, Sigal R, Rich-Edwards J</AU>
<TI>Walking compared with vigorous physical activity and risk of type 2 diabetes in women</TI>
<SO>JAMA</SO>
<YR>1999</YR>
<VL>182</VL>
<PG>1433-39</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hu-2000" NAME="Hu 2000" TYPE="JOURNAL_ARTICLE">
<AU>Hu F, Stampfer M, Colditz G</AU>
<TI>Physical activity and risk of stroke in women</TI>
<SO>JAMA</SO>
<YR>2000</YR>
<VL>283</VL>
<PG>2961-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jadad-1996" NAME="Jadad 1996" TYPE="JOURNAL_ARTICLE">
<AU>Jadad A, Moore A, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ et al</AU>
<TI>Assessing the quality of reports of randomized clinical trials: is blinding necessary?</TI>
<SO>Controlled Clinical Trials</SO>
<YR>1996</YR>
<VL>17</VL>
<PG>1-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-King-2001" NAME="King 2001" TYPE="JOURNAL_ARTICLE">
<AU>King G, Fitzhugh E, Basset D, McLaughlin J, Strath S, Swartz A</AU>
<TI>Relationship of leisure-time physical activity and occupational activity to the prevalence of obesity</TI>
<SO>International Journal of Obesity</SO>
<YR>2001</YR>
<VL>25</VL>
<PG>606-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Liao-2000" NAME="Liao 2000" TYPE="JOURNAL_ARTICLE">
<AU>Liao K</AU>
<TI>Cognitive-behavioural approaches and weight management: an overview</TI>
<SO>Journal of the Royal Society of Health</SO>
<YR>2000</YR>
<VL>120</VL>
<NO>1</NO>
<PG>27-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McTigue-2003" NAME="McTigue 2003" TYPE="JOURNAL_ARTICLE">
<AU>McTigue K, Harris R, Hemphill B, Lux L, Sutton S, Bunton A</AU>
<TI>Screening and interventions for obesity in adults: summary of the evidence for the US preventive services taskforce</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2003</YR>
<VL>139</VL>
<PG>933-49</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Miller-1997" NAME="Miller 1997" TYPE="JOURNAL_ARTICLE">
<AU>Miller W, Koceja D, Hamilton E</AU>
<TI>A meta-analysis of the past 25 years of weight loss research using diet, exercise or diet plus exercise intervention</TI>
<SO>International Journal of Obesity and Related Metabolic Disorders</SO>
<YR>1997</YR>
<VL>21</VL>
<PG>941-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moher-1999" NAME="Moher 1999" TYPE="JOURNAL_ARTICLE">
<AU>Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF</AU>
<TI>Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses</TI>
<SO>Lancet</SO>
<YR>1999</YR>
<VL>354</VL>
<NO>9193</NO>
<PG>1896-900</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Montoye-1972" NAME="Montoye 1972" TYPE="JOURNAL_ARTICLE">
<AU>Montoye H, Metzner H, Keller J, Johnson B, Epstein F</AU>
<TI>Habitual physical activity and blood pressure</TI>
<SO>Medicine Science Sports and Exercise</SO>
<YR>1972</YR>
<VL>4</VL>
<PG>175-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-NHLBI-1998" NAME="NHLBI 1998" TYPE="BOOK">
<AU>National Heart Lung and Blood Institute</AU>
<SO>Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report</SO>
<YR>1998</YR>
<PB>National Institute of Health</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-NHMRC-1997" NAME="NHMRC 1997" TYPE="BOOK">
<AU>National Health and Medical Research Council</AU>
<SO>Acting on Australia's weight: a strategic plan for the prevention of overweight and obesity</SO>
<YR>1997</YR>
<PB>Australian Government Publishing Services</PB>
<CY>Springfield</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Paffenbarger-1983" NAME="Paffenbarger 1983" TYPE="JOURNAL_ARTICLE">
<AU>Paffenbarger R, Wing A, Hyde R, Jung D</AU>
<TI>Physical activity and incidence of hypertension in college alumni</TI>
<SO>American Journal of Epidemiology</SO>
<YR>1983</YR>
<VL>117</VL>
<PG>245-57</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rossner-2001" NAME="Rossner 2001" TYPE="JOURNAL_ARTICLE">
<AU>Rossner S</AU>
<TI>Obesity in the elderly - a future matter of concern?</TI>
<SO>Obesity Reviews</SO>
<YR>2001</YR>
<VL>2</VL>
<PG>183-188</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sandvik-1993" NAME="Sandvik 1993" TYPE="JOURNAL_ARTICLE">
<AU>Sandvik L, Erikssen J, Thaulow E, Erikssen G, Mundal R, Rodahl K</AU>
<TI>Physical fitness as a predictor of mortality among healthy middle aged Norwegian men</TI>
<SO>New England Journal of Medicine</SO>
<YR>1993</YR>
<VL>328</VL>
<PG>533-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schubert-2006" NAME="Schubert 2006" TYPE="JOURNAL_ARTICLE">
<AU>Schubert C, Rogers N, Remsberg K, Sun S, Chumlea W, Demerath E</AU>
<TI>Lipids, lipoproteins, lifestyle, adiposity and fat-free mass during middle age: the Fels Longitudinal Study</TI>
<SO>International Journal of Obesity</SO>
<YR>2006</YR>
<VL>30</VL>
<PG>251-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schulz-1995" NAME="Schulz 1995" TYPE="JOURNAL_ARTICLE">
<AU>Schultz KF, Chalmers I, Hayes RJ, Altman DG</AU>
<TI>Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials</TI>
<SO>JAMA</SO>
<YR>1995</YR>
<VL>273</VL>
<PG>408-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stewart-1997" NAME="Stewart 1997" TYPE="BOOK_SECTION">
<AU>Stewart A, Hays R</AU>
<TI>Conceptual, measurement, and analytical issues in assessing health status of older populations</TI>
<SO>Public Health and Aging</SO>
<YR>1997</YR>
<PG>163-89</PG>
<ED>Hickey T, Speers M, Prohaska T</ED>
<PB>Johns Hopkins University Press</PB>
<CY>Baltimore</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Swinburn-2004" NAME="Swinburn 2004" TYPE="JOURNAL_ARTICLE">
<AU>Swinburn B, Caterson I, Seidell J, James W</AU>
<TI>Diet, nutrition and the prevention of excess weight gain and obesity</TI>
<SO>Public Health Nutrition</SO>
<YR>2004</YR>
<VL>7</VL>
<PG>123-246</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tremblay-1986" NAME="Tremblay 1986" TYPE="JOURNAL_ARTICLE">
<AU>Tremblay A, Fontaine E, Poehlman E</AU>
<TI>The effect of exercise-training on resting metabolic rate in lean and moderately obese individuals</TI>
<SO>International Journal of Obestiy</SO>
<YR>1986</YR>
<VL>10</VL>
<PG>511-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tremblay-1990" NAME="Tremblay 1990" TYPE="JOURNAL_ARTICLE">
<AU>Tremblay A, Despres J, Leblanc C et al</AU>
<TI>Effect of intensity of physical activity on body fatness and fat distribution</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1990</YR>
<VL>51</VL>
<PG>153-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Westerterp-2001" NAME="Westerterp 2001" TYPE="JOURNAL_ARTICLE">
<AU>Westerterp K, Meijer E</AU>
<TI>Physical activity and parameters of aging: a physiological perspective</TI>
<SO>Journals of Gerontology</SO>
<YR>2001</YR>
<VL>56</VL>
<PG>7-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2003" MODIFIED="2008-10-03 12:20:11 +0200" MODIFIED_BY="[Empty name]" NAME="WHO 2003" TYPE="BOOK_SECTION">
<AU>WHO</AU>
<TI>Report of a Joint WHO/FAO Expert Consultation Report of a Joint WHO/FAO Expert Consultation Joint WHO / FAO Expert Report on Diet, Nutrition and the Prevention of Chronic Disease.</TI>
<SO>Diet, Nutrition and the Prevention of Chronic Disease</SO>
<YR>2003</YR>
<PB>World Health Organization</PB>
<CY>Geneva</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2006" NAME="WHO 2006" TYPE="OTHER">
<AU>World Health Organisation</AU>
<TI>Obesity and Overweight</TI>
<SO>Global Strategy on Diet, Physical Activity and Health. http://www.who.int/dietphysicalactivity/publications/facts/obesity/en/</SO>
<YR>2006</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Williamson-1993" NAME="Williamson 1993" TYPE="JOURNAL_ARTICLE">
<AU>Williamson D, Madans J, Anda R, Kleinman J, Kahn H, Byers T</AU>
<TI>Recreational physical activity and ten-year weight change in a US national cohort</TI>
<SO>International Journal of Obesity and Related Metabolic Disorders</SO>
<YR>1993</YR>
<VL>17</VL>
<PG>279-86</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES>
<CHARACTERISTICS_OF_INCLUDED_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR STUDY_ID="STD-Aggel_x002d_Leijssen-2001">
<CHAR_METHODS>
<P>DESIGN: Factorial; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 12 weeks<BR/>DROPOUTS: 7.5%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: Netherlands<BR/>n: 40<BR/>AGE: N=38.9 years<BR/>MALES=all<BR/>WEIGHT ENTRY CRITERIA: BMI &gt; 27<BR/>EXCLUSION CRITERIA: &gt;2 hrs a week spent in sports activities, subjects with physically demanding jobs</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=17): modifast very low calorie diet for 6 weeks then low calorie diet <BR/>INTERVENTION 2 (n=20): modifast for 6 weeks then low calorie diet + exercise (cycle ergometer, walking or aqua jogging) 4 times a week for 60 minutes a session at 40% VO2 max intensity<BR/>FOLLOW-UP: 12 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), BMI, body density<BR/>OTHER: VO2 max, physical activity questionnaire</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Aggel_x002d_Leijssen-2001b">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 12 weeks<BR/>DROPOUTS: none<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: Netherlands<BR/>n: 13<BR/>AGE: N=40.7 years<BR/>MALES=none<BR/>WEIGHT ENTRY CRITERIA: BMI &gt; 29<BR/>EXCLUSION CRITERIA: abnormal menstrual cycle, poor health as assessed by medical history and physical examination, &gt; 3 kg weight change in the previous 2 months, taking medication known to affect the variables measured, &lt; 2 hours a week in sports activities, physically demanding employment</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=7): cycle ergometry 3 days a week for 57 minutes at 40% VO2max <BR/>INTERVENTION 2 (n=6): no exercise FOLLOW-UP: 12 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), hydrostatic weighing, WHR, waist circumference<BR/>OTHER: VO2 max, indirect calorimetry, U-13C palmitate infusion, 1,2-13C acetate infusion, free fatty acids, glucose, glycerol, triglycerides, insulin, catecholamines</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>All upper body obese. Lower body obese participants were not part of a randomised controlled trial. Variance for change in weight with interventions not reported therefore results reported narratively only.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Aggel_x002d_Leijssen-2002">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 12 weeks<BR/>DROPOUTS: 10%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: Netherlands<BR/>n: 24<BR/>AGE: N=43.4 years<BR/>MALES=all<BR/>WEIGHT ENTRY CRITERIA: BMI &gt; 27<BR/>EXCLUSION CRITERIA: poor physical health, use of medication known to influence the variables measured, &gt; 3 kg body weight change during 2 months before selection, &gt; 2 hours a week in sports activities, physically demanding job</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=8): cycle ergometry 3 days a week for 33 minutes at 70% VO2max <BR/>INTERVENTION 2 (n=8): cycle ergometry 3 days a week for 57 minutes at 40% VO2max<BR/>CONTROL (n=8): no intervention FOLLOW-UP: 12 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), BMI, hydrostatic weighing<BR/>OTHER: VO2 max, U-13C palmitate infusion, 1,2-13C acetate infusion, free fatty acids, glucose, glycerol, triglycerides</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Variance for change in weight with interventions not reported therefore results reported narratively only.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Anderson-1999">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - yes<BR/>DURATION OF INTERVENTION: 16 weeks<BR/>DROPOUTS: 2%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: USA<BR/>n: 40<BR/>AGE: N=42.9 years<BR/>MALES=none<BR/>WEIGHT ENTRY CRITERIA: minimum of 15 kg overweight (Metropolitan Life Insurance tables)<BR/>EXCLUSION CRITERIA: subjects with bulimia nervosa, binge eating disorder, significant depression, and other psychiatric disturbances, identified contra indications to diet, exercise or both, including recent myocardial infarction, a history of cerebrovascular, kidney, or liver disease, cancer type 1 diabetes mellitus, pregnancy or use of medications known to affect weight or energy expenditure</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=20): low fat, low calorie diet of 1200 kcal a day + structured aerobic exercise by step aerobics 3 days a week for 45 minutes a session at intensity of 7 - 8.5 METS with bursts to 10.5 - 11 METS<BR/>INTERVENTION 2 (n=20): low fat, low calorie diet as above + instruction to increase levels of moderate intensity physical activity in their daily life by 30 minutes per day most days of the week FOLLOW-UP: 16 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), DXA body composition<BR/>OTHER: treadmill testing, lipids, lipoproteins, mood</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Anderssen-1996">
<CHAR_METHODS>
<P>DESIGN: Factorial; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 52 weeks<BR/>DROPOUTS: 1%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: Norway<BR/>n: 219<BR/>AGE: all over 40 years<BR/>MALES=not stated<BR/>WEIGHT ENTRY CRITERIA: BMI &gt; 24<BR/>EXCLUSION CRITERIA: &gt;1 workout per week, diastolic blood pressure outside 86-99 mm Hg, cholesterol outside 5.2-7.74 mmol / L, HDL &gt; 1.2, fasting triglycerides &lt;1.4</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=54):walk / jog, aerobics or circuit training for 3 days a week at 60-80% maximum heart rate <BR/>INTERVENTION 2 (n=55): low fat diet<BR/>INTERVENTION 3 (n=67): low fat diet + exercise regimen as outlined above<BR/>CONTROL (n=43): no intervention<BR/>FOLLOW-UP: 52 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: BMI<BR/>OTHER: BP, cholesterol, triglycerides, insulin, glucose, VO2 max, factor VII, total energy intake</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No raw scores for weight loss in kilograms provided.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Balkestein-1999">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 12 weeks<BR/>DROPOUTS: 11%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: The Netherlands<BR/>n: 37<BR/>AGE: N=37 years<BR/>MALES=all<BR/>WEIGHT ENTRY CRITERIA: BMI between 27 and 40<BR/>EXCLUSION CRITERIA: levels of physical activity more than 2 hours a week in sports or physically demanding labour, diabetes, respiratory disease, cardiovascular disorders other than mild hypertension, medication use, diet, psychiatric disorders and impairment of ability to exert physical activity</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=18): low calorie liquid formula diet INTERVENTION 2 (n=19): low calorie liquid formula diet + exercise 4 days a week for 60 minutes a session at 40% of maximum heart rate<BR/>FOLLOW-UP: 12 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), BMI<BR/>OTHER: blood pressure, resting heart rate, vascular compliance</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Variance for change in weight with interventions not reported therefore results reported narratively only.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Cox-1996">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 16 weeks<BR/>DROPOUTS: 15%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: Australia<BR/>n: 60<BR/>AGE: 20-50 years<BR/>MALES=all<BR/>WEIGHT ENTRY CRITERIA: 120 - 160 % of ideal body weight<BR/>EXCLUSION CRITERIA: cigarette smoking, alcohol consumption &gt; 210 ml/week, weight loss of &gt; 10 kg in the preceding 12 months, hypertension, history of myocardial infarction, stroke, coronary bypass surgery, renal or hepatic disease, diabetes mellitus, asthma, musculoskeletal exercise that precludes exercise</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=13): vigorous intensity stationary cycling exercise 3 days a week for 30 minutes at 60-70% maximum heart rate<BR/>INTERVENTION 2 (n=17): light exercise by flexibility stretching once a week and stationary cycling against zero resistance twice a week or slow walking (&lt;2 km in 30 minutes)<BR/>FOLLOW-UP: 16 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg)<BR/>OTHER: dietary compliance, physical fitness assessment, BP, alcohol, biochemistry</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Cox-2004">
<CHAR_METHODS>
<P>DESIGN: Factorial; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 16 weeks<BR/>DROPOUTS: 15%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: Australia<BR/>n: 51<BR/>AGE: 20-50 years<BR/>MALES=all<BR/>WEIGHT ENTRY CRITERIA: 120-160% of ideal weight for height<BR/>EXCLUSION CRITERIA: Weight loss of &gt; 10 kg in the preceding 12 months, greater than two 30-minute sessions of vigorous exercise per week in the previous 6 months, musculoskeletal injury that precluded exercise, non-steroidal anti-inflammatory drugs, history of diabetes, asthma or heart, renal or hepatic disease, blood pressure not 130 - 160 systolic and 80 - 100 diastolic, taking antihypertensive medication, alcohol consumption &gt; 210 mL/wk.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=17): normal energy intake + light exercise (flexibility exercises once a week and stationary cycling against zero resistance twice a week for 30 mins. Every second week subjects substituted one cycling session for a slow walking session of &lt;=2km in 30 mins) INTERVENTION 2 (n=13): normal energy intake + vigorous exercise (stationary cycling for 30 mins at 60-70% maximum workload 3 times a week)<BR/>INTERVENTION 3 (n=14): low energy intake + light exercise (reduced daily intake by 1000 - 1500 kcal/d) INTERVENTION 4 (n=15): low energy intake + vigorous exercise FOLLOW-UP: 16 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), WHR, BMI<BR/>OTHER: HbA1c, insulin, glucose, VO2 max, total energy intake, dietary components</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Gillett-1987">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method by random number table<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 16 weeks<BR/>DROPOUTS: 6%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: USA<BR/>n: 38<BR/>AGE: N=49 years<BR/>MALES=none<BR/>WEIGHT ENTRY CRITERIA: mean % body fat 42.5 +/- 7.1%<BR/>EXCLUSION CRITERIA: smokers, hypertension, pregnancy, non-sedentary for 6 months prior to the study, known coronary heart disease</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=20): dance exercise up to 53 minutes a session at 60-80 % of maximum heart rate INTERVENTION 2 (n=18): commercial aerobics for up to 53 minutes a session at 70-80 % of maximum heart rate<BR/>FOLLOW-UP: 16 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (lb), body fat %<BR/>OTHER: muscular endurance, flexibility, VO2 max, cholesterol, triglyceride, glucose, HDL, blood pressure, resting heart rate</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Variance for change in weight with interventions not reported therefore results reported narratively only.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Gordon-1997">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 12 weeks<BR/>DROPOUTS: 13%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: USA<BR/>n: 55<BR/>AGE: N=48 years<BR/>MALES= 31%<BR/>WEIGHT ENTRY CRITERIA: percentage body fat &gt;27%<BR/>EXCLUSION CRITERIA: known cardiovascular disease apart from hypertension, &gt; 15 minutes of continuous aerobic exercise &gt; 2 days a week during the previous 3 months, contraindications to maximal exercise testing, participation in dietary program aimed at weight reduction, consumption of &gt; 3 alcoholic drinks a day, pregnancy, lactation, current use of antihypertensive medication</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=15):low fat, low calorie diet <BR/>INTERVENTION 2 (n=14): aerobic exercise (predominantly walking) 3 to 5 days a week for 30 to 45 minutes at 60-85% of maximum heart rate<BR/>INTERVENTION 3 (n=19): diet and exercise as described above<BR/>FOLLOW-UP: 12 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), skinfold thickness<BR/>OTHER: food diary, heart rate monitoring, BP, treadmill testing, maximal oxygen uptake</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>All subjects had hypertension.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Hays-2004">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 12 weeks<BR/>DROPOUTS: 5%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: USA<BR/>n: 34<BR/>AGE: N=66 years<BR/>MALES:N = 14<BR/>WEIGHT ENTRY CRITERIA: participants stated as overweight (method not stated but BMI, % body fat and body weight reported)<BR/>EXCLUSION CRITERIA: current smoker, &gt; 2 d/wk of structured physical activity, weight unstable in past 6 months (+/- &gt;5 kg), normal OGTT, taking medication known to affect glucose metabolism</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=11):low fat, high carbohydrate diet (providing 150% of predicted energy requirements) + exercise training 4 days a week on cycle ergometer at 80% to 85% of maximal heart rate for 45 mins<BR/>INTERVENTION 2 (n=11): low fat, high carbohydrate diet<BR/>INTERVENTION 3 (n=12): control<BR/>FOLLOW-UP: 14 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), BMI, % body fat (BOD POD)<BR/>OTHER: macronutrient intake, reported physical activity, maximal aerobic capacity, resting energy expenditure, resting respiratory exchange ratio, change in fat and lean tissue cross-sectional area of the thigh</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Hellenius-1993">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 26 weeks<BR/>DROPOUTS: 1%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: USA<BR/>n: 157<BR/>AGE: N=46.2 years<BR/>MALES= all<BR/>WEIGHT ENTRY CRITERIA: mean BMI = 25.3<BR/>EXCLUSION CRITERIA: poor general health, history of cardiovascular disease, diabetes, regular use of medications, serum cholesterol not between 5.2-7.8 mmol/L, fasting triglycerides &gt;5.6 mmol/L, fasting blood glucose &gt;6.7 mmol/L, diastolic blood pressure &gt; 100 mmHg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=40): low fat, low calorie diet <BR/>INTERVENTION 2 (n=39): walk / jog 2-3 days a week at 60-80% of maximum heart rate for 30-45 minutes<BR/>INTERVENTION 3 (n=39): diet and exercise as described above<BR/>CONTROL (n=39): no intervention<BR/>FOLLOW-UP: 26 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: BMI, waist circumference, WHR<BR/>OTHER: food diary, blood pressure, serum cholesterol and triglycerides</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Irwin-2003">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method by random number generation <BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - for DXA scans<BR/>DURATION OF INTERVENTION: 52 weeks<BR/>DROPOUTS: 2%<BR/>Analysis by intention to treat</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: USA<BR/>n: 173<BR/>AGE: 50 - 75 years<BR/>MALES= none<BR/>WEIGHT ENTRY CRITERIA: BMI &gt;= 24 and &gt;33% body fat<BR/>EXCLUSION CRITERIA: non- postmenopausal, non-sedentary (&gt;60 mins / wk of moderate and vigorous intensity recreational activity and maximal oxygen consumption &gt; 25 mL/kg/min, taking hormone replacement therapy, diabetes, smokers</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION (n=87): 45 mins of moderate intensity exercise 5 d/wk for 12 months (aim 60 - 75% MHR for 45 mins per session). <BR/>CONTROL (n=86): weekly 45-minute stretching sessions for 1 year<BR/>FOLLOW-UP: 52 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight, height, waist and hip circumference, DXA total body fat and body fat %, CT intra- abdominal and subcutaneous fat<BR/>OTHER: food frequency questionnaire, Minnesota Physical Activity Questionnaire, VO2 max</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Jakicic-1995">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 20 weeks<BR/>DROPOUTS: 15%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: USA<BR/>n: 38<BR/>AGE: N=40.6 years<BR/>MALES=none<BR/>WEIGHT ENTRY CRITERIA: 120- 175% of ideal body weight (Metropolitan Life Insurance tables)<BR/>EXCLUSION CRITERIA: medical problems that prevent participation in regular exercise &amp; / or calorie restricted diet, medication which affects heart rate response to exercise</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=25): low fat, low calorie diet (1200 - 1500 kcal / day) + discussion of behavioral strategies to modify diet and exercise + short bout exercise (multiple 10 minute bouts of exercise to a total of 20-40 minutes) 5 days a week at 70% maximum heart rate<BR/>INTERVENTION 2 (n=27): low fat, low calorie diet (1200 - 1500 kcal / day) + discussion of behavioral strategies to modify diet and exercise + long bout exercise (single 20-40 minute bout of exercise) 5 days a week at 70% maximum heart rate FOLLOW-UP: 20 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), BMI<BR/>OTHER: exercise participation, food frequency questionnaires, accelerometer data, cardiorespiratory fitness, resting heart rate, BP</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Jakicic-2003">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 52 weeks<BR/>DROPOUTS: 6%<BR/>Analysis by intention to treat</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: USA<BR/>n: 201<BR/>AGE: N=37 years<BR/>MALES=none<BR/>WEIGHT ENTRY CRITERIA: BMI 27 to 40<BR/>EXCLUSION CRITERIA: exercise &gt; 3 days per week for &gt; 20 mins / d in the previous 6 months, history of myocardial infarction, taking medication that would alter heart rate response during exercise or affect metabolism or weight loss, treatment for psychological conditions, currently pregnant, pregnant within the previous 6 months, planning to become pregnant during the intervention period, any medical condition that could affect metabolism or body weight or limit exercise participation</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=50): vigorous intensity high duration exercise (5 days a week of brisk walking to expend 2000 kcal / week)<BR/>INTERVENTION 2 (n=50): moderate intensity high duration exercise (5 days a week of slower walking to expend 2000 kcal / week)<BR/>INTERVENTION 3 (n=50): moderate intensity moderate duration exercise (5 days a week of slower walking to expend 1000 kcal / week)<BR/>INTERVENTION 4 (n=51): vigorous intensity moderate duration exercise (5 days a week of brisk walking to expend 1000 kcal / week)<BR/>FOLLOW-UP: 52 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), BMI<BR/>OTHER: exercise participation, food frequency questionnaires, cardiorespiratory fitness, heart rate per exercise session, exercise duration, time to achieve 85% of maximal heart rate</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Janssen-2002">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 16 weeks<BR/>DROPOUTS: none<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: Canada<BR/>n: 38<BR/>AGE: N=40.1 years<BR/>MALES=none<BR/>WEIGHT ENTRY CRITERIA: BMI &gt; 27 and WHR &gt; 0.85<BR/>EXCLUSION CRITERIA: unstable weight in the 6 months prior to the study, taking medications, consuming greater than 2 standard alcoholic drinks a day, not premenopausal, irregular menstrual cycle</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=11): low calorie diet + aerobic exercise (treadmill walking, exercise bicycle or stair stepper) 5 days a week for 60 minutes to 50-85% of maximum heart rate<BR/>INTERVENTION 2 (n=14): low calorie diet + resistance training (weights machine 3 days a week for 30 minutes a session until 120 kcal expended) <BR/>INTERVENTION 3 (n=13): low calorie diet only<BR/>FOLLOW-UP: 16 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), % body fat, MRI body fat, WHR, waist circumference<BR/>OTHER: glucose, insulin, glucose tolerance test, serum cholesterol, diet record</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Jeffery-1998">
<CHAR_METHODS>
<P>DESIGN: Factorial; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 26 weeks<BR/>DROPOUTS: 13%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: USA<BR/>n: 193<BR/>AGE: N=41 years<BR/>MALES=15%<BR/>WEIGHT ENTRY CRITERIA: between 14 and 32 kg overweight according to actuarial norms<BR/>EXCLUSION CRITERIA: serious medical complaints, unable to walk for exercise, unwilling to be randomized to treatment conditions</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=40): standard behaviour therapy<BR/>INTERVENTION 2 (n=41): standard behaviour therapy + supervised walks 3 days a week <BR/>INTERVENTION 3 (n=42): standard behaviour therapy + supervised walks 3 days a week with personal trainer+ reminders from personal trainer<BR/>INTERVENTION 4 (n=37): standard behaviour therapy + supervised walks with a personal trainer + money<BR/>INTERVENTION 5 (n=36): standard behaviour therapy + supervised walks with a personal trainer + reminders + money<BR/>FOLLOW-UP: 26 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg)<BR/>OTHER: physical activity questionnaire, food frequency questionnaire, Beck depression inventory, binge eating questionnaire, barriers to adherence questionnaire</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Jeffery-2003">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 78 weeks<BR/>DROPOUTS: 13% at 6 months<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: USA<BR/>n: 202<BR/>AGE: N=42.2 years<BR/>MALES=42%<BR/>WEIGHT ENTRY CRITERIA: between 14 and 32 kg overweight according to actuarial norms<BR/>EXCLUSION CRITERIA: serious medical or psychological problems thought to interfere with treatment, not aged between 25 - 50 years</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=82): standard behaviour therapy<BR/>INTERVENTION 2 (n=100): standard behaviour therapy + physical activity (energy expenditure equivalent of 2500 kcal/wk) <BR/>FOLLOW-UP: 26 weeks (dropout rate &gt; 15% at 52 and 78 weeks)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), BMI<BR/>OTHER: Paffenbarger Physical Activity Questionnaire, Block diet questionnaire</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kiernan-2001">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 52 weeks<BR/>DROPOUTS: 13%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: USA<BR/>n: 119<BR/>AGE: N=38.5 years<BR/>MALES=50%<BR/>WEIGHT ENTRY CRITERIA: BMI of 28 to 34 (males) and 24 to 30 (females)<BR/>EXCLUSION CRITERIA: smokers, non sedentary, poor health, use of blood pressure or lipid lowering medication, postmenopausal women</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=81): low fat diet + exercise by brisk walking / jogging 3 days a week for 45 minutes a session to intensity of 60- 80% of maximum heart rate <BR/>INTERVENTION 2 (n=71): low fat diet only <BR/>CONTROL (n=79): waiting list control<BR/>FOLLOW-UP: 52 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), BMI<BR/>OTHER: VO2 max, eating inventory, depression inventory, aerobic capacity</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Leutholtz-1995">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 12 weeks<BR/>DROPOUTS: 0%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: USA<BR/>n: 40<BR/>AGE: N=41 years<BR/>MALES=18%<BR/>WEIGHT ENTRY CRITERIA: body fat % &gt; 25% for men and &gt; 30% for women<BR/>EXCLUSION CRITERIA: coronary or peripheral atherosclerosis, ketosis prone diabetes mellitus, chronic use of steroids, bleeding peptic ulcer, history of suicide attempts, active thrombophlebitis, alcohol abuse, pregnancy, lactation, inability to exercise, use of beta blockers or other exercise limiting medications</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=20): liquid formula Optifast diet (420 kcal / day) + exercise by walking at a target heart rate of 60% of maximum heart rate to a distance that expended 300 kcal of energy<BR/>INTERVENTION 2 (n=20): liquid formula Optifast diet (420 kcal / day) + exercise by walking at a target heart rate of 40% of maximum heart rate to a distance that expended 300 kcal of energy <BR/>FOLLOW-UP: 12 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), lean body mass, fat mass<BR/>OTHER: resting heart rate, BP, VO2 max</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Manning-1991">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 12 weeks<BR/>DROPOUTS: 9%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: USA<BR/>n: 24<BR/>AGE: 22-57 years<BR/>MALES=none<BR/>WEIGHT ENTRY CRITERIA: BMI &gt; 30<BR/>EXCLUSION CRITERIA: physical activity in the previous 6 months, unstable weight in the previous 6 months</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION (n=40): strength training with weights 3 days a week for 12 weeks to 60-70% of maximum heart rate<BR/>CONTROL (n=6): no intervention<BR/>FOLLOW-UP: 12 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), BMI<BR/>OTHER: dietary record, LDL, HDL, cholesterol, triglycerides, apolipoproteins</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Variance for change in weight with interventions not reported therefore results reported narratively only.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Neumark-1995">
<CHAR_METHODS>
<P>DESIGN: Factorial; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 12 weeks<BR/>DROPOUTS: 5%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: Israel<BR/>n: 42<BR/>AGE: 25-50 years<BR/>MALES=none<BR/>WEIGHT ENTRY CRITERIA: BMI &gt; 27<BR/>EXCLUSION CRITERIA: health problems, lack of interest in participation</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION (n=19): low calorie diet (&lt;1000 kcal) + self monitoring<BR/>INTERVENTION 2 (n=21): diet + self monitoring as above + supervised aerobic exercise for 1 hour per week + 15 minutes of walking / jogging 5 days a week + 10 minutes of other unspecified exercise 6 days a week<BR/>FOLLOW-UP: 12 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), skinfold thicknesses, WHR, waist circumference, BMI<BR/>OTHER: exercise compliance, physical fitness</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Nieman-1998">
<CHAR_METHODS>
<P>DESIGN: Factorial; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 12 weeks<BR/>DROPOUTS: 11%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: USA<BR/>n: 91<BR/>AGE: N=45.6 years<BR/>MALES=none<BR/>WEIGHT ENTRY CRITERIA: BMI between 25 and 65<BR/>EXCLUSION CRITERIA: serious medical complaints, unable to walk for exercise, unwilling to be randomized to treatment conditions</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=21): 45 minutes of walking 5 days a week at 60-75% maximum heart rate INTERVENTION 2 (n=26): 1200 - 1300 kcal a day diet<BR/>INTERVENTION 3 (n=22): low calorie diet and exercise as outlined above <BR/>INTERVENTION 4 (n=22): no treatment control<BR/>FOLLOW-UP: 12 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), body composition, body fat %<BR/>OTHER: adaptive immunity, natural killer cell activity, phagocytosis and oxidative burst, aerobic power, VO2 max, glucose, triglycerides, cholesterol, maximum heart rate</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Variance for change in weight with exercise only and control interventions not reported therefore results reported narratively only.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Pritchard-1997">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 52 weeks<BR/>DROPOUTS: 12%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: Australia<BR/>n: 39<BR/>AGE: N=43.4 years<BR/>MALES=all<BR/>WEIGHT ENTRY CRITERIA: mean BMI 29 +/- 2.6<BR/>EXCLUSION CRITERIA: inability to satisfactorily complete standardized fitness test</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=21): 3 sessions of 30 minutes a week of aerobic exercise of the participants choice to an intensity of 65-75% of maximum heart rate<BR/>INTERVENTION 2 (n=18): low fat diet<BR/>FOLLOW-UP: 52 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>MEASURES: weight loss (kg), waist circumference, WHR, body composition (DXA)<BR/>OTHER: 24 hour food recall, 3 day food diary, activity log</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Raz--1994">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 12 weeks<BR/>DROPOUTS: none<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: Israel<BR/>n: 40<BR/>AGE: N=56.6 years<BR/>MALES=35%<BR/>WEIGHT ENTRY CRITERIA: BMI &gt; 25 <BR/>EXCLUSION CRITERIA: Ischaemic heart disease, systolic hypertension, inability to use a bicycle ergometer, unwillingness to accept control group treatment assignment</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION (n=19): 45 mins of cycle ergometry, treadmill and or rowing machine to 65% of VO2 max for 3 days a week<BR/>CONTROL (n=19): no change to lifestyle<BR/>FOLLOW-UP: 12 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg)<BR/>OTHER: glucose, fructosamine, HbA1c, cholesterol, HDL, triglycerides, resting heart rate, maximal work capacity</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Variance for change in weight with interventions not reported therefore results reported narratively only.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Ross-1996">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 16 weeks<BR/>DROPOUTS: none<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: Canada<BR/>n: 33<BR/>AGE: N=44.5 years<BR/>MALES=all<BR/>WEIGHT ENTRY CRITERIA: BMI &gt; 27<BR/>EXCLUSION CRITERIA: change in weight of more than 2 kg in the previous 6 months, taking medication known to affect the study variables, consumption of &gt; 2 alcoholic beverages daily</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=11): low calorie diet (1000 kcal / d)<BR/>INTERVENTION 2 (n=11): low calorie diet as above + aerobic exercise by bicycling / walking / stair stepping 5 days a week for 60 minutes a session <BR/>INTERVENTION 3 (n=11): low calorie diet as outlined above + resistance exercise using a weights machine 3 days a week with 8-12 repetitions per session to a calculated energy expenditure of 120 kcal per session<BR/>FOLLOW-UP: 16 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), waist circumference, WHR, regional adipose tissue distribution (MRI)<BR/>OTHER: VO2 max, strength-training performance, dietary records</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>All subjects had upper body obesity</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Schwartz-1987">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 12 weeks<BR/>DROPOUTS: none<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: USA<BR/>n: 26<BR/>AGE: N=31.4 years<BR/>MALES=all<BR/>WEIGHT ENTRY CRITERIA: 110-185% of ideal body weight (Metropolitan Life Insurance tables)<BR/>EXCLUSION CRITERIA: poor health, unstable weight, cigarette smoking, use of prescription or over the counter medications, participation in regular exercise</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=12): low calorie diet (1200 kcal / d)<BR/>INTERVENTION 2 (n=14): brisk walking / jogging 3 days a week for 40 minutes a session at 70-85% maximum heart rate<BR/>FOLLOW-UP: 12 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), body fat % <BR/>OTHER: lipoproteins, total and fractionated cholesterol, VO2 max</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Schwartz-1990">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 12 weeks<BR/>DROPOUTS: 9%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: USA<BR/>n: 31<BR/>AGE: N=30.9 years<BR/>MALES=all<BR/>WEIGHT ENTRY CRITERIA: mean body fat % of groups was 28.4% for the diet group and 30.1% for the exercise group<BR/>EXCLUSION CRITERIA: poor health, unstable weight, cigarette smoking, participation in a regular exercise program, use of prescribed or over the counter medications</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=13): low calorie diet (1200 kcal / d)<BR/>INTERVENTION 2 (n=18): brisk walking / jogging 3 days a week for 40 minutes a session at 70-85% of maximum heart rate<BR/>FOLLOW-UP: 12 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), body fat mass, % body fat<BR/>OTHER: food diary, plasma epinephrine and norepinephrine clearance, baseline pulse rate</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Stefanick-1998">
<CHAR_METHODS>
<P>DESIGN: Factorial; Randomisation by computer - the Efron method<BR/>BLINDING: <BR/>patients - no<BR/>caregivers - no<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 52 weeks<BR/>DROPOUTS: 3%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: USA<BR/>n: 377<BR/>AGE: 30-64 years<BR/>MALES=52%<BR/>WEIGHT ENTRY CRITERIA: not stated - WHR for men &gt; 0.94 and women &gt; 0.82<BR/>EXCLUSION CRITERIA: elevated HDL levels, history of heart disease, stroke, diabetes, recent cancer, other life-threatening illnesses or any condition limiting their ability to engage in moderate exercise, taking insulin or heart medications, blood pressure or high serum cholesterol, smoking more than 9 cigarettes daily, consuming more than 4 alcoholic drinks a day</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n= 43): supervised aerobic exercise equivalent to brisk walking or jogging 3 days per week for 60 minutes per session<BR/>INTERVENTION 2 (n=46): low fat diet<BR/>INTERVENTION 3 (n=43): diet and exercise as outlined above CONTROL (n= 45): no change to diet or exercise<BR/>FOLLOW-UP: 52 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), WHR<BR/>OTHER: cholesterol, triglycerides, HDL, LDL, glucose, BP, VO2max</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Stensel-1994">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - no<BR/>caregivers - no<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 52 weeks<BR/>DROPOUTS: 10%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: UK<BR/>n: 72<BR/>AGE: 42-59 years<BR/>MALES=all<BR/>WEIGHT ENTRY CRITERIA: not stated - BMI was &gt; 25.2 for participants<BR/>EXCLUSION CRITERIA: non-sedentary, employed in a strenuous job</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n= 48): walking up to 40-45 minutes a day a minimum of 3 days a week<BR/>CONTROL (n= 24): no change to diet or exercise<BR/>FOLLOW-UP: 52 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), BMI, WHR, body density, % body fat<BR/>OTHER: VO2 max, blood lactate, dietary intake</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Variance for change in weight with interventions not reported therefore results reported narratively only</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Svendsen-1993">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 12 weeks<BR/>DROPOUTS: 3%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: Denmark<BR/>n: 121<BR/>AGE: N=53.8 years<BR/>MALES=none<BR/>WEIGHT ENTRY CRITERIA: BMI &gt; 25<BR/>EXCLUSION CRITERIA: menstrual bleeding in the preceding 6 months, hysterectomy, weight loss in the preceding 3 months, lack of motivation or ability to participate, psychiatric illness, cardiovascular, pulmonary, catabolic, renal or hepatic disease, medication known to influence body composition, hormones, antihistamines and catabolic drugs</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=51): diet only (formula diet providing 1.6 MJ daily) INTERVENTION 2 (n=49): supervised aerobic exercise and resistance weights training 3 days a week for 60 - 90 minutes per session at 70% VO2 max intensity + diet as outlined above<BR/>CONTROL (n= 21): no change to diet or exercise<BR/>FOLLOW-UP: 12 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), body composition, bone mineral density, fat tissue and lean tissue mass, skinfold thicknesses, WHR <BR/>OTHER: blood pressure, pulse, food diaries, HDL, cholesterol, triglycerides, alkaline phosphatase</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Thong-2000">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 12 weeks<BR/>DROPOUTS: none<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: Canada<BR/>n: 52<BR/>AGE: N=44.4 years<BR/>MALES=all<BR/>WEIGHT ENTRY CRITERIA: BMI &gt; 30<BR/>EXCLUSION CRITERIA: none stated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=14): low calorie diet INTERVENTION 2 (n=14): brisk walking or jogging on a motorized treadmill daily for 12 weeks at intensity up to but not exceeding 75% of maximum heart rate in conjunction with a weight maintenance diet of 700 kcal/day<BR/>CONTROL (n= 8): no change to diet or exercise<BR/>FOLLOW-UP: 12 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), BMI, waist circumference, WHR, MRI fat stores<BR/>OTHER: VO2 max, leptin levels</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>The standard deviation data, calculated from standard error data, for this study is not consistent with data recorded from any other study included in this review and does not appear to be reliable. Therefore an editorial decision was made by the Cochrane Metabolic and Endocrine Disorders Review Group to exclude data from this study in this review.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Utter-2000">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 12 weeks<BR/>DROPOUTS: 4%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: USA<BR/>n: 27<BR/>AGE: N=42.3 years<BR/>MALES=none<BR/>WEIGHT ENTRY CRITERIA: BMI between 25-34<BR/>EXCLUSION CRITERIA: physically active &gt; 3 moderate to vigorous aerobic sessions of greater than 20 mins duration per week, poor health, diabetes, cancer, heart disease, cigarette smoking, history of gastrointestinal disease, gallstones, gallbladder sludge or other pathology of the gallbladder, currently on weight reduction diet, weight loss of &gt; 5% in the previous 3 months</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=16): walking 5 days a week, 45 mins a session to intensity of 60-80 % of maximum heart rate <BR/>CONTROL (n= 11): no change to diet or exercise<BR/>FOLLOW-UP: 12 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), BMI, body fat %<BR/>OTHER: gallbladder emptying, VO2 max, energy intake, treadmill time, BP, VO2 max</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Variance for change in weight with interventions not reported therefore results reported narratively only.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wadden-1997">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 24 weeks<BR/>DROPOUTS: 12%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: USA<BR/>n: 120<BR/>AGE: N=41.1 years<BR/>MALES=none<BR/>WEIGHT ENTRY CRITERIA: BMI &gt; 30<BR/>EXCLUSION CRITERIA: bulimia nervosa, significant depression, other major psychiatric disorders, recent myocardial infarction, cerebrovascular, kidney or liver disease, cancer, type 1 diabetes, pregnancy, use of medications known to affect weight and energy expenditure</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=29): low calorie diet (900 kcal / d including liquid formula diet )<BR/>INTERVENTION 2 (n=31): diet as above + step aerobics 3 days a week for 50-55 minutes a session at intensity of 11-15 on Borgs Rating of Perceived Exertion Scale<BR/>INTERVENTION 3 (n=31): diet as above + strength training using fixed weights 3 days a week for 10-14 repetitions up to 40 minutes duration<BR/>INTERVENTION 4 (n=29): diet as above + aerobic training as above + strength training as above<BR/>FOLLOW-UP: 24 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), body densitometry, % body fat, fat free mass<BR/>OTHER: indirect calorimetry, food cravings/ hunger/ satiety/ preoccupation measures, Beck Depression Inventory and mood questionnaire, resting energy expenditure</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wallace-1997">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 14 weeks<BR/>DROPOUTS: none<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: USA<BR/>n: 16<BR/>AGE: N=41.2 years<BR/>MALES=all<BR/>WEIGHT ENTRY CRITERIA: WHR&gt;1.02<BR/>EXCLUSION CRITERIA: non- hyper insulinaemic, non-sedentary, non- dyslipidaemic, normotensive</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=8): 60 mins of aerobic exercise (30 minutes each of cycle ergometry and treadmill walking) at 60-70 % maximum heart rate for 3 days a week<BR/>INTERVENTION 2 (n=8): endurance training as above + resistance weights for 8-12 sets at intensity of 75% 1RM<BR/>FOLLOW-UP: 14 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), % body fat, WHR, body composition<BR/>OTHER: electrolytes strength testing</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Whatley-1994">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 12 weeks<BR/>DROPOUTS: none<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: USA<BR/>n: 23<BR/>AGE: N=38.5 years<BR/>MALES=none<BR/>WEIGHT ENTRY CRITERIA: BMI between 30 and 42<BR/>EXCLUSION CRITERIA: significant medical illness, unstable weight or participation in weight loss activities in the previous 6 months</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=7): very low energy liquid formula diet <BR/>INTERVENTION 2 (n=8): very low energy liquid formula diet + walking and weights training 3 days a week at 50-65% of maximum heart rate<BR/>INTERVENTION 3 (n=8): very low energy liquid formula diet + walking 5 days a week and weights training 3 days a week at 50-65% of maximum heart rate FOLLOW-UP: 12 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), % body fat, WHR<BR/>OTHER: VO2 max, resting metabolic rate</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wing-1988">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - no<BR/>caregivers - no<BR/>outcome assessors - yes<BR/>DURATION OF INTERVENTION: 52 weeks<BR/>DROPOUTS: 7%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: USA<BR/>n: 30<BR/>AGE: N=55.6 years<BR/>MALES=not stated<BR/>WEIGHT ENTRY CRITERIA: &gt;120 % of ideal body weight <BR/>EXCLUSION CRITERIA: non- diabetic, not aged between 30 and 65 years, history of coronary heart disease, taking medications which could interfere with weight loss or heart rate during exercise, orthopaedic problems that would limit walking</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=15): walking 3 miles four days a week + low calorie diet calculated to produce 1 kg / wk weight loss<BR/>INTERVENTION 2 (n=15): low calorie diet only<BR/>FOLLOW-UP: 52 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), BMI<BR/>OTHER: HbA1c, cholesterol, triglycerides, BP, glucose, insulin</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>All type 2 diabetes. Variance for change in weight with interventions not reported therefore results reported narratively only.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wing-1998">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 26 weeks<BR/>DROPOUTS: 15%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: USA<BR/>n: 154<BR/>AGE: N=45.7 years<BR/>MALES=21%<BR/>WEIGHT ENTRY CRITERIA: 130 - 200% of ideal body weight<BR/>EXCLUSION CRITERIA: diabetics, no family history of diabetes</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=37): walking for 50-60 minutes up to 5 days a week to expend 1500 kcal a week<BR/>INTERVENTION 2 (n=37): low calorie, low fat diet<BR/>INTERVENTION 3 (n=40): low fat, low calorie diet + aerobic exercise as outlined above<BR/>CONTROL (n=40): given self-help behavioral manual with information on healthy eating, exercise and behavioral strategies for weight control<BR/>FOLLOW-UP: 26 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg), waist circumference, WHR<BR/>OTHER: glucose tolerance test, insulin, fasting glucose, HbA1c, cholesterol and triglycerides, HDL, blood pressure, physical activity assessment, food frequency measures</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>All subjects had a family history of non-insulin dependent diabetes mellitus.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wirth-1985">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 16 weeks<BR/>DROPOUTS: 7%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: Germany<BR/>n: 21<BR/>AGE: N=43 years<BR/>MALES=all<BR/>WEIGHT ENTRY CRITERIA: not stated - mean body fat % = 24<BR/>EXCLUSION CRITERIA: no hyper triglyceridaemia</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=10): jogging, ball games and calisthenics 3 times a week for 1 hour to achieve a pulse between 120 and 150 beats per minute<BR/>CONTROL (n=11): no treatment<BR/>FOLLOW-UP: 16 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg)<BR/>OTHER: cholesterol, LDL, HDL, apo lipoprotein A1, insulin, blood pressure, body fat %, energy expenditure, glycerol release</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>All patients had hyper triglyceridaemia. Variance for change in weight with interventions not reported therefore results reported narratively only.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wood-1988">
<CHAR_METHODS>
<P>DESIGN: Parallel; Randomisation method by envelopes<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - unclear<BR/>DURATION OF INTERVENTION: 52 weeks<BR/>DROPOUTS: 15%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: USA<BR/>n: 131<BR/>AGE: N=44.6 years<BR/>MALES=all<BR/>WEIGHT ENTRY CRITERIA: 120-160 % of ideal body weight<BR/>EXCLUSION CRITERIA: smokers, consumed more than four alcoholic drinks per day, taking medications affecting blood pressure or lipids, were not expected to remain living in the local area for 12 months</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>EXERCISE INTERVENTION (n=47): jogging 60-80% of maximum heart rate for 40 to 50 minutes at least 3 days a week<BR/>DIET INTERVENTION (n=42): low fat diet<BR/>CONTROL (n=42): waiting list<BR/>FOLLOW-UP: 52 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg)<BR/>OTHER: serum cholesterol and triglycerides, LDL and HDL</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wood-1991">
<CHAR_METHODS>
<P>DESIGN: Factorial; Randomisation method not stated<BR/>BLINDING: <BR/>patients - not stated<BR/>caregivers - not stated<BR/>outcome assessors - not stated<BR/>DURATION OF INTERVENTION: 52 weeks<BR/>DROPOUTS: 12.5%<BR/>Analysis by treatment received</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>COUNTRY: USA<BR/>n: 231<BR/>AGE: 25-49 years<BR/>MALES=50%<BR/>WEIGHT ENTRY CRITERIA: 120-150% of ideal body weight<BR/>EXCLUSION CRITERIA: smokers, non sedentary, consumed four or more alcoholic drinks per day, poor physical health, taking medications known to affect blood pressure or lipid metabolism, pregnancy, lactation, use of oral contraceptives, blood pressure over 160/95 at rest, plasma total cholesterol above 6.72 mmol per liter, plasma triglycerides above 5.65 mmol per liter</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>INTERVENTION 1 (n=81): brisk walking / jogging for 40 to 50 minutes at least 3 days a week + low fat / low calorie diet<BR/>INTERVENTION 2 (n=71): low calorie, low fat diet<BR/>CONTROL (n=79): waiting list<BR/>FOLLOW-UP: 52 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>BODY MEASURES: weight loss (kg)<BR/>OTHER: serum cholesterol and triglycerides, LDL and HDL, blood pressure</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>n=number of subjects; N=mean; kg=kilograms; BMI=body mass index; HDL=high-density lipoprotein; LDL=low-density lipoprotein; BP=blood pressure; HbA1c=glycosylated haemoglobin; WHR=waist-to-hip ratio; RCT = randomised controlled trial.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Ades-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Participants not overweight or obese</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Aiello-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>No weight loss data for controls</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Aldred-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Participants not overweight or obese</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Asikainen-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Participants not overweight or obese</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Blumenthal-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Loss to follow-up of greater than 15%</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cox-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Loss to follow-up of greater than 15%</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cuff-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Initial sample size not specified - only the number who completed the study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Donnelly-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Loss to follow-up of greater than 15%</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Dunn-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Loss to follow-up of greater than 15%</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Dzator-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Loss to follow-up of greater than 15%</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Esposito-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Loss to follow-up of greater than 15%</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Esposito-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Diet + exercise versus no treatment control</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Figueroa-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Participants not all overweight or obese</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Fogelholm-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Weight maintenance study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Grant-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Loss to follow-up of greater than 15%</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hartwell-1986">
<CHAR_REASON_FOR_EXCLUSION>
<P>Numbers in each intervention group not given</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hinderliter-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Loss to follow-up of greater than 15%</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Houmard-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Loss to follow-up of greater than 15%</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Huttunen-1979">
<CHAR_REASON_FOR_EXCLUSION>
<P>Weight loss discouraged whilst dieting and exercising</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Jakicic-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Unable to extract mean and standard deviation data for primary or secondary outcomes</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kirk-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Loss to follow-up of greater than 15%</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kraemer-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Unable to extract mean and standard deviation data for primary or secondary outcomes</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kraemer-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Loss to follow-up of greater than 15%</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lehmann-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomized controlled clinical trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lejeune-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Loss to follow-up of greater than 15%</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Levesque-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Participants not overweight or obese</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lindstrom-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Loss to follow-up of greater than 15%</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Loreto-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Participants not all overweight or obese</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mensink-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Loss to follow-up of greater than 15%</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Messier-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Unable to extract mean and standard deviation data for primary or secondary outcomes</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Nicklas-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Loss to follow-up of greater than 15%</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Okura-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Non-random allocation to groups</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Potteiger-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Loss to follow-up of greater than 15%</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Probart-1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>Participants not overweight or obese</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Proper-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Loss to follow-up of greater than 15%</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Racette-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Loss to follow-up of greater than 15%</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ribeiro-1984">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomized controlled clinical trial or pretest-intervention-post test design</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Samaras-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>No exercise prescription</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Schmitz-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Participants not all overweight or obese</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Schuler-1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>Participants not overweight or obese</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Slentz-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Loss to follow-up of greater than 15%</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Stahle-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Participants not overweight or obese</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Teixeira-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Participants not overweight or obese</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Watkins-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Loss to follow-up of greater than 15%</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Weinstock-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Unable to extract mean and standard deviation data for primary or secondary outcomes</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Yamanouchi-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Intervention &lt; 12 weeks duration</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>RCT = randomised controlled trial</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Aggel_x002d_Leijssen-2001">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Aggel_x002d_Leijssen-2001b">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Aggel_x002d_Leijssen-2002">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Anderson-1999">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Anderssen-1996">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Balkestein-1999">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cox-1996">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cox-2004">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Gillett-1987">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Gordon-1997">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hays-2004">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hellenius-1993">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Irwin-2003">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Jakicic-1995">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Jakicic-2003">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Janssen-2002">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Jeffery-1998">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Jeffery-2003">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kiernan-2001">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Leutholtz-1995">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Manning-1991">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Neumark-1995">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Nieman-1998">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Pritchard-1997">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Raz--1994">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ross-1996">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schwartz-1987">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schwartz-1990">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Stefanick-1998">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Stensel-1994">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Svendsen-1993">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Thong-2000">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Utter-2000">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wadden-1997">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wallace-1997">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Whatley-1994">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wing-1988">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wing-1998">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wirth-1985">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wood-1988">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wood-1991">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2008-10-03 13:15:39 +0200" MODIFIED_BY="[Empty name]"/>
<ADDITIONAL_TABLES MODIFIED="2008-10-23 13:27:32 +0200" MODIFIED_BY="Gudrun Paletta">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2008-10-23 13:27:32 +0200" MODIFIED_BY="Gudrun Paletta" NO="1">
<TITLE MODIFIED="2008-10-23 13:24:10 +0200" MODIFIED_BY="Gudrun Paletta">Summary of main findings from comparisons for each outcome</TITLE>
<TABLE COLS="9" ROWS="7">
<TR>
<TH>
<P>Intervention</P>
</TH>
<TH>
<P>Body Weight</P>
</TH>
<TH>
<P>BMI</P>
</TH>
<TH>
<P>Systolic BP</P>
</TH>
<TH>
<P>Diastolic BP</P>
</TH>
<TH>
<P>Cholesterol</P>
</TH>
<TH>
<P>Triglycerides</P>
</TH>
<TH>
<P>HDL</P>
</TH>
<TH>
<P>Glucose</P>
</TH>
</TR>
<TR>
<TD>
<P>Exercise versus No Treatment</P>
</TD>
<TD>
<P>Exercise increased weight loss compared with no treatment. <BR/>Exercisers lost 0.5 to 4.0 kg. <BR/>No treatment changed weight from -0.1 kg loss to 0.7 kg gain.<BR/>
</P>
</TD>
<TD>
<P>Exercise reduced BMI more than no treatment.<BR/>Exercisers lost between 0.3 and 0.7 kg/m2.<BR/>No treatment changed BMI from 0.3 to 0.4 kg/m2 gain.<BR/>
</P>
</TD>
<TD>
<P>Exercise did not reduce SBP significantly more than no treatment. Exercisers reduced SBP by 0.8 to 5.0 mmHg. <BR/>No treatment reduced SBP by 1.0 mmHg.<BR/>
</P>
</TD>
<TD>
<P>Exercise reduced DBP 2.1 mmHg more than no treatment.<BR/>Exercisers reduced DBP 0.8 to 5.0 mmHg.<BR/>No treatment changed DBP from 1.0 loss to 0.6 mmHg gain.<BR/>
</P>
</TD>
<TD>
<P>Exercise did not reduce cholesterol significantly more than no treatment.<BR/>Exercisers reduced cholesterol 0.1 to 0.3 mmol/L.<BR/>No treatment reduced cholesterol 0.1 to 0.2 mmol/L.<BR/>
</P>
</TD>
<TD>
<P>Exercise reduced TG 0.2 mmol/L more than no treatment.<BR/>Exercisers reduced TG 0.1 to 0.2 mmol/L.<BR/>No treatment changed TG from no change to 0.1 mmol/L gain.<BR/>
</P>
</TD>
<TD>
<P>Exercise increased HDL more than no treatment.<BR/>Exercisers increased HDL 0.01 to 0.1 mmol/L.<BR/>No treatment changed HDL from 0.02 loss to 0.01 mmol/L gain.<BR/>
</P>
</TD>
<TD>
<P>Exercise reduced glucose 0.2 mmol/L more than no treatment.<BR/>Exercisers reduced glucose 0.1 to 0.4 mmol/L.<BR/>No treatment changed glucose from 0.2 loss to 0.1 mmol/L gain.<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>High versus Low Intensity Exercise</P>
</TD>
<TD>
<P>Increasing the intensity increased the weight loss if participants were not on a diet. <BR/>High intensity exercisers lost 1.5 kg more than low intensity exercisers. <BR/>Range of weight change for high intensity exercisers was from 1.3 kg to 8.9 kg loss. <BR/>Range for low intensity exercisers was from 6.3 kg loss to 0.1 kg gain.<BR/>
</P>
</TD>
<TD>
<P>Insufficient data for analysis.</P>
</TD>
<TD>
<P>SBP was reduced with both high and low intensity exercise.<BR/>Increased exercise intensity did not reduce SBP significantly more than low intensity.<BR/>
</P>
</TD>
<TD>
<P>No consistent effect of exercise on DBP was seen.<BR/>Increased exercise intensity did not reduce DBP significantly more than low intensity.<BR/>
</P>
</TD>
<TD>
<P>Insufficient data for analysis.</P>
</TD>
<TD>
<P>TG was reduced by both high and low intensity exercise.<BR/>Increased exercise intensity did not reduce TG significantly more than low intensity.<BR/>
</P>
</TD>
<TD>
<P>HDL was increased by both high and low intensity exercise.<BR/>Increased exercise intensity increased HDL 0.1 mmol/L more than low intensity.<BR/>
</P>
</TD>
<TD>
<P>Glucose was reduced with both high and low intensity exercise.<BR/>High intensity reduced glucose 0.3 mmol/L more than low intensity.<BR/>Range was 0.01 to 0.6 reduction with high intensity and 0.3 reduction to 0.5 gain with low intensity.<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>High versus Low Intensity Exercise with Dietary Change</P>
</TD>
<TD>
<P>Increasing the intensity did not increase the weight loss if they were on a diet. <BR/>Range of weight change was 6.4 kg to 19.6 kg loss across groups.<BR/>
</P>
</TD>
<TD>
<P>Insufficient data for analysis.</P>
</TD>
<TD>
<P>SBP was reduced with both high and low intensity exercise.<BR/>Increased exercise intensity did not reduce SBP significantly more than low intensity.<BR/>
</P>
</TD>
<TD>
<P>No consistent effect of exercise on DBP was seen.<BR/>Increased exercise intensity did not reduce DBP significantly more than low intensity.<BR/>
</P>
</TD>
<TD>
<P>No consistent effect of exercise on cholesterol was seen.<BR/>Increased exercise intensity did not reduce cholesterol significantly more than low intensity.<BR/>
</P>
</TD>
<TD>
<P>TG was reduced by both high and low intensity exercise.<BR/>Increased exercise intensity did not reduce TG significantly more than low intensity.<BR/>
</P>
</TD>
<TD>
<P>HDL was reduced by both high and low intensity exercise.<BR/>Increased exercise intensity did not reduce TG significantly more than low intensity.<BR/>
</P>
</TD>
<TD>
<P>Glucose was reduced by both high and low intensity exercise.<BR/>Increased exercise intensity did not reduce glucose significantly more than low intensity.<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Exercise versus Diet</P>
</TD>
<TD>
<P>Diet resulted in greater weight losses compared with exercise.<BR/>Dieters lost 2.8 kg to 13.6 kg of weight.<BR/>Exercisers lost 0.5 kg to 4.0 kg of weight.<BR/>
</P>
</TD>
<TD>
<P>Diet resulted in greater BMI reductions than exercise.<BR/>Diet resulted in a loss of 0.3 to 3.3 kg/m2. Exercise resulted in a loss of 0.3 to 0.8 kg/m2.<BR/>
<BR/>
</P>
</TD>
<TD>
<P>Diet resulted in greater SBP reductions than exercise.<BR/>Diet reduced SBP by 2.2 mmHg more than exercise.<BR/>Range of SBP change with diet was 2.6 to 11.3 mmHg reduction.<BR/>Range with exercise was 0.8 to 9.9 mmHg reduction.<BR/>
</P>
</TD>
<TD>
<P>There was no significant difference between diet and exercise for DBP reduction.<BR/>Dieters reduced DBP from 1.1 to 7.5 mmHg.<BR/>Exercisers reduced DBP from 1.2 to 5.9 mmHg.<BR/>
</P>
</TD>
<TD>
<P>Diet resulted in greater cholesterol reductions than exercise.<BR/>Range of cholesterol change with diet was 0.2 to 0.7 mmol/L reduction.<BR/>Range with exercise was 0.2 to 0.3 mmol/L reduction.<BR/>
</P>
</TD>
<TD>
<P>There was no significant difference between diet and exercise on TG.<BR/>Range of TG change with diet was 0.6 loss to 0.03 mmol/L gain.<BR/>Range with exercise was 0.2 loss to 0.1 gain.<BR/>
</P>
</TD>
<TD>
<P>There was no significant difference between diet and exercise on HDL.<BR/>Range of HDL change with diet was 0.01 loss to 0.1 mmol/L gain.<BR/>Range with exercise was 0.01 to 0.1 mmol/L gain.<BR/>
</P>
</TD>
<TD>
<P>Diet resulted in greater glucose reductions than exercise.<BR/>Diet reduced glucose by 0.1 mmol/L more than exercise.<BR/>Range of glucose reduction with diet was 0.2 to 0.4 mmol/L.<BR/>Range with exercise was 0.0 to 0.4 mmol/L reduction.<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Exercise and Diet versus Diet Alone</P>
</TD>
<TD>
<P>Diet + exercise resulted in greater weight loss than diet alone.<BR/>Dieters + exercisers lost 1.1 kg more than dieters.<BR/>Range of weight change for dieters + exercisers was from 3.4 kg to 17.7 kg loss.<BR/>Range for dieters was 2.3 kg to 16.7 kg loss.<BR/>
</P>
</TD>
<TD>
<P>Diet + exercise resulted in greater reductions in BMI than diet alone.<BR/>Dieters + exercisers lost 0.4 kg/m2 more than dieters.<BR/>Range of BMI change for dieters + exercisers was from 0.6 to 4.0 kg/m2 loss.<BR/>Range for dieters was 0.3 to 4.0 kg/m2 loss.<BR/>
</P>
</TD>
<TD>
<P>Adding exercise to diet did not improve SBP reduction.<BR/>Range of SBP change was 2.6 to 13 mmHg drop across groups.<BR/>
</P>
</TD>
<TD>
<P>Adding exercise to diet did not improve DBP reduction.<BR/>Range of DBP change was 1.1 to 9.0 mmHg drop across groups.<BR/>
</P>
</TD>
<TD>
<P>Adding exercise to diet did not improve cholesterol reduction.<BR/>Range of cholesterol change was 0.15 to 1.4 mmol/L drop across groups.<BR/>
</P>
</TD>
<TD>
<P>Adding exercise to diet did not improve TG reduction.<BR/>Range of TG change was 0.69 drop to 0.03 mmol/L gain across groups.<BR/>
</P>
</TD>
<TD>
<P>Adding exercise to diet did not improve HDL levels.<BR/>Range of HDL change was 0.1 drop to 0.1 mmol/L gain across groups.<BR/>
</P>
</TD>
<TD>
<P>Adding exercise to diet did not improve glucose levels.<BR/>Range of glucose change was 0.1 to 0.4 mmol/L loss across groups.<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>kg=kilograms; BMI=body mass index; HDL=high-density lipoprotein; LDL=low-density lipoprotein; BP=blood pressure; HbA1c=glycosylated haemoglobin; WHR=waist--hip ratio<BR/>
<BR/>kg=kilograms; m=metres; BMI=body mass index; BP=blood pressure; HDL=high-density lipoprotein; LDL=low-density lipoprotein; TG=triglycerides; HbA1c=glycosylated haemoglobin; mmHg=millimetres of mercury; mmol/L=millimoles per litre<BR/>
<BR/>n=number of subjects; N=mean;kg=kilograms;BMI=body mass index;HDL=high-density lipoprotein;LDL=low-density lipoprotein;BP=blood pressure;HbA1c=glycosylated haemoglobin;WHR=waist--hip ratio<BR/>
<BR/>n=number of subjects; N=mean;kg=kilograms;BMI=body mass index;HDL=high-density lipoprotein;LDL=low-density lipoprotein;BP=blood pressure;HbA1c=glycosylated haemoglobin;WHR=waist--hip ratio<BR/>
<BR/>
</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES">
<COMPARISON ID="CMP-001" NO="1">
<NAME>Exercise versus no treatment control</NAME>
<CONT_OUTCOME CHI2="13.660686372941326" CI_END="-1.2310836806780778" CI_START="-2.8248213156645154" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.0279524981712966" ESTIMABLE="YES" I2="92.6797236046589" I2_Q="0.0" ID="CMP-001.01" NO="1" P_CHI2="2.1899362337352013E-4" P_Q="1.0" P_Z="6.103443703327876E-7" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="137" TOTAL_2="133" UNITS="" WEIGHT="100.0" Z="4.987914913369785">
<NAME>Weight change in kilograms</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>No treatment</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.22709523633792772" CI_START="-2.072904763662072" EFFECT_SIZE="-1.15" ESTIMABLE="YES" MEAN_1="-0.5" MEAN_2="0.65" ORDER="9985" SD_1="2.8" SD_2="3.5" SE="0.4708784298802566" STUDY_ID="STD-Stefanick-1998" TOTAL_1="90" TOTAL_2="91" WEIGHT="74.55210150228126"/>
<CONT_DATA CI_END="-3.020350004005471" CI_START="-6.179649995994528" EFFECT_SIZE="-4.6" ESTIMABLE="YES" MEAN_1="-4.0" MEAN_2="0.6" ORDER="9986" SD_1="3.9" SD_2="3.7" SE="0.805958685187384" STUDY_ID="STD-Wood-1988" TOTAL_1="47" TOTAL_2="42" WEIGHT="25.447898497718747"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.9164358980577312" CI_END="-0.45809566705515087" CI_START="-0.9934979687924284" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.7257968179237896" ESTIMABLE="YES" I2="47.81980440809527" I2_Q="0.0" ID="CMP-001.02" NO="2" P_CHI2="0.16625034583333276" P_Q="1.0" P_Z="1.0730686941826086E-7" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="88" TOTAL_2="82" UNITS="" WEIGHT="100.0" Z="5.313894313149378">
<NAME>Change in body mass index (BMI)</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>No treatment</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.5267105232586139" CI_START="-1.4932894767413862" EFFECT_SIZE="-1.01" ESTIMABLE="YES" MEAN_1="-0.65" MEAN_2="0.36" ORDER="9987" SD_1="1.5" SD_2="0.8" SE="0.24658079462352972" STUDY_ID="STD-Anderssen-1996" TOTAL_1="49" TOTAL_2="43" WEIGHT="30.682150713119402"/>
<CONT_DATA CI_END="-0.27846541127161417" CI_START="-0.9215345887283858" EFFECT_SIZE="-0.6" ESTIMABLE="YES" MEAN_1="-0.3" MEAN_2="0.3" ORDER="9988" SD_1="0.8" SD_2="0.64" SE="0.16405127403595657" STUDY_ID="STD-Hellenius-1993" TOTAL_1="39" TOTAL_2="39" WEIGHT="69.3178492868806"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.3886587665054457" CI_END="1.4913559164209444" CI_START="-2.661658439588462" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.5851512615837589" ESTIMABLE="YES" I2="58.13550206407349" I2_Q="0.0" ID="CMP-001.03" NO="3" P_CHI2="0.12221863084931162" P_Q="1.0" P_Z="0.5807360757161548" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="129" TOTAL_2="130" UNITS="" WEIGHT="100.0" Z="0.5523098645458888">
<NAME>Change in systolic blood pressure (mmHg)</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>No treatment</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.802655280640618" CI_START="-8.802655280640618" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="-5.0" MEAN_2="-1.0" ORDER="9989" SD_1="13.9" SD_2="6.4" SE="2.4503793531530937" STUDY_ID="STD-Hellenius-1993" TOTAL_1="39" TOTAL_2="39" WEIGHT="18.694077656756164"/>
<CONT_DATA CI_END="2.502885505270382" CI_START="-2.1028855052703816" EFFECT_SIZE="0.19999999999999996" ESTIMABLE="YES" MEAN_1="-0.8" MEAN_2="-1.0" ORDER="9990" SD_1="8.1" SD_2="7.7" SE="1.17496317454568" STUDY_ID="STD-Stefanick-1998" TOTAL_1="90" TOTAL_2="91" WEIGHT="81.30592234324384"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.40491170366352125" CI_END="-0.5060957445185508" CI_START="-3.6776849214419958" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.0918903329802734" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.04" NO="4" P_CHI2="0.524563501961802" P_Q="1.0" P_Z="0.009724537855267402" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="129" TOTAL_2="130" UNITS="" WEIGHT="99.99999999999999" Z="2.5854733911193457">
<NAME>Change in diastolic blood pressure (mmHg)</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>No treatment</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.21534588728385762" CI_START="-6.215345887283858" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="-4.0" MEAN_2="-1.0" ORDER="9991" SD_1="8.0" SD_2="6.4" SE="1.6405127403595656" STUDY_ID="STD-Hellenius-1993" TOTAL_1="39" TOTAL_2="39" WEIGHT="24.324194415022816"/>
<CONT_DATA CI_END="0.022923338195229626" CI_START="-3.6229233381952293" EFFECT_SIZE="-1.7999999999999998" ESTIMABLE="YES" MEAN_1="-1.2" MEAN_2="0.6" ORDER="9992" SD_1="6.5" SD_2="6.0" SE="0.930080018089218" STUDY_ID="STD-Stefanick-1998" TOTAL_1="90" TOTAL_2="91" WEIGHT="75.67580558497717"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.2123248241785523" CI_END="0.15205358101913424" CI_START="-0.09472928151399036" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.028662149752571944" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.05" NO="5" P_CHI2="0.8992785843169723" P_Q="1.0" P_Z="0.6489128837161975" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="176" TOTAL_2="172" UNITS="" WEIGHT="99.99999999999999" Z="0.45527295256974554">
<NAME>Change in total serum cholesterol (mmol/l)</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>No treatment</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.31468878357012325" CI_START="-0.29468878357012324" EFFECT_SIZE="0.010000000000000009" ESTIMABLE="YES" MEAN_1="-0.12" MEAN_2="-0.13" ORDER="9993" SD_1="0.73" SD_2="0.64" SE="0.15545631755148026" STUDY_ID="STD-Hellenius-1993" TOTAL_1="39" TOTAL_2="39" WEIGHT="16.400499290196617"/>
<CONT_DATA CI_END="0.20609345873611695" CI_START="-0.10609345873611697" EFFECT_SIZE="0.04999999999999999" ESTIMABLE="YES" MEAN_1="-0.14" MEAN_2="-0.19" ORDER="9994" SD_1="0.56" SD_2="0.51" SE="0.07964098318508005" STUDY_ID="STD-Stefanick-1998" TOTAL_1="90" TOTAL_2="91" WEIGHT="62.488571379304226"/>
<CONT_DATA CI_END="0.24855381476827906" CI_START="-0.288553814768279" EFFECT_SIZE="-0.01999999999999999" ESTIMABLE="YES" MEAN_1="-0.25" MEAN_2="-0.23" ORDER="9995" SD_1="0.64" SD_2="0.65" SE="0.13701977020322684" STUDY_ID="STD-Wood-1988" TOTAL_1="47" TOTAL_2="42" WEIGHT="21.110929330499143"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.09548492546663803" CI_END="-0.05261091836954146" CI_START="-0.3062130437715376" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.17941198107053952" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.06" NO="6" P_CHI2="0.9533792881454681" P_Q="1.0" P_Z="0.005551295305798483" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="176" TOTAL_2="172" UNITS="" WEIGHT="100.00000000000001" Z="2.7731709325056917">
<NAME>Change in serum triglycerides (mmol/l)</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>No treatment</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.11450262704039296" CI_START="-0.434502627040393" EFFECT_SIZE="-0.16" ESTIMABLE="YES" MEAN_1="-0.1" MEAN_2="0.06" ORDER="9996" SD_1="0.75" SD_2="0.45" SE="0.14005493427717788" STUDY_ID="STD-Hellenius-1993" TOTAL_1="39" TOTAL_2="39" WEIGHT="21.337954094400885"/>
<CONT_DATA CI_END="-0.017980482243455498" CI_START="-0.3820195177565445" EFFECT_SIZE="-0.2" ESTIMABLE="YES" MEAN_1="-0.14" MEAN_2="0.06" ORDER="9997" SD_1="0.54" SD_2="0.7" SE="0.092868807382325" STUDY_ID="STD-Stefanick-1998" TOTAL_1="90" TOTAL_2="91" WEIGHT="48.52995267634879"/>
<CONT_DATA CI_END="0.07099801187694402" CI_START="-0.39099801187694405" EFFECT_SIZE="-0.16" ESTIMABLE="YES" MEAN_1="-0.16" MEAN_2="0.0" ORDER="9998" SD_1="0.5" SD_2="0.6" SE="0.11785829418245787" STUDY_ID="STD-Wood-1988" TOTAL_1="47" TOTAL_2="42" WEIGHT="30.132093229250334"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="9.078760772597162" CI_END="0.0902984884663594" CI_START="0.030466251336271573" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.06038236990131549" ESTIMABLE="YES" I2="77.97056173088411" I2_Q="0.0" ID="CMP-001.07" NO="7" P_CHI2="0.01068003844693699" P_Q="1.0" P_Z="7.622469764888649E-5" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="176" TOTAL_2="172" UNITS="" WEIGHT="99.99999999999999" Z="3.9559700918567344">
<NAME>Change in serum HDL (mmol/l)</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>No treatment</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours no treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exercise</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.11680535251473671" CI_START="-0.056805352514736715" EFFECT_SIZE="0.03" ESTIMABLE="YES" MEAN_1="0.01" MEAN_2="-0.02" ORDER="9999" SD_1="0.18" SD_2="0.21" SE="0.04428925898610702" STUDY_ID="STD-Hellenius-1993" TOTAL_1="39" TOTAL_2="39" WEIGHT="11.877293306217624"/>
<CONT_DATA CI_END="0.06937001582907558" CI_START="-0.009370015829075581" EFFECT_SIZE="0.03" ESTIMABLE="YES" MEAN_1="0.04" MEAN_2="0.01" ORDER="10000" SD_1="0.14" SD_2="0.13" SE="0.020087111875330996" STUDY_ID="STD-Stefanick-1998" TOTAL_1="90" TOTAL_2="91" WEIGHT="57.74033679246688"/>
<CONT_DATA CI_END="0.1842743239251328" CI_START="0.07572567607486722" EFFECT_SIZE="0.13" ESTIMABLE="YES" MEAN_1="0.11" MEAN_2="-0.02" ORDER="10001" SD_1="0.15" SD_2="0.11" SE="0.027691490432090453" STUDY_ID="STD-Wood-1988" TOTAL_1="47" TOTAL_2="42" WEIGHT="30.382369901315492"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.05508262861036474" CI_END="-0.04941208851246312" CI_START="-0.29987207118459924" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.17464207984853117" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.08" NO="8" P_CHI2="0.814444006118294" P_Q="1.0" P_Z="0.006270159290108157" Q="0.0" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="139" TOTAL_2="134" UNITS="" WEIGHT="100.0" Z="2.7333083955081645">
<NAME>Change in fasting serum glucose (mmol/l)</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>No treatment</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.01502608366831551" CI_START="-0.33502608366831554" EFFECT_SIZE="-0.16" ESTIMABLE="YES" MEAN_1="-0.09" MEAN_2="0.07" ORDER="10002" SD_1="0.4" SD_2="0.45" SE="0.08930066320039497" STUDY_ID="STD-Anderssen-1996" TOTAL_1="49" TOTAL_2="43" WEIGHT="51.19306717156285"/>
<CONT_DATA CI_END="-0.010746521361245542" CI_START="-0.36925347863875446" EFFECT_SIZE="-0.19" ESTIMABLE="YES" MEAN_1="-0.37" MEAN_2="-0.18" ORDER="10003" SD_1="0.49" SD_2="0.72" SE="0.09145753700204852" STUDY_ID="STD-Stefanick-1998" TOTAL_1="90" TOTAL_2="91" WEIGHT="48.80693282843715"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" NO="2">
<NAME>Exercise versus diet</NAME>
<CONT_OUTCOME CHI2="41.66957811371689" CI_END="4.25965873591399" CI_START="2.9542784864840623" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="MD" EFFECT_SIZE="3.6069686111990262" ESTIMABLE="YES" I2="85.6010061257978" I2_Q="0.0" ID="CMP-002.01" NO="1" P_CHI2="2.1367099178881688E-7" P_Q="1.0" P_Z="2.4446857574511265E-27" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="237" TOTAL_2="230" UNITS="" WEIGHT="100.0" Z="10.83137051354022">
<NAME>Weight change in kilograms</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Diet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours diet</GRAPH_LABEL_2>
<CONT_DATA CI_END="6.987295721035171" CI_START="2.6127042789648285" EFFECT_SIZE="4.8" ESTIMABLE="YES" MEAN_1="-1.0" MEAN_2="-5.8" ORDER="10004" SD_1="1.8" SD_2="3.9" SE="1.1159877111458583" STUDY_ID="STD-Gordon-1997" TOTAL_1="14" TOTAL_2="15" WEIGHT="8.904285510156495"/>
<CONT_DATA CI_END="5.792591799918675" CI_START="1.8074082000813256" EFFECT_SIZE="3.8000000000000003" ESTIMABLE="YES" MEAN_1="-2.6" MEAN_2="-6.4" ORDER="10005" SD_1="3.0" SD_2="3.3" SE="1.0166471504762253" STUDY_ID="STD-Pritchard-1997" TOTAL_1="21" TOTAL_2="18" WEIGHT="10.729448663102188"/>
<CONT_DATA CI_END="14.232914551339173" CI_START="6.367085448660829" EFFECT_SIZE="10.3" ESTIMABLE="YES" MEAN_1="-2.8" MEAN_2="-13.1" ORDER="10006" SD_1="3.6" SD_2="6.1" SE="2.0066259290280333" STUDY_ID="STD-Schwartz-1987" TOTAL_1="14" TOTAL_2="12" WEIGHT="2.754133970761116"/>
<CONT_DATA CI_END="15.26634882796389" CI_START="7.333651172036111" EFFECT_SIZE="11.3" ESTIMABLE="YES" MEAN_1="-2.3" MEAN_2="-13.6" ORDER="10007" SD_1="3.4" SD_2="6.7" SE="2.023684546884505" STUDY_ID="STD-Schwartz-1990" TOTAL_1="18" TOTAL_2="13" WEIGHT="2.707897808939249"/>
<CONT_DATA CI_END="3.211032245304518" CI_START="1.3889677546954817" EFFECT_SIZE="2.3" ESTIMABLE="YES" MEAN_1="-0.5" MEAN_2="-2.8" ORDER="10008" SD_1="2.8" SD_2="3.5" SE="0.4648209112466475" STUDY_ID="STD-Stefanick-1998" TOTAL_1="90" TOTAL_2="95" WEIGHT="51.32708332725012"/>
<CONT_DATA CI_END="9.559108972142603" CI_START="4.440891027857397" EFFECT_SIZE="7.0" ESTIMABLE="YES" MEAN_1="-2.1" MEAN_2="-9.1" ORDER="10009" SD_1="4.2" SD_2="6.4" SE="1.3056918353237754" STUDY_ID="STD-Wing-1998" TOTAL_1="33" TOTAL_2="35" WEIGHT="6.504838593553747"/>
<CONT_DATA CI_END="4.779649995994529" CI_START="1.620350004005472" EFFECT_SIZE="3.2" ESTIMABLE="YES" MEAN_1="-4.0" MEAN_2="-7.2" ORDER="10010" SD_1="3.9" SD_2="3.7" SE="0.805958685187384" STUDY_ID="STD-Wood-1988" TOTAL_1="47" TOTAL_2="42" WEIGHT="17.072312126237083"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="27.025539679035138" CI_END="0.8740416288061476" CI_START="0.23525534734035436" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.554648488073251" ESTIMABLE="YES" I2="92.59959274170762" I2_Q="0.0" ID="CMP-002.02" NO="2" P_CHI2="1.3535756735461035E-6" P_Q="1.0" P_Z="6.650058395149556E-4" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="121" TOTAL_2="127" UNITS="" WEIGHT="99.99999999999999" Z="3.4036142986936673">
<NAME>Change in body mass index (BMI)</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Diet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours diet</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.5947836470392618" CI_START="0.30521635296073835" EFFECT_SIZE="0.9500000000000001" ESTIMABLE="YES" MEAN_1="-0.65" MEAN_2="-1.6" ORDER="10011" SD_1="1.5" SD_2="1.8" SE="0.3289772935243876" STUDY_ID="STD-Anderssen-1996" TOTAL_1="49" TOTAL_2="52" WEIGHT="24.53709482480945"/>
<CONT_DATA CI_END="0.40367767855466824" CI_START="-0.40367767855466824" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="-0.3" MEAN_2="-0.3" ORDER="10012" SD_1="0.8" SD_2="1.02" SE="0.2059617838586965" STUDY_ID="STD-Hellenius-1993" TOTAL_1="39" TOTAL_2="40" WEIGHT="62.601061685688094"/>
<CONT_DATA CI_END="3.390582126355764" CI_START="1.6094178736442362" EFFECT_SIZE="2.5" ESTIMABLE="YES" MEAN_1="-0.8" MEAN_2="-3.3" ORDER="10013" SD_1="1.5" SD_2="2.2" SE="0.45438698536328315" STUDY_ID="STD-Wing-1988" TOTAL_1="33" TOTAL_2="35" WEIGHT="12.861843489502444"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.538419649489655" CI_END="4.195674187337174" CI_START="0.29002874970741566" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="MD" EFFECT_SIZE="2.2428514685222947" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.03" NO="3" P_CHI2="0.46838811140368997" P_Q="1.0" P_Z="0.024382159291540514" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="176" TOTAL_2="185" UNITS="" WEIGHT="100.0" Z="2.2510533386482923">
<NAME>Change in systolic blood pressure (mmHg)</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Diet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours diet</GRAPH_LABEL_2>
<CONT_DATA CI_END="8.38098918579665" CI_START="-5.580989185796649" EFFECT_SIZE="1.4000000000000004" ESTIMABLE="YES" MEAN_1="-9.9" MEAN_2="-11.3" ORDER="10014" SD_1="6.4" SD_2="12.1" SE="3.5617946252389334" STUDY_ID="STD-Gordon-1997" TOTAL_1="14" TOTAL_2="15" WEIGHT="7.825132633039719"/>
<CONT_DATA CI_END="7.594093127027473" CI_START="-3.594093127027473" EFFECT_SIZE="2.0" ESTIMABLE="YES" MEAN_1="-5.0" MEAN_2="-7.0" ORDER="10015" SD_1="13.9" SD_2="11.3" SE="2.854181592699134" STUDY_ID="STD-Hellenius-1993" TOTAL_1="39" TOTAL_2="40" WEIGHT="12.186142547169023"/>
<CONT_DATA CI_END="4.093594249616922" CI_START="-0.49359424961692233" EFFECT_SIZE="1.8" ESTIMABLE="YES" MEAN_1="-0.8" MEAN_2="-2.6" ORDER="10016" SD_1="8.1" SD_2="7.8" SE="1.1702226508795575" STUDY_ID="STD-Stefanick-1998" TOTAL_1="90" TOTAL_2="95" WEIGHT="72.49239625378934"/>
<CONT_DATA CI_END="14.932446326785051" CI_START="0.6675536732149467" EFFECT_SIZE="7.799999999999999" ESTIMABLE="YES" MEAN_1="-2.4" MEAN_2="-10.2" ORDER="10017" SD_1="18.9" SD_2="9.2" SE="3.639070096718551" STUDY_ID="STD-Wing-1998" TOTAL_1="33" TOTAL_2="35" WEIGHT="7.496328566001924"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="4.178116949055191" CI_END="2.1755582440936054" CI_START="-0.437160813629919" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.8691987152318432" ESTIMABLE="YES" I2="28.197318634692643" I2_Q="0.0" ID="CMP-002.04" NO="4" P_CHI2="0.24286207636721246" P_Q="1.0" P_Z="0.19220608728680225" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="176" TOTAL_2="185" UNITS="" WEIGHT="100.0" Z="1.3040806452012896">
<NAME>Change in diastolic blood pressure (mmHg)</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Diet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours diet</GRAPH_LABEL_2>
<CONT_DATA CI_END="4.846741267364201" CI_START="-1.6467412673642015" EFFECT_SIZE="1.5999999999999996" ESTIMABLE="YES" MEAN_1="-5.9" MEAN_2="-7.5" ORDER="10018" SD_1="4.6" SD_2="4.3" SE="1.656531085761821" STUDY_ID="STD-Gordon-1997" TOTAL_1="14" TOTAL_2="15" WEIGHT="16.18937462027254"/>
<CONT_DATA CI_END="5.2189242462445975" CI_START="-1.2189242462445975" EFFECT_SIZE="2.0" ESTIMABLE="YES" MEAN_1="-4.0" MEAN_2="-6.0" ORDER="10019" SD_1="8.0" SD_2="6.5" SE="1.642338467255042" STUDY_ID="STD-Hellenius-1993" TOTAL_1="39" TOTAL_2="40" WEIGHT="16.47039150449491"/>
<CONT_DATA CI_END="1.5897048531132227" CI_START="-1.7897048531132225" EFFECT_SIZE="-0.09999999999999987" ESTIMABLE="YES" MEAN_1="-1.2" MEAN_2="-1.1" ORDER="10020" SD_1="6.5" SD_2="5.1" SE="0.8621101542892619" STUDY_ID="STD-Stefanick-1998" TOTAL_1="90" TOTAL_2="95" WEIGHT="59.77281811234522"/>
<CONT_DATA CI_END="9.248855116295726" CI_START="-0.24885511629572576" EFFECT_SIZE="4.5" ESTIMABLE="YES" MEAN_1="-1.7" MEAN_2="-6.2" ORDER="10021" SD_1="12.2" SD_2="6.9" SE="2.4229297853195715" STUDY_ID="STD-Wing-1998" TOTAL_1="33" TOTAL_2="35" WEIGHT="7.567415762887324"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="16.813196367859877" CI_END="0.3313106189517101" CI_START="0.10811882632888235" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.21971472264029623" ESTIMABLE="YES" I2="76.20916384676025" I2_Q="0.0" ID="CMP-002.05" NO="5" P_CHI2="0.00210133209060015" P_Q="1.0" P_Z="1.1391715712710362E-4" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="223" TOTAL_2="224" UNITS="" WEIGHT="100.0" Z="3.858860025161546">
<NAME>Change in total serum cholesterol (mmol/l)</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Diet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours diet</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.44795608532145453" CI_START="-0.3079560853214545" EFFECT_SIZE="0.07" ESTIMABLE="YES" MEAN_1="-0.12" MEAN_2="-0.19" ORDER="10022" SD_1="0.73" SD_2="0.97" SE="0.19283828085756874" STUDY_ID="STD-Hellenius-1993" TOTAL_1="39" TOTAL_2="40" WEIGHT="8.717937779536102"/>
<CONT_DATA CI_END="1.3782373361082236" CI_START="0.46176266389177617" EFFECT_SIZE="0.9199999999999999" ESTIMABLE="YES" MEAN_1="0.18" MEAN_2="-0.74" ORDER="10023" SD_1="0.44" SD_2="0.7" SE="0.23379885534772138" STUDY_ID="STD-Schwartz-1987" TOTAL_1="14" TOTAL_2="12" WEIGHT="5.930830416508286"/>
<CONT_DATA CI_END="0.28327900053840105" CI_START="-0.02327900053840104" EFFECT_SIZE="0.13" ESTIMABLE="YES" MEAN_1="-0.14" MEAN_2="-0.27" ORDER="10024" SD_1="0.56" SD_2="0.5" SE="0.07820500873865348" STUDY_ID="STD-Stefanick-1998" TOTAL_1="90" TOTAL_2="95" WEIGHT="53.00674418939554"/>
<CONT_DATA CI_END="0.9478257677080464" CI_START="0.27217423229195353" EFFECT_SIZE="0.61" ESTIMABLE="YES" MEAN_1="0.12" MEAN_2="-0.49" ORDER="10025" SD_1="0.72" SD_2="0.7" SE="0.17236325278054748" STUDY_ID="STD-Wing-1998" TOTAL_1="33" TOTAL_2="35" WEIGHT="10.912164508102883"/>
<CONT_DATA CI_END="0.3510535882973712" CI_START="-0.1310535882973712" EFFECT_SIZE="0.10999999999999999" ESTIMABLE="YES" MEAN_1="-0.25" MEAN_2="-0.36" ORDER="10026" SD_1="0.6" SD_2="0.56" SE="0.12298878458929405" STUDY_ID="STD-Wood-1988" TOTAL_1="47" TOTAL_2="42" WEIGHT="21.432323106457197"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="9.33163607341977" CI_END="0.13225912145983648" CI_START="-0.1134211239109556" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.009418998774440445" ESTIMABLE="YES" I2="57.135062184930256" I2_Q="0.0" ID="CMP-002.06" NO="6" P_CHI2="0.053324226044979106" P_Q="1.0" P_Z="0.8805405983954875" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="223" TOTAL_2="224" UNITS="" WEIGHT="99.99999999999999" Z="0.15028394603292694">
<NAME>Change in serum triglycerides (mmol/l)</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Diet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours diet</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.13459932583699669" CI_START="-0.3945993258369967" EFFECT_SIZE="-0.13" ESTIMABLE="YES" MEAN_1="-0.1" MEAN_2="0.03" ORDER="10027" SD_1="0.75" SD_2="0.39" SE="0.13500213673522699" STUDY_ID="STD-Hellenius-1993" TOTAL_1="39" TOTAL_2="40" WEIGHT="21.55276612916136"/>
<CONT_DATA CI_END="1.0532555004881146" CI_START="0.10674449951188547" EFFECT_SIZE="0.58" ESTIMABLE="YES" MEAN_1="-0.02" MEAN_2="-0.6" ORDER="10028" SD_1="0.4" SD_2="0.75" SE="0.24146132491264813" STUDY_ID="STD-Schwartz-1987" TOTAL_1="14" TOTAL_2="12" WEIGHT="6.737350515025595"/>
<CONT_DATA CI_END="0.09961115447572536" CI_START="-0.25961115447572536" EFFECT_SIZE="-0.08000000000000002" ESTIMABLE="YES" MEAN_1="-0.14" MEAN_2="-0.06" ORDER="10029" SD_1="0.54" SD_2="0.7" SE="0.09164002802728786" STUDY_ID="STD-Stefanick-1998" TOTAL_1="90" TOTAL_2="95" WEIGHT="46.775008415957814"/>
<CONT_DATA CI_END="1.1683591777070392" CI_START="-0.3283591777070392" EFFECT_SIZE="0.42" ESTIMABLE="YES" MEAN_1="0.12" MEAN_2="-0.3" ORDER="10030" SD_1="1.64" SD_2="1.5" SE="0.38182292307919985" STUDY_ID="STD-Wing-1998" TOTAL_1="33" TOTAL_2="35" WEIGHT="2.694389049718477"/>
<CONT_DATA CI_END="0.37047623508380356" CI_START="-0.15047623508380356" EFFECT_SIZE="0.11000000000000001" ESTIMABLE="YES" MEAN_1="-0.16" MEAN_2="-0.27" ORDER="10031" SD_1="0.5" SD_2="0.72" SE="0.13289848034882623" STUDY_ID="STD-Wood-1988" TOTAL_1="47" TOTAL_2="42" WEIGHT="22.240485890136743"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="8.75581071789335" CI_END="0.04346395640064364" CI_START="-0.013412725765431815" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.015025615317605913" ESTIMABLE="YES" I2="54.31605217520736" I2_Q="0.0" ID="CMP-002.07" NO="7" P_CHI2="0.06750148001694645" P_Q="1.0" P_Z="0.3004065506578284" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="223" TOTAL_2="224" UNITS="" WEIGHT="99.99999999999997" Z="1.0355619823979971">
<NAME>Change in serum HDL (mmol/l)</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Diet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours diet</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.08159829884976882" CI_START="-0.08159829884976882" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="0.01" MEAN_2="0.01" ORDER="10032" SD_1="0.18" SD_2="0.19" SE="0.041632550135311565" STUDY_ID="STD-Hellenius-1993" TOTAL_1="39" TOTAL_2="40" WEIGHT="12.146364452345587"/>
<CONT_DATA CI_END="0.11671330011663829" CI_START="-0.1567133001166383" EFFECT_SIZE="-0.020000000000000004" ESTIMABLE="YES" MEAN_1="0.08" MEAN_2="0.1" ORDER="10033" SD_1="0.08" SD_2="0.23" SE="0.06975296546008772" STUDY_ID="STD-Schwartz-1987" TOTAL_1="14" TOTAL_2="12" WEIGHT="4.327000882702765"/>
<CONT_DATA CI_END="0.08898666017233042" CI_START="0.011013339827669583" EFFECT_SIZE="0.05" ESTIMABLE="YES" MEAN_1="0.04" MEAN_2="-0.01" ORDER="10034" SD_1="0.14" SD_2="0.13" SE="0.019891518660471428" STUDY_ID="STD-Stefanick-1998" TOTAL_1="90" TOTAL_2="95" WEIGHT="53.20794089320307"/>
<CONT_DATA CI_END="0.005850331591299579" CI_START="-0.16585033159129958" EFFECT_SIZE="-0.08" ESTIMABLE="YES" MEAN_1="0.02" MEAN_2="0.1" ORDER="10035" SD_1="0.16" SD_2="0.2" SE="0.04380199445932478" STUDY_ID="STD-Wing-1998" TOTAL_1="33" TOTAL_2="35" WEIGHT="10.972979393257457"/>
<CONT_DATA CI_END="0.054656452566373" CI_START="-0.07465645256637299" EFFECT_SIZE="-0.009999999999999995" ESTIMABLE="YES" MEAN_1="0.11" MEAN_2="0.12" ORDER="10036" SD_1="0.15" SD_2="0.16" SE="0.03298859217637407" STUDY_ID="STD-Wood-1988" TOTAL_1="47" TOTAL_2="42" WEIGHT="19.3457143784911"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.90847591119636" CI_END="0.1963232737359603" CI_START="-0.0016401265181088254" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.09734157360892574" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.08" NO="8" P_CHI2="0.6349316597829706" P_Q="1.0" P_Z="0.05391891852866472" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="172" TOTAL_2="182" UNITS="" WEIGHT="100.0" Z="1.9274873863258721">
<NAME>Change in fasting serum glucose (mmol/l)</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Diet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours diet</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.29610250148398254" CI_START="-0.056102501483982575" EFFECT_SIZE="0.12" ESTIMABLE="YES" MEAN_1="-0.09" MEAN_2="-0.21" ORDER="10037" SD_1="0.4" SD_2="0.5" SE="0.08984986605522174" STUDY_ID="STD-Anderssen-1996" TOTAL_1="49" TOTAL_2="52" WEIGHT="31.592119831271585"/>
<CONT_DATA CI_END="0.19313470784669998" CI_START="-0.07313470784669998" EFFECT_SIZE="0.06" ESTIMABLE="YES" MEAN_1="-0.37" MEAN_2="-0.43" ORDER="10038" SD_1="0.49" SD_2="0.43" SE="0.06792711952711863" STUDY_ID="STD-Stefanick-1998" TOTAL_1="90" TOTAL_2="95" WEIGHT="55.27480751861214"/>
<CONT_DATA CI_END="0.4731314659720528" CI_START="-0.07313146597205278" EFFECT_SIZE="0.2" ESTIMABLE="YES" MEAN_1="0.0" MEAN_2="-0.2" ORDER="10039" SD_1="0.7" SD_2="0.4" SE="0.13935534944849953" STUDY_ID="STD-Wing-1998" TOTAL_1="33" TOTAL_2="35" WEIGHT="13.133072650116278"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" NO="3">
<NAME>Exercise + diet versus diet alone</NAME>
<CONT_OUTCOME CHI2="59.27982863881757" CI_END="-0.3625855519918589" CI_START="-0.7622842022843503" CI_STUDY="95" CI_TOTAL="95" DF="35.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.5624348771381046" ESTIMABLE="YES" I2="40.95799396916386" I2_Q="31.77991883453296" ID="CMP-003.01" NO="1" P_CHI2="0.0063499309902012024" P_Q="0.20958648962893356" P_Z="3.4696783954264794E-8" Q="5.863376196076409" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="15" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="1278" TOTAL_2="969" UNITS="" WEIGHT="100.0" Z="5.515916063430368">
<NAME>Weight change in kilograms</NAME>
<GROUP_LABEL_1>Diet + exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Diet alone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Diet + exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Diet alone</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="23.591276278855755" CI_END="-0.33337409683699465" CI_START="-0.9686741173527316" DF="14.0" EFFECT_SIZE="-0.6510241070948631" ESTIMABLE="YES" I2="40.65602965046942" ID="CMP-003.01.01" NO="1" P_CHI2="0.05130344506674356" P_Z="5.895654621909141E-5" STUDIES="15" TAU2="0.0" TOTAL_1="595" TOTAL_2="484" WEIGHT="39.582901419413005" Z="4.016948722707216">
<NAME>Weight change - all studies</NAME>
<CONT_DATA CI_END="3.3377561197127" CI_START="-4.137756119712697" EFFECT_SIZE="-0.3999999999999986" ESTIMABLE="YES" MEAN_1="-15.2" MEAN_2="-14.8" ORDER="10040" SD_1="6.3" SD_2="5.3" SE="1.9070534709798963" STUDY_ID="STD-Aggel_x002d_Leijssen-2001" TOTAL_1="20" TOTAL_2="17" WEIGHT="0.28587978690225696"/>
<CONT_DATA CI_END="1.0654999952333504" CI_START="-3.66549999523335" EFFECT_SIZE="-1.2999999999999998" ESTIMABLE="YES" MEAN_1="-7.1" MEAN_2="-5.8" ORDER="10041" SD_1="2.9" SD_2="3.9" SE="1.20690992992326" STUDY_ID="STD-Gordon-1997" TOTAL_1="19" TOTAL_2="15" WEIGHT="0.7137719371494846"/>
<CONT_DATA CI_END="-0.7135729355460053" CI_START="-2.486427064453994" EFFECT_SIZE="-1.5999999999999996" ESTIMABLE="YES" MEAN_1="-4.8" MEAN_2="-3.2" ORDER="10042" SD_1="0.9" SD_2="1.2" SE="0.45226701686664544" STUDY_ID="STD-Hays-2004" TOTAL_1="11" TOTAL_2="11" WEIGHT="5.082991192000948"/>
<CONT_DATA CI_END="2.0467467626091063" CI_START="-3.0467467626091063" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="-10.5" MEAN_2="-10.0" ORDER="10043" SD_1="3.6" SD_2="3.9" SE="1.299384469662463" STUDY_ID="STD-Janssen-2002" TOTAL_1="25" TOTAL_2="13" WEIGHT="0.6157917222331057"/>
<CONT_DATA CI_END="-0.6132453780837661" CI_START="-4.186754621916235" EFFECT_SIZE="-2.4000000000000004" ESTIMABLE="YES" MEAN_1="-6.9" MEAN_2="-4.5" ORDER="10044" SD_1="5.5" SD_2="5.7" SE="0.9116262523239849" STUDY_ID="STD-Kiernan-2001" TOTAL_1="81" TOTAL_2="71" WEIGHT="1.2510525249191282"/>
<CONT_DATA CI_END="1.6301440696028495" CI_START="-1.23014406960285" EFFECT_SIZE="0.19999999999999973" ESTIMABLE="YES" MEAN_1="-3.6" MEAN_2="-3.8" ORDER="10045" SD_1="2.6" SD_2="2.0" SE="0.7296787496523628" STUDY_ID="STD-Neumark-1995" TOTAL_1="21" TOTAL_2="19" WEIGHT="1.9527461626037088"/>
<CONT_DATA CI_END="2.022466569168997" CI_START="-1.6224665691689966" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" MEAN_1="-7.8" MEAN_2="-8.0" ORDER="10046" SD_1="3.3" SD_2="3.1" SE="0.9298469683853277" STUDY_ID="STD-Nieman-1998" TOTAL_1="22" TOTAL_2="26" WEIGHT="1.2025031734554168"/>
<CONT_DATA CI_END="1.6332172662643876" CI_START="-3.6332172662643876" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="-12.4" MEAN_2="-11.4" ORDER="10047" SD_1="3.9" SD_2="3.5" SE="1.34350288425444" STUDY_ID="STD-Ross-1996" TOTAL_1="22" TOTAL_2="11" WEIGHT="0.5760126004533938"/>
<CONT_DATA CI_END="0.18202002612585777" CI_START="-1.9820200261258585" EFFECT_SIZE="-0.9000000000000004" ESTIMABLE="YES" MEAN_1="-3.7" MEAN_2="-2.8" ORDER="10048" SD_1="4.0" SD_2="3.5" SE="0.5520611779913784" STUDY_ID="STD-Stefanick-1998" TOTAL_1="91" TOTAL_2="95" WEIGHT="3.411416726562239"/>
<CONT_DATA CI_END="0.350049682389846" CI_START="-1.9500496823898474" EFFECT_SIZE="-0.8000000000000007" ESTIMABLE="YES" MEAN_1="-10.3" MEAN_2="-9.5" ORDER="10049" SD_1="3.0" SD_2="2.8" SE="0.5867708240872239" STUDY_ID="STD-Svendsen-1993" TOTAL_1="48" TOTAL_2="50" WEIGHT="3.0197581870995522"/>
<CONT_DATA CI_END="0.2626274249283285" CI_START="-0.662627424928327" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="-7.6" MEAN_2="-7.4" ORDER="10050" SD_1="0.4" SD_2="0.8" SE="0.23603873774083295" STUDY_ID="STD-Thong-2000" TOTAL_1="16" TOTAL_2="14" WEIGHT="18.661331299304177"/>
<CONT_DATA CI_END="2.8013224728546158" CI_START="-2.2013224728546144" EFFECT_SIZE="0.3000000000000007" ESTIMABLE="YES" MEAN_1="-16.4" MEAN_2="-16.7" ORDER="10051" SD_1="7.3" SD_2="5.5" SE="1.276208385758477" STUDY_ID="STD-Wadden-1997" TOTAL_1="91" TOTAL_2="29" WEIGHT="0.6383604940106217"/>
<CONT_DATA CI_END="-1.880408085867474" CI_START="-7.319591914132525" EFFECT_SIZE="-4.6" ESTIMABLE="YES" MEAN_1="-17.7" MEAN_2="-13.1" ORDER="10052" SD_1="4.2" SD_2="2.4" SE="1.3875723919338923" STUDY_ID="STD-Whatley-1994" TOTAL_1="16" TOTAL_2="7" WEIGHT="0.5400051349826472"/>
<CONT_DATA CI_END="2.2413230260350274" CI_START="-4.64132302603503" EFFECT_SIZE="-1.200000000000001" ESTIMABLE="YES" MEAN_1="-10.3" MEAN_2="-9.1" ORDER="10053" SD_1="7.7" SD_2="6.4" SE="1.7558093175077427" STUDY_ID="STD-Wing-1998" TOTAL_1="31" TOTAL_2="35" WEIGHT="0.3372519670313812"/>
<CONT_DATA CI_END="0.6568341448113884" CI_START="-2.8568341448113888" EFFECT_SIZE="-1.1" ESTIMABLE="YES" MEAN_1="-3.4" MEAN_2="-2.3" ORDER="10054" SD_1="4.9" SD_2="6.0" SE="0.8963604222674865" STUDY_ID="STD-Wood-1991" TOTAL_1="81" TOTAL_2="71" WEIGHT="1.2940285107049518"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.3523508637923634" CI_END="0.22576855872718898" CI_START="-0.6788321353225943" DF="2.0" EFFECT_SIZE="-0.22653178829770265" ESTIMABLE="YES" I2="0.0" ID="CMP-003.01.02" NO="2" P_CHI2="0.8384709116140615" P_Z="0.3262793892329988" STUDIES="3" TAU2="0.0" TOTAL_1="58" TOTAL_2="42" WEIGHT="19.523223686659826" Z="0.9816356528077455">
<NAME>Weight change - males</NAME>
<CONT_DATA CI_END="3.3377561197127" CI_START="-4.137756119712697" EFFECT_SIZE="-0.3999999999999986" ESTIMABLE="YES" MEAN_1="-15.2" MEAN_2="-14.8" ORDER="10055" SD_1="6.3" SD_2="5.3" SE="1.9070534709798963" STUDY_ID="STD-Aggel_x002d_Leijssen-2001" TOTAL_1="20" TOTAL_2="17" WEIGHT="0.28587978690225696"/>
<CONT_DATA CI_END="1.6332172662643876" CI_START="-3.6332172662643876" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="-12.4" MEAN_2="-11.4" ORDER="10056" SD_1="3.9" SD_2="3.5" SE="1.34350288425444" STUDY_ID="STD-Ross-1996" TOTAL_1="22" TOTAL_2="11" WEIGHT="0.5760126004533938"/>
<CONT_DATA CI_END="0.2626274249283285" CI_START="-0.662627424928327" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="-7.6" MEAN_2="-7.4" ORDER="10057" SD_1="0.4" SD_2="0.8" SE="0.23603873774083295" STUDY_ID="STD-Thong-2000" TOTAL_1="16" TOTAL_2="14" WEIGHT="18.661331299304177"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="10.852862801616235" CI_END="0.15767277464594398" CI_START="-1.2582066663204459" DF="5.0" EFFECT_SIZE="-0.5502669458372509" ESTIMABLE="YES" I2="53.929206593716565" ID="CMP-003.01.03" NO="3" P_CHI2="0.05437663453077246" P_Z="0.1276487641757504" STUDIES="6" TAU2="0.0" TOTAL_1="223" TOTAL_2="144" WEIGHT="7.9691648743850525" Z="1.523439587466213">
<NAME>Weight change - females</NAME>
<CONT_DATA CI_END="2.0467467626091063" CI_START="-3.0467467626091063" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="-10.5" MEAN_2="-10.0" ORDER="10058" SD_1="3.6" SD_2="3.9" SE="1.299384469662463" STUDY_ID="STD-Janssen-2002" TOTAL_1="25" TOTAL_2="13" WEIGHT="0.6157917222331057"/>
<CONT_DATA CI_END="1.6301440696028495" CI_START="-1.23014406960285" EFFECT_SIZE="0.19999999999999973" ESTIMABLE="YES" MEAN_1="-3.6" MEAN_2="-3.8" ORDER="10059" SD_1="2.6" SD_2="2.0" SE="0.7296787496523628" STUDY_ID="STD-Neumark-1995" TOTAL_1="21" TOTAL_2="19" WEIGHT="1.9527461626037088"/>
<CONT_DATA CI_END="2.022466569168997" CI_START="-1.6224665691689966" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" MEAN_1="-7.8" MEAN_2="-8.0" ORDER="10060" SD_1="3.3" SD_2="3.1" SE="0.9298469683853277" STUDY_ID="STD-Nieman-1998" TOTAL_1="22" TOTAL_2="26" WEIGHT="1.2025031734554168"/>
<CONT_DATA CI_END="0.350049682389846" CI_START="-1.9500496823898474" EFFECT_SIZE="-0.8000000000000007" ESTIMABLE="YES" MEAN_1="-10.3" MEAN_2="-9.5" ORDER="10061" SD_1="3.0" SD_2="2.8" SE="0.5867708240872239" STUDY_ID="STD-Svendsen-1993" TOTAL_1="48" TOTAL_2="50" WEIGHT="3.0197581870995522"/>
<CONT_DATA CI_END="2.8013224728546158" CI_START="-2.2013224728546144" EFFECT_SIZE="0.3000000000000007" ESTIMABLE="YES" MEAN_1="-16.4" MEAN_2="-16.7" ORDER="10062" SD_1="7.3" SD_2="5.5" SE="1.276208385758477" STUDY_ID="STD-Wadden-1997" TOTAL_1="91" TOTAL_2="29" WEIGHT="0.6383604940106217"/>
<CONT_DATA CI_END="-1.880408085867474" CI_START="-7.319591914132525" EFFECT_SIZE="-4.6" ESTIMABLE="YES" MEAN_1="-17.7" MEAN_2="-13.1" ORDER="10063" SD_1="4.2" SD_2="2.4" SE="1.3875723919338923" STUDY_ID="STD-Whatley-1994" TOTAL_1="16" TOTAL_2="7" WEIGHT="0.5400051349826472"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="15.15675829578152" CI_END="-0.023549577546907507" CI_START="-0.8649097956581115" DF="6.0" EFFECT_SIZE="-0.4442296866025095" ESTIMABLE="YES" I2="60.413698741439056" ID="CMP-003.01.04" NO="4" P_CHI2="0.01907194419474023" P_Z="0.038482102908382804" STUDIES="7" TAU2="0.0" TOTAL_1="271" TOTAL_2="162" WEIGHT="22.568433562805332" Z="2.0696823259817014">
<NAME>Weight change - mean age &lt; 45 years</NAME>
<CONT_DATA CI_END="3.3377561197127" CI_START="-4.137756119712697" EFFECT_SIZE="-0.3999999999999986" ESTIMABLE="YES" MEAN_1="-15.2" MEAN_2="-14.8" ORDER="10064" SD_1="6.3" SD_2="5.3" SE="1.9070534709798963" STUDY_ID="STD-Aggel_x002d_Leijssen-2001" TOTAL_1="20" TOTAL_2="17" WEIGHT="0.28587978690225696"/>
<CONT_DATA CI_END="2.0467467626091063" CI_START="-3.0467467626091063" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="-10.5" MEAN_2="-10.0" ORDER="10065" SD_1="3.6" SD_2="3.9" SE="1.299384469662463" STUDY_ID="STD-Janssen-2002" TOTAL_1="25" TOTAL_2="13" WEIGHT="0.6157917222331057"/>
<CONT_DATA CI_END="-0.6132453780837661" CI_START="-4.186754621916235" EFFECT_SIZE="-2.4000000000000004" ESTIMABLE="YES" MEAN_1="-6.9" MEAN_2="-4.5" ORDER="10066" SD_1="5.5" SD_2="5.7" SE="0.9116262523239849" STUDY_ID="STD-Kiernan-2001" TOTAL_1="81" TOTAL_2="71" WEIGHT="1.2510525249191282"/>
<CONT_DATA CI_END="1.6332172662643876" CI_START="-3.6332172662643876" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="-12.4" MEAN_2="-11.4" ORDER="10067" SD_1="3.9" SD_2="3.5" SE="1.34350288425444" STUDY_ID="STD-Ross-1996" TOTAL_1="22" TOTAL_2="11" WEIGHT="0.5760126004533938"/>
<CONT_DATA CI_END="0.2626274249283285" CI_START="-0.662627424928327" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="-7.6" MEAN_2="-7.4" ORDER="10068" SD_1="0.4" SD_2="0.8" SE="0.23603873774083295" STUDY_ID="STD-Thong-2000" TOTAL_1="16" TOTAL_2="14" WEIGHT="18.661331299304177"/>
<CONT_DATA CI_END="2.8013224728546158" CI_START="-2.2013224728546144" EFFECT_SIZE="0.3000000000000007" ESTIMABLE="YES" MEAN_1="-16.4" MEAN_2="-16.7" ORDER="10069" SD_1="7.3" SD_2="5.5" SE="1.276208385758477" STUDY_ID="STD-Wadden-1997" TOTAL_1="91" TOTAL_2="29" WEIGHT="0.6383604940106217"/>
<CONT_DATA CI_END="-1.880408085867474" CI_START="-7.319591914132525" EFFECT_SIZE="-4.6" ESTIMABLE="YES" MEAN_1="-17.7" MEAN_2="-13.1" ORDER="10070" SD_1="4.2" SD_2="2.4" SE="1.3875723919338923" STUDY_ID="STD-Whatley-1994" TOTAL_1="16" TOTAL_2="7" WEIGHT="0.5400051349826472"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.463204202695284" CI_END="-0.503010207619575" CI_START="-1.7450367134047786" DF="4.0" EFFECT_SIZE="-1.1240234605121768" ESTIMABLE="YES" I2="0.0" ID="CMP-003.01.05" NO="5" P_CHI2="0.4834952783726484" P_Z="3.88903408240072E-4" STUDIES="5" TAU2="0.0" TOTAL_1="131" TOTAL_2="137" WEIGHT="10.356276456736785" Z="3.547501587317883">
<NAME>Weight change - mean age &gt; 45 years</NAME>
<CONT_DATA CI_END="1.0654999952333504" CI_START="-3.66549999523335" EFFECT_SIZE="-1.2999999999999998" ESTIMABLE="YES" MEAN_1="-7.1" MEAN_2="-5.8" ORDER="10071" SD_1="2.9" SD_2="3.9" SE="1.20690992992326" STUDY_ID="STD-Gordon-1997" TOTAL_1="19" TOTAL_2="15" WEIGHT="0.7137719371494846"/>
<CONT_DATA CI_END="-0.7135729355460053" CI_START="-2.486427064453994" EFFECT_SIZE="-1.5999999999999996" ESTIMABLE="YES" MEAN_1="-4.8" MEAN_2="-3.2" ORDER="10072" SD_1="0.9" SD_2="1.2" SE="0.45226701686664544" STUDY_ID="STD-Hays-2004" TOTAL_1="11" TOTAL_2="11" WEIGHT="5.082991192000948"/>
<CONT_DATA CI_END="2.022466569168997" CI_START="-1.6224665691689966" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" MEAN_1="-7.8" MEAN_2="-8.0" ORDER="10073" SD_1="3.3" SD_2="3.1" SE="0.9298469683853277" STUDY_ID="STD-Nieman-1998" TOTAL_1="22" TOTAL_2="26" WEIGHT="1.2025031734554168"/>
<CONT_DATA CI_END="0.350049682389846" CI_START="-1.9500496823898474" EFFECT_SIZE="-0.8000000000000007" ESTIMABLE="YES" MEAN_1="-10.3" MEAN_2="-9.5" ORDER="10074" SD_1="3.0" SD_2="2.8" SE="0.5867708240872239" STUDY_ID="STD-Svendsen-1993" TOTAL_1="48" TOTAL_2="50" WEIGHT="3.0197581870995522"/>
<CONT_DATA CI_END="2.2413230260350274" CI_START="-4.64132302603503" EFFECT_SIZE="-1.200000000000001" ESTIMABLE="YES" MEAN_1="-10.3" MEAN_2="-9.1" ORDER="10075" SD_1="7.7" SD_2="6.4" SE="1.7558093175077427" STUDY_ID="STD-Wing-1998" TOTAL_1="31" TOTAL_2="35" WEIGHT="0.3372519670313812"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="4.7580277385763114" CI_END="-0.07008524276599246" CI_START="-0.5521693949980085" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.3111273188820005" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.02" NO="2" P_CHI2="0.44611880314802754" P_Q="1.0" P_Z="0.011411393918201508" Q="0.0" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="257" TOTAL_2="225" UNITS="" WEIGHT="100.0" Z="2.5298418825506124">
<NAME>Change in body mass index (BMI)</NAME>
<GROUP_LABEL_1>Diet + exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Diet alone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Diet + exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Diet alone</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.05637975409244933" CI_START="-1.2563797540924495" EFFECT_SIZE="-0.6000000000000001" ESTIMABLE="YES" MEAN_1="-2.2" MEAN_2="-1.6" ORDER="10076" SD_1="1.8" SD_2="1.8" SE="0.33489378339086284" STUDY_ID="STD-Anderssen-1996" TOTAL_1="65" TOTAL_2="52" WEIGHT="13.485758087576047"/>
<CONT_DATA CI_END="0.1410616902857415" CI_START="-0.7410616902857414" EFFECT_SIZE="-0.3" ESTIMABLE="YES" MEAN_1="-0.6" MEAN_2="-0.3" ORDER="10077" SD_1="1.0" SD_2="1.0" SE="0.22503560971771921" STUDY_ID="STD-Hellenius-1993" TOTAL_1="39" TOTAL_2="40" WEIGHT="29.86668651901652"/>
<CONT_DATA CI_END="0.8747001762600287" CI_START="-0.8747001762600287" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="-4.0" MEAN_2="-4.0" ORDER="10078" SD_1="1.1" SD_2="1.4" SE="0.44628380070223334" STUDY_ID="STD-Janssen-2002" TOTAL_1="25" TOTAL_2="13" WEIGHT="7.593942256946501"/>
<CONT_DATA CI_END="-0.12645076307210745" CI_START="-1.273549236927892" EFFECT_SIZE="-0.6999999999999997" ESTIMABLE="YES" MEAN_1="-2.3" MEAN_2="-1.6" ORDER="10079" SD_1="1.8" SD_2="1.8" SE="0.29263253888947727" STUDY_ID="STD-Kiernan-2001" TOTAL_1="81" TOTAL_2="71" WEIGHT="17.662179981144956"/>
<CONT_DATA CI_END="0.4626274249283278" CI_START="-0.4626274249283278" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="-2.4" MEAN_2="-2.4" ORDER="10080" SD_1="0.4" SD_2="0.8" SE="0.23603873774083295" STUDY_ID="STD-Thong-2000" TOTAL_1="16" TOTAL_2="14" WEIGHT="27.147070422445978"/>
<CONT_DATA CI_END="0.7700020238799212" CI_START="-1.570002023879922" EFFECT_SIZE="-0.40000000000000036" ESTIMABLE="YES" MEAN_1="-3.7" MEAN_2="-3.3" ORDER="10081" SD_1="2.6" SD_2="2.2" SE="0.5969507772126162" STUDY_ID="STD-Wing-1998" TOTAL_1="31" TOTAL_2="35" WEIGHT="4.244362732870007"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="3.582520310717406" CI_END="1.2477932495177566" CI_START="-1.476434437787148" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.11432059413469561" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.03" NO="3" P_CHI2="0.6109398505977701" P_Q="1.0" P_Z="0.8693395579405506" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="309" TOTAL_2="306" UNITS="" WEIGHT="100.0" Z="0.16449744508462324">
<NAME>Change in systolic blood pressure (mmHg)</NAME>
<GROUP_LABEL_1>Diet + exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Diet alone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Diet + exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Diet alone</GRAPH_LABEL_2>
<CONT_DATA CI_END="5.546836618513053" CI_START="-7.946836618513052" EFFECT_SIZE="-1.1999999999999993" ESTIMABLE="YES" MEAN_1="-12.5" MEAN_2="-11.3" ORDER="10082" SD_1="6.3" SD_2="12.1" SE="3.4423268344373867" STUDY_ID="STD-Gordon-1997" TOTAL_1="19" TOTAL_2="15" WEIGHT="4.075927278865966"/>
<CONT_DATA CI_END="7.619584354732946" CI_START="-1.6195843547329458" EFFECT_SIZE="3.0" ESTIMABLE="YES" MEAN_1="-4.0" MEAN_2="-7.0" ORDER="10083" SD_1="9.6" SD_2="11.3" SE="2.356974103183343" STUDY_ID="STD-Hellenius-1993" TOTAL_1="39" TOTAL_2="40" WEIGHT="8.694027508807022"/>
<CONT_DATA CI_END="1.713237923699281" CI_START="-2.713237923699281" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="-3.1" MEAN_2="-2.6" ORDER="10084" SD_1="7.6" SD_2="7.8" SE="1.1292237720473535" STUDY_ID="STD-Stefanick-1998" TOTAL_1="91" TOTAL_2="95" WEIGHT="37.8765668327339"/>
<CONT_DATA CI_END="6.554896140136698" CI_START="-2.554896140136698" EFFECT_SIZE="2.0" ESTIMABLE="YES" MEAN_1="-11.0" MEAN_2="-13.0" ORDER="10085" SD_1="11.0" SD_2="12.0" SE="2.3239693055919077" STUDY_ID="STD-Svendsen-1993" TOTAL_1="48" TOTAL_2="50" WEIGHT="8.942724596138937"/>
<CONT_DATA CI_END="2.42474826674151" CI_START="-6.624748266741513" EFFECT_SIZE="-2.1000000000000014" ESTIMABLE="YES" MEAN_1="-12.3" MEAN_2="-10.2" ORDER="10086" SD_1="9.5" SD_2="9.2" SE="2.3085874548880225" STUDY_ID="STD-Wing-1998" TOTAL_1="31" TOTAL_2="35" WEIGHT="9.062290275165116"/>
<CONT_DATA CI_END="2.032793669877668" CI_START="-2.8327936698776686" EFFECT_SIZE="-0.40000000000000036" ESTIMABLE="YES" MEAN_1="-4.5" MEAN_2="-4.1" ORDER="10087" SD_1="8.0" SD_2="7.3" SE="1.2412440682927004" STUDY_ID="STD-Wood-1991" TOTAL_1="81" TOTAL_2="71" WEIGHT="31.34846350828906"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="10.903430321480021" CI_END="0.004818345902193433" CI_START="-1.885285794743155" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.9402337244204807" ESTIMABLE="YES" I2="54.14287199002062" I2_Q="0.0" ID="CMP-003.04" NO="4" P_CHI2="0.05332869180486666" P_Q="1.0" P_Z="0.051179562229300604" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="309" TOTAL_2="306" UNITS="" WEIGHT="100.0" Z="1.949971112475205">
<NAME>Change in diastolic blood pressure (mmHg)</NAME>
<GROUP_LABEL_1>Diet + exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Diet alone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Diet + exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Diet alone</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.510942153033491" CI_START="-3.310942153033492" EFFECT_SIZE="-0.40000000000000036" ESTIMABLE="YES" MEAN_1="-7.9" MEAN_2="-7.5" ORDER="10088" SD_1="4.3" SD_2="4.3" SE="1.4852018588069127" STUDY_ID="STD-Gordon-1997" TOTAL_1="19" TOTAL_2="15" WEIGHT="10.540090150889998"/>
<CONT_DATA CI_END="7.2189242462445975" CI_START="0.7810757537554025" EFFECT_SIZE="4.0" ESTIMABLE="YES" MEAN_1="-2.0" MEAN_2="-6.0" ORDER="10089" SD_1="8.0" SD_2="6.5" SE="1.642338467255042" STUDY_ID="STD-Hellenius-1993" TOTAL_1="39" TOTAL_2="40" WEIGHT="8.619656582595207"/>
<CONT_DATA CI_END="-0.25870937274144135" CI_START="-3.3412906272585583" EFFECT_SIZE="-1.7999999999999998" ESTIMABLE="YES" MEAN_1="-2.9" MEAN_2="-1.1" ORDER="10090" SD_1="5.6" SD_2="5.1" SE="0.7863872190591573" STUDY_ID="STD-Stefanick-1998" TOTAL_1="91" TOTAL_2="95" WEIGHT="37.59606578474966"/>
<CONT_DATA CI_END="1.1684400554132814" CI_START="-5.168440055413281" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="-9.0" MEAN_2="-7.0" ORDER="10091" SD_1="8.0" SD_2="8.0" SE="1.6165807537309522" STUDY_ID="STD-Svendsen-1993" TOTAL_1="48" TOTAL_2="50" WEIGHT="8.89652668402055"/>
<CONT_DATA CI_END="3.6160694270638585" CI_START="-5.016069427063859" EFFECT_SIZE="-0.7000000000000002" ESTIMABLE="YES" MEAN_1="-6.9" MEAN_2="-6.2" ORDER="10092" SD_1="10.4" SD_2="6.9" SE="2.202116702709062" STUDY_ID="STD-Wing-1998" TOTAL_1="31" TOTAL_2="35" WEIGHT="4.794404051622215"/>
<CONT_DATA CI_END="0.5384134141044172" CI_START="-2.9384134141044176" EFFECT_SIZE="-1.2000000000000002" ESTIMABLE="YES" MEAN_1="-3.5" MEAN_2="-2.3" ORDER="10093" SD_1="4.9" SD_2="5.9" SE="0.8869619175744047" STUDY_ID="STD-Wood-1991" TOTAL_1="81" TOTAL_2="71" WEIGHT="29.553256746122365"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="36.34377615383592" CI_END="0.1255789111056501" CI_START="-0.06610964671657336" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.029734632194538358" ESTIMABLE="YES" I2="86.24248625449376" I2_Q="0.0" ID="CMP-003.05" NO="5" P_CHI2="8.106786955064393E-7" P_Q="1.0" P_Z="0.5431495107829716" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="315" TOTAL_2="304" UNITS="" WEIGHT="100.0" Z="0.6080572451162113">
<NAME>Change in total serum cholesterol (mmol/l)</NAME>
<GROUP_LABEL_1>Diet + exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Diet alone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Diet + exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Diet alone</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.17913439465908654" CI_START="-0.6991343946590866" EFFECT_SIZE="-0.26" ESTIMABLE="YES" MEAN_1="-0.45" MEAN_2="-0.19" ORDER="10094" SD_1="1.02" SD_2="0.97" SE="0.22405227755352783" STUDY_ID="STD-Hellenius-1993" TOTAL_1="39" TOTAL_2="40" WEIGHT="4.763624064911402"/>
<CONT_DATA CI_END="0.95147610201547" CI_START="0.4085238979845299" EFFECT_SIZE="0.6799999999999999" ESTIMABLE="YES" MEAN_1="-0.15" MEAN_2="-0.83" ORDER="10095" SD_1="0.48" SD_2="0.36" SE="0.13851076048174296" STUDY_ID="STD-Janssen-2002" TOTAL_1="25" TOTAL_2="13" WEIGHT="12.464336900102218"/>
<CONT_DATA CI_END="-0.07178742325956325" CI_START="-0.3682125767404367" EFFECT_SIZE="-0.21999999999999997" ESTIMABLE="YES" MEAN_1="-0.49" MEAN_2="-0.27" ORDER="10096" SD_1="0.53" SD_2="0.5" SE="0.07562005113844877" STUDY_ID="STD-Stefanick-1998" TOTAL_1="91" TOTAL_2="95" WEIGHT="41.817905138840736"/>
<CONT_DATA CI_END="0.4672970989310255" CI_START="-0.12729709893102564" EFFECT_SIZE="0.16999999999999993" ESTIMABLE="YES" MEAN_1="-1.23" MEAN_2="-1.4" ORDER="10097" SD_1="0.7" SD_2="0.8" SE="0.15168498057926938" STUDY_ID="STD-Svendsen-1993" TOTAL_1="48" TOTAL_2="50" WEIGHT="10.39324215054978"/>
<CONT_DATA CI_END="0.47849314006050875" CI_START="-0.1584931400605088" EFFECT_SIZE="0.15999999999999998" ESTIMABLE="YES" MEAN_1="-0.33" MEAN_2="-0.49" ORDER="10098" SD_1="0.61" SD_2="0.71" SE="0.16249948599706016" STUDY_ID="STD-Wing-1998" TOTAL_1="31" TOTAL_2="35" WEIGHT="9.055912619564022"/>
<CONT_DATA CI_END="0.28667915706925096" CI_START="-0.1266791570692509" EFFECT_SIZE="0.08000000000000002" ESTIMABLE="YES" MEAN_1="-0.32" MEAN_2="-0.4" ORDER="10099" SD_1="0.7" SD_2="0.6" SE="0.10545048720257602" STUDY_ID="STD-Wood-1991" TOTAL_1="81" TOTAL_2="71" WEIGHT="21.504979126031838"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="8.96157317724548" CI_END="0.020723992723359896" CI_START="-0.17744098630034988" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.07835849678849499" ESTIMABLE="YES" I2="44.206224720726425" I2_Q="0.0" ID="CMP-003.06" NO="6" P_CHI2="0.11060686016999666" P_Q="1.0" P_Z="0.12113673704246233" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="315" TOTAL_2="304" UNITS="" WEIGHT="100.0" Z="1.5500199111344732">
<NAME>Change in serum triglycerides (mmol/l)</NAME>
<GROUP_LABEL_1>Diet + exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Diet alone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Diet + exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Diet alone</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.07906361842413265" CI_START="-0.3790636184241326" EFFECT_SIZE="-0.15" ESTIMABLE="YES" MEAN_1="-0.12" MEAN_2="0.03" ORDER="10100" SD_1="0.62" SD_2="0.39" SE="0.11687134061184656" STUDY_ID="STD-Hellenius-1993" TOTAL_1="39" TOTAL_2="40" WEIGHT="18.710335987925443"/>
<CONT_DATA CI_END="0.9220112300459828" CI_START="-0.9020112300459828" EFFECT_SIZE="0.010000000000000009" ESTIMABLE="YES" MEAN_1="-0.31" MEAN_2="-0.32" ORDER="10101" SD_1="0.7" SD_2="1.6" SE="0.4653204024358667" STUDY_ID="STD-Janssen-2002" TOTAL_1="25" TOTAL_2="13" WEIGHT="1.1803028284931922"/>
<CONT_DATA CI_END="0.14711178525964805" CI_START="-0.22711178525964806" EFFECT_SIZE="-0.04000000000000001" ESTIMABLE="YES" MEAN_1="-0.1" MEAN_2="-0.06" ORDER="10102" SD_1="0.6" SD_2="0.7" SE="0.09546695078866853" STUDY_ID="STD-Stefanick-1998" TOTAL_1="91" TOTAL_2="95" WEIGHT="28.04087329727573"/>
<CONT_DATA CI_END="0.4336251857371026" CI_START="-0.0336251857371026" EFFECT_SIZE="0.2" ESTIMABLE="YES" MEAN_1="-0.3" MEAN_2="-0.5" ORDER="10103" SD_1="0.46" SD_2="0.7" SE="0.11919871363959147" STUDY_ID="STD-Svendsen-1993" TOTAL_1="48" TOTAL_2="50" WEIGHT="17.986824642324233"/>
<CONT_DATA CI_END="0.31092764948959245" CI_START="-1.0909276494895923" EFFECT_SIZE="-0.38999999999999996" ESTIMABLE="YES" MEAN_1="-0.69" MEAN_2="-0.3" ORDER="10104" SD_1="1.45" SD_2="1.45" SE="0.3576227191001571" STUDY_ID="STD-Wing-1998" TOTAL_1="31" TOTAL_2="35" WEIGHT="1.9982390237963255"/>
<CONT_DATA CI_END="-0.035073118797183" CI_START="-0.384926881202817" EFFECT_SIZE="-0.21" ESTIMABLE="YES" MEAN_1="-0.24" MEAN_2="-0.03" ORDER="10105" SD_1="0.6" SD_2="0.5" SE="0.08925004876753752" STUDY_ID="STD-Wood-1991" TOTAL_1="81" TOTAL_2="71" WEIGHT="32.083424220185066"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="19.091999925003773" CI_END="0.04218140649005063" CI_START="-0.013199947629961186" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.014490729430044721" ESTIMABLE="YES" I2="73.81102021977401" I2_Q="0.0" ID="CMP-003.07" NO="7" P_CHI2="0.001847750137418891" P_Q="1.0" P_Z="0.30505039158301617" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="315" TOTAL_2="304" UNITS="" WEIGHT="100.0" Z="1.0256631764928112">
<NAME>Change in serum HDL (mmol/l)</NAME>
<GROUP_LABEL_1>Diet + exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Diet alone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Diet + exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Diet alone</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.04837827799512968" CI_START="-0.12837827799512969" EFFECT_SIZE="-0.04" ESTIMABLE="YES" MEAN_1="-0.03" MEAN_2="0.01" ORDER="10106" SD_1="0.21" SD_2="0.19" SE="0.04509178673294318" STUDY_ID="STD-Hellenius-1993" TOTAL_1="39" TOTAL_2="40" WEIGHT="9.816938693772686"/>
<CONT_DATA CI_END="0.13153558301509477" CI_START="-0.15153558301509473" EFFECT_SIZE="-0.009999999999999995" ESTIMABLE="YES" MEAN_1="-0.06" MEAN_2="-0.05" ORDER="10107" SD_1="0.14" SD_2="0.24" SE="0.07221335908797782" STUDY_ID="STD-Janssen-2002" TOTAL_1="25" TOTAL_2="13" WEIGHT="3.8276822047313326"/>
<CONT_DATA CI_END="0.04041270286521414" CI_START="-0.04041270286521414" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="-0.01" MEAN_2="-0.01" ORDER="10108" SD_1="0.15" SD_2="0.13" SE="0.02061910483252977" STUDY_ID="STD-Stefanick-1998" TOTAL_1="91" TOTAL_2="95" WEIGHT="46.94954135478925"/>
<CONT_DATA CI_END="0.057781684878959974" CI_START="-0.15778168487896" EFFECT_SIZE="-0.05" ESTIMABLE="YES" MEAN_1="-0.1" MEAN_2="-0.05" ORDER="10109" SD_1="0.23" SD_2="0.31" SE="0.05499166603525787" STUDY_ID="STD-Svendsen-1993" TOTAL_1="48" TOTAL_2="50" WEIGHT="6.600505735532822"/>
<CONT_DATA CI_END="0.03965079349237392" CI_START="-0.11965079349237394" EFFECT_SIZE="-0.04000000000000001" ESTIMABLE="YES" MEAN_1="0.06" MEAN_2="0.1" ORDER="10110" SD_1="0.16" SD_2="0.17" SE="0.04063890669453583" STUDY_ID="STD-Wing-1998" TOTAL_1="31" TOTAL_2="35" WEIGHT="12.086120952195733"/>
<CONT_DATA CI_END="0.19083408321641238" CI_START="0.06916591678358765" EFFECT_SIZE="0.13" ESTIMABLE="YES" MEAN_1="0.08" MEAN_2="-0.05" ORDER="10111" SD_1="0.18" SD_2="0.2" SE="0.03103836789668782" STUDY_ID="STD-Wood-1991" TOTAL_1="81" TOTAL_2="71" WEIGHT="20.71921105897818"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.18890480352569686" CI_END="0.08221875089178611" CI_START="-0.10404122450961319" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.010911236808913533" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.08" NO="8" P_CHI2="0.9793602580822628" P_Q="1.0" P_Z="0.8183776903278233" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="212" TOTAL_2="195" UNITS="" WEIGHT="100.0" Z="0.2296320626712336">
<NAME>Change in fasting serum glucose (mmol/l)</NAME>
<GROUP_LABEL_1>Diet + exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Diet alone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Diet + exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Diet alone</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.14935978519392054" CI_START="-0.24935978519392057" EFFECT_SIZE="-0.05000000000000002" ESTIMABLE="YES" MEAN_1="-0.26" MEAN_2="-0.21" ORDER="10112" SD_1="0.6" SD_2="0.5" SE="0.10171604517554664" STUDY_ID="STD-Anderssen-1996" TOTAL_1="65" TOTAL_2="52" WEIGHT="21.82247361782706"/>
<CONT_DATA CI_END="0.2927355143892096" CI_START="-0.2927355143892096" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="-0.1" MEAN_2="-0.1" ORDER="10113" SD_1="0.5" SD_2="0.4" SE="0.14935759876113539" STUDY_ID="STD-Janssen-2002" TOTAL_1="25" TOTAL_2="13" WEIGHT="10.121112764130133"/>
<CONT_DATA CI_END="0.1390487601586163" CI_START="-0.1390487601586163" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="-0.43" MEAN_2="-0.43" ORDER="10114" SD_1="0.53" SD_2="0.43" SE="0.07094454860161471" STUDY_ID="STD-Stefanick-1998" TOTAL_1="91" TOTAL_2="95" WEIGHT="44.858510564185394"/>
<CONT_DATA CI_END="0.19335935158333586" CI_START="-0.19335935158333586" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="-0.2" MEAN_2="-0.2" ORDER="10115" SD_1="0.4" SD_2="0.4" SE="0.09865454320004334" STUDY_ID="STD-Wing-1998" TOTAL_1="31" TOTAL_2="35" WEIGHT="23.197903053857416"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" NO="4">
<NAME>High versus low intensity exercise with dietary change</NAME>
<CONT_OUTCOME CHI2="8.948743676609107" CI_END="1.0362828480865645" CI_START="-1.1950138138532491" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.07936548288334228" ESTIMABLE="YES" I2="32.95148216522005" I2_Q="0.0" ID="CMP-004.01" NO="1" P_CHI2="0.17648133910553232" P_Q="1.0" P_Z="0.8891113296760406" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="112" TOTAL_2="112" UNITS="" WEIGHT="100.0" Z="0.13942878212505197">
<NAME>Weight change in kilograms</NAME>
<GROUP_LABEL_1>High intensity</GROUP_LABEL_1>
<GROUP_LABEL_2>Low intensity</GROUP_LABEL_2>
<GRAPH_LABEL_1>High intensity</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Low intensity</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.082277169937591" CI_START="-2.8822771699375918" EFFECT_SIZE="-0.40000000000000036" ESTIMABLE="YES" MEAN_1="-8.3" MEAN_2="-7.9" ORDER="10116" SD_1="3.8" SD_2="4.2" SE="1.2664912159190052" STUDY_ID="STD-Anderson-1999" TOTAL_1="20" TOTAL_2="20" WEIGHT="20.2001267315926"/>
<CONT_DATA CI_END="1.554352329975035" CI_START="-3.1143523299750338" EFFECT_SIZE="-0.7799999999999994" ESTIMABLE="YES" MEAN_1="-11.66" MEAN_2="-10.88" ORDER="10117" SD_1="3.1" SD_2="3.3" SE="1.1910179719566827" STUDY_ID="STD-Cox-2004" TOTAL_1="15" TOTAL_2="14" WEIGHT="22.84135314468311"/>
<CONT_DATA CI_END="5.182789079754969" CI_START="-0.18278907975496939" EFFECT_SIZE="2.5" ESTIMABLE="YES" MEAN_1="-6.4" MEAN_2="-8.9" ORDER="10118" SD_1="4.5" SD_2="5.3" SE="1.3687950905814938" STUDY_ID="STD-Jakicic-1995" TOTAL_1="27" TOTAL_2="25" WEIGHT="17.29344752213628"/>
<CONT_DATA CI_END="1.9381699699484325" CI_START="-4.138169969948432" EFFECT_SIZE="-1.0999999999999996" ESTIMABLE="YES" MEAN_1="-11.1" MEAN_2="-10.0" ORDER="10119" SD_1="4.4" SD_2="3.0" SE="1.5501152030920615" STUDY_ID="STD-Janssen-2002" TOTAL_1="11" TOTAL_2="14" WEIGHT="13.48436521654707"/>
<CONT_DATA CI_END="3.6529295460728264" CI_START="-5.052929546072825" EFFECT_SIZE="-0.6999999999999993" ESTIMABLE="YES" MEAN_1="-15.7" MEAN_2="-15.0" ORDER="10120" SD_1="5.3" SD_2="8.4" SE="2.220923231451281" STUDY_ID="STD-Leutholtz-1995" TOTAL_1="20" TOTAL_2="20" WEIGHT="6.568880542823019"/>
<CONT_DATA CI_END="4.985660960807909" CI_START="-1.3856609608079107" EFFECT_SIZE="1.799999999999999" ESTIMABLE="YES" MEAN_1="-11.4" MEAN_2="-13.2" ORDER="10121" SD_1="3.5" SD_2="4.1" SE="1.625367091403718" STUDY_ID="STD-Ross-1996" TOTAL_1="11" TOTAL_2="11" WEIGHT="12.264660566146592"/>
<CONT_DATA CI_END="0.31592436753411324" CI_START="-7.915924367534115" EFFECT_SIZE="-3.8000000000000007" ESTIMABLE="YES" MEAN_1="-19.6" MEAN_2="-15.8" ORDER="10122" SD_1="4.2" SD_2="4.2" SE="2.1" STUDY_ID="STD-Whatley-1994" TOTAL_1="8" TOTAL_2="8" WEIGHT="7.347166276071323"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.02" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="11" TOTAL_2="14" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Change in body mass index (BMI)</NAME>
<GROUP_LABEL_1>High intensity</GROUP_LABEL_1>
<GROUP_LABEL_2>Low intensity</GROUP_LABEL_2>
<GRAPH_LABEL_1>High intensity</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Low intensity</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.5816301933042233" CI_START="-1.181630193304224" EFFECT_SIZE="-0.30000000000000027" ESTIMABLE="YES" MEAN_1="-4.2" MEAN_2="-3.9" ORDER="10123" SD_1="1.2" SD_2="1.0" SE="0.44981958865489874" STUDY_ID="STD-Janssen-2002" TOTAL_1="11" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.03" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="20" TOTAL_2="20" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Change in systolic blood pressure (mmHg)</NAME>
<GROUP_LABEL_1>High Intensity</GROUP_LABEL_1>
<GROUP_LABEL_2>Low Intensity</GROUP_LABEL_2>
<GRAPH_LABEL_1>High intensity</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Low intensity</GRAPH_LABEL_2>
<CONT_DATA CI_END="6.86051439920999" CI_START="-5.060514399209989" EFFECT_SIZE="0.9000000000000004" ESTIMABLE="YES" MEAN_1="-7.0" MEAN_2="-7.9" ORDER="10124" SD_1="7.1" SD_2="11.6" SE="3.0411346566701054" STUDY_ID="STD-Anderson-1999" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.04" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="20" TOTAL_2="20" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Change in diastolic blood pressure (mmHg)</NAME>
<GROUP_LABEL_1>High Intensity</GROUP_LABEL_1>
<GROUP_LABEL_2>Low Intensity</GROUP_LABEL_2>
<GRAPH_LABEL_1>High intensity</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Low intensity</GRAPH_LABEL_2>
<CONT_DATA CI_END="3.4183154884223095" CI_START="-14.01831548842231" EFFECT_SIZE="-5.3" ESTIMABLE="YES" MEAN_1="-2.9" MEAN_2="2.4" ORDER="10125" SD_1="7.8" SD_2="18.3" SE="4.448201883907699" STUDY_ID="STD-Anderson-1999" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.05" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="31" TOTAL_2="34" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Change in serum cholesterol (mmol/l)</NAME>
<GROUP_LABEL_1>High Intensity</GROUP_LABEL_1>
<GROUP_LABEL_2>Low Intensity</GROUP_LABEL_2>
<GRAPH_LABEL_1>High intensity</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Low intensity</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.2733375322160938" CI_START="-0.4333375322160937" EFFECT_SIZE="-0.07999999999999996" ESTIMABLE="YES" MEAN_1="-0.58" MEAN_2="-0.5" ORDER="10126" SD_1="0.4" SD_2="0.7" SE="0.18027756377319948" STUDY_ID="STD-Anderson-1999" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0"/>
<CONT_DATA CI_END="1.431852955577185" CI_START="0.608147044422815" EFFECT_SIZE="1.02" ESTIMABLE="YES" MEAN_1="0.42" MEAN_2="-0.6" ORDER="10127" SD_1="0.6" SD_2="0.4" SE="0.21013292020967148" STUDY_ID="STD-Janssen-2002" TOTAL_1="11" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.12748344370860923" CI_END="0.18582582581976073" CI_START="-0.1803291370780389" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0027483443708609173" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.06" NO="6" P_CHI2="0.7210557699878938" P_Q="1.0" P_Z="0.9765273720746979" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="31" TOTAL_2="34" UNITS="" WEIGHT="100.0" Z="0.029422821099405954">
<NAME>Change in serum triglycerides (mmol/l)</NAME>
<GROUP_LABEL_1>High Intensity</GROUP_LABEL_1>
<GROUP_LABEL_2>Low Intensity</GROUP_LABEL_2>
<GRAPH_LABEL_1>High intensity</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Low intensity</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.18599639845400542" CI_START="-0.20599639845400544" EFFECT_SIZE="-0.010000000000000009" ESTIMABLE="YES" MEAN_1="-0.2" MEAN_2="-0.19" ORDER="10128" SD_1="0.2" SD_2="0.4" SE="0.1" STUDY_ID="STD-Anderson-1999" TOTAL_1="20" TOTAL_2="20" WEIGHT="87.25165562913907"/>
<CONT_DATA CI_END="0.6027527946070866" CI_START="-0.4227527946070867" EFFECT_SIZE="0.08999999999999997" ESTIMABLE="YES" MEAN_1="-0.26" MEAN_2="-0.35" ORDER="10129" SD_1="0.5" SD_2="0.8" SE="0.2616133758842587" STUDY_ID="STD-Janssen-2002" TOTAL_1="11" TOTAL_2="14" WEIGHT="12.748344370860929"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.3649289099526064" CI_END="0.10634253119708126" CI_START="-0.04984964020182059" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.028246445497630335" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.07" NO="7" P_CHI2="0.5457817637798981" P_Q="1.0" P_Z="0.47838891855679255" Q="0.0" RANDOM="NO" SCALE="0.5" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="31" TOTAL_2="34" UNITS="" WEIGHT="100.0" Z="0.708896167724553">
<NAME>Change in serum HDL (mmol/l)</NAME>
<GROUP_LABEL_1>High Intensity</GROUP_LABEL_1>
<GROUP_LABEL_2>Low Intensity</GROUP_LABEL_2>
<GRAPH_LABEL_1>High intensity</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Low intensity</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.10799819922700273" CI_START="-0.08799819922700271" EFFECT_SIZE="0.010000000000000009" ESTIMABLE="YES" MEAN_1="-0.13" MEAN_2="-0.14" ORDER="10130" SD_1="0.2" SD_2="0.1" SE="0.05" STUDY_ID="STD-Anderson-1999" TOTAL_1="20" TOTAL_2="20" WEIGHT="63.50710900473934"/>
<CONT_DATA CI_END="0.18927815099156983" CI_START="-0.06927815099156984" EFFECT_SIZE="0.06" ESTIMABLE="YES" MEAN_1="-0.03" MEAN_2="-0.09" ORDER="10131" SD_1="0.2" SD_2="0.1" SE="0.06595945232223621" STUDY_ID="STD-Janssen-2002" TOTAL_1="11" TOTAL_2="14" WEIGHT="36.492890995260666"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.08" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="11" TOTAL_2="14" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Change in serum glucose (mmol/l)</NAME>
<GROUP_LABEL_1>High Intensity</GROUP_LABEL_1>
<GROUP_LABEL_2>Low Intensity</GROUP_LABEL_2>
<GRAPH_LABEL_1>High intensity</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Low intensity</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.3622268195629935" CI_START="-0.3622268195629935" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="-0.1" MEAN_2="-0.1" ORDER="10132" SD_1="0.5" SD_2="0.4" SE="0.18481299780005778" STUDY_ID="STD-Janssen-2002" TOTAL_1="11" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" NO="5">
<NAME>High versus low intensity exercise without dietary change</NAME>
<CONT_OUTCOME CHI2="1.0896543996403527" CI_END="-0.6601984276782611" CI_START="-2.2777700727379586" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.4689842502081099" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.01" NO="1" P_CHI2="0.7795721511727357" P_Q="1.0" P_Z="3.7106665932021716E-4" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="157" TOTAL_2="160" UNITS="" WEIGHT="100.0" Z="3.559850017225313">
<NAME>Weight change in kilograms</NAME>
<GROUP_LABEL_1>High intensity</GROUP_LABEL_1>
<GROUP_LABEL_2>Low intensity</GROUP_LABEL_2>
<GRAPH_LABEL_1>High intensity</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Low intensity</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.45019185102056425" CI_START="-2.6701918510205642" EFFECT_SIZE="-1.11" ESTIMABLE="YES" MEAN_1="-1.55" MEAN_2="-0.44" ORDER="10133" SD_1="2.4" SD_2="1.8" SE="0.7960308777748767" STUDY_ID="STD-Cox-2004" TOTAL_1="13" TOTAL_2="17" WEIGHT="26.872684237965927"/>
<CONT_DATA CI_END="-0.3566360008660614" CI_START="-2.443363999133939" EFFECT_SIZE="-1.4000000000000001" ESTIMABLE="YES" MEAN_1="-1.3" MEAN_2="0.1" ORDER="10134" SD_1="3.6" SD_2="3.4" SE="0.5323383528288584" STUDY_ID="STD-Irwin-2003" TOTAL_1="87" TOTAL_2="86" WEIGHT="60.089053683687645"/>
<CONT_DATA CI_END="-0.023895167982080245" CI_START="-5.176104832017921" EFFECT_SIZE="-2.6000000000000005" ESTIMABLE="YES" MEAN_1="-8.9" MEAN_2="-6.3" ORDER="10135" SD_1="7.3" SD_2="5.6" SE="1.314363351744168" STUDY_ID="STD-Jakicic-2003" TOTAL_1="49" TOTAL_2="49" WEIGHT="9.856891931031031"/>
<CONT_DATA CI_END="2.234468914632154" CI_START="-6.834468914632154" EFFECT_SIZE="-2.3000000000000003" ESTIMABLE="YES" MEAN_1="-4.2" MEAN_2="-1.9" ORDER="10136" SD_1="4.1" SD_2="5.1" SE="2.313547060251855" STUDY_ID="STD-Wallace-1997" TOTAL_1="8" TOTAL_2="8" WEIGHT="3.181370147315395"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.02" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="13" TOTAL_2="17" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Change in systolic blood pressure (mmHg)</NAME>
<GROUP_LABEL_1>High intensity</GROUP_LABEL_1>
<GROUP_LABEL_2>Low intensity</GROUP_LABEL_2>
<GRAPH_LABEL_1>High intensity</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Low intensity</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.3696109672861345" CI_START="-3.1696109672861343" EFFECT_SIZE="-0.3999999999999999" ESTIMABLE="YES" MEAN_1="-3.6" MEAN_2="-3.2" ORDER="10137" SD_1="4.15" SD_2="3.38" SE="1.4130927859554931" STUDY_ID="STD-Cox-1996" TOTAL_1="13" TOTAL_2="17" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.03" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="13" TOTAL_2="17" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Change in diastolic blood pressure</NAME>
<GROUP_LABEL_1>High intensity</GROUP_LABEL_1>
<GROUP_LABEL_2>Low intensity</GROUP_LABEL_2>
<GRAPH_LABEL_1>High intensity</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Low intensity</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.097830009023321" CI_START="-1.6978300090233205" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" MEAN_1="-2.9" MEAN_2="-3.1" ORDER="10138" SD_1="2.2" SD_2="3.1" SE="0.9682984095591355" STUDY_ID="STD-Cox-1996" TOTAL_1="13" TOTAL_2="17" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.04" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Change in serum triglycerides (mmol/l)</NAME>
<GROUP_LABEL_1>High intensity</GROUP_LABEL_1>
<GROUP_LABEL_2>Low intensity</GROUP_LABEL_2>
<GRAPH_LABEL_1>High intensity</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Low intensity</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.012181844986984297" CI_START="-0.2721818449869843" EFFECT_SIZE="-0.13" ESTIMABLE="YES" MEAN_1="-0.49" MEAN_2="-0.36" ORDER="10139" SD_1="0.15" SD_2="0.14" SE="0.07254309064273454" STUDY_ID="STD-Wallace-1997" TOTAL_1="8" TOTAL_2="8" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.05" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="0.5" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Change in serum HDL (mmol/l)</NAME>
<GROUP_LABEL_1>High intensity</GROUP_LABEL_1>
<GROUP_LABEL_2>Low intensity</GROUP_LABEL_2>
<GRAPH_LABEL_1>High intensity</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Low intensity</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.09464759560874195" CI_START="0.02535240439125805" EFFECT_SIZE="0.06" ESTIMABLE="YES" MEAN_1="0.13" MEAN_2="0.07" ORDER="10140" SD_1="0.03" SD_2="0.04" SE="0.017677669529663688" STUDY_ID="STD-Wallace-1997" TOTAL_1="8" TOTAL_2="8" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.6319866584858898" CI_END="-0.16326028972809262" CI_START="-0.4477894895801272" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.3055248896541099" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.06" NO="6" P_CHI2="0.42662775723904456" P_Q="1.0" P_Z="2.562953924645308E-5" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="21" TOTAL_2="25" UNITS="" WEIGHT="99.99999999999999" Z="4.209183313445765">
<NAME>Change in serum glucose (mmol/l)</NAME>
<GROUP_LABEL_1>High intensity</GROUP_LABEL_1>
<GROUP_LABEL_2>Low intensity</GROUP_LABEL_2>
<GRAPH_LABEL_1>High intensity</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Low intensity</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.027578646418444208" CI_START="-1.0675786464184442" EFFECT_SIZE="-0.52" ESTIMABLE="YES" MEAN_1="-0.01" MEAN_2="0.51" ORDER="10141" SD_1="0.5" SD_2="1.0" SE="0.27938199412727716" STUDY_ID="STD-Cox-2004" TOTAL_1="13" TOTAL_2="17" WEIGHT="6.74995202352604"/>
<CONT_DATA CI_END="-0.1426764026473633" CI_START="-0.43732359735263665" EFFECT_SIZE="-0.29" ESTIMABLE="YES" MEAN_1="-0.62" MEAN_2="-0.33" ORDER="10142" SD_1="0.16" SD_2="0.14" SE="0.07516648189186455" STUDY_ID="STD-Wallace-1997" TOTAL_1="8" TOTAL_2="8" WEIGHT="93.25004797647395"/>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-01" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Funnel plot.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAAAAAFUAAKoAAP8AJAAA
JFUAJKoAJP8ASQAASVUASaoASf8AawAAa1UAa6oAa/8AkgAAklUAkqoAkv8AtgAAtlUAtqoAtv8A
2wAA21UA26oA2/8A/wAA/1UA/6oA//8kAAAkAFUkAKokAP8kJAAkJFUkJKokJP8kSQAkSVUkSaok
Sf8kawAka1Uka6oka/8kkgAkklUkkqokkv8ktgAktlUktqoktv8k2wAk21Uk26ok2/8k/wAk/1Uk
/6ok//9JAABJAFVJAKpJAP9JJABJJFVJJKpJJP9JSQBJSVVJSapJSf9JawBJa1VJa6pJa/9JkgBJ
klVJkqpJkv9JtgBJtlVJtqpJtv9J2wBJ21VJ26pJ2/9J/wBJ/1VJ/6pJ//9rAABrAFVrAKprAP9r
JABrJFVrJKprJP9rSQBrSVVrSaprSf9rawBra1Vra6pra/9rkgBrklVrkqprkv9rtgBrtlVrtqpr
tv9r2wBr21Vr26pr2/9r/wBr/1Vr/6pr//+SAACSAFWSAKqSAP+SJACSJFWSJKqSJP+SSQCSSVWS
SaqSSf+SawCSa1WSa6qSa/+SkgCSklWSkqqSkv+StgCStlWStqqStv+S2wCS21WS26qS2/+S/wCS
/1WS/6qS//+2AAC2AFW2AKq2AP+2JAC2JFW2JKq2JP+2SQC2SVW2Saq2Sf+2awC2a1W2a6q2a/+2
kgC2klW2kqq2kv+2tgC2tlW2tqq2tv+22wC221W226q22/+2/wC2/1W2/6q2///bAADbAFXbAKrb
AP/bJADbJFXbJKrbJP/bSQDbSVXbSarbSf/bawDba1Xba6rba//bkgDbklXbkqrbkv/btgDbtlXb
tqrbtv/b2wDb21Xb26rb2//b/wDb/1Xb/6rb////AAD/AFX/AKr/AP//JAD/JFX/JKr/JP//SQD/
SVX/Sar/Sf//awD/a1X/a6r/a///kgD/klX/kqr/kv//tgD/tlX/tqr/tv//2wD/21X/26r/2///
/wD//1X//6r////30rcGAAALOUlEQVR42u3diYKiOhRFUdOp//9jOt0yJogKCBbK2u9VOTE1tT03
iVFDugDb88cpALFALBALIBaIBWIBxAKxQCyAWCAWiNURr4zuWr7pia082lxcc/ixuIyX2buL6/aH
ufxM3ltdT301vmcp1ZKH4po9rDqs11bEBqWwTpzYPb+zWwue8e0K7crZZpo460ItlguVOx8eiDdb
/H/Z3BPHa2Y36oeLXcZ8a3hXYsX6OX0NkSFI+luxqi+qWU5VVb14u/Jwrf3pN1oulO9uuN49EKtL
vo3Gj6p7YHIz/cP9LqsotH6jFDZ/vEvzJ2//Ru2t2YWrWaYaNtXJ2Jj0X7rJwMg33e68Xzt3J1to
SvOJSt7+C+odF/80vEms9i9Ybdcsqe7IW61ce9XhVPmzBr863BAvedFoby16nscqjrtmsdvU8+5g
v6s43B7fN6OZFIveYHdE6uH7E+t6zssSMy44z/8mcRBhWLm71lwWG717Y6rWZdupYnFMU5u5LjXe
Jan2JHzDmynWK0KutyfWx0j1SuuPVxIL39V4B4gFYuGcYt2fl1C0mp8sUb4auGyyQ/FonL3PGSt6
dfD3eoXlq4TTPB/GKl8NXDbZYeG+Nl8ReyRW9yJzN02gv7yUEw2K2QLdZITHf9qZkx2ymVbZGm0C
3d3GsJ3pFfP07A55Tjhjq8QqcqubnpDNELhkEwy62QLX39V0QRpeAp472SE/hljG383RTU2EmF6x
3Nnlzi6xt1ijzGnqWSyuV9Wc9fNSOG+yQxx8bHeZxcrtlIfhOEbXxyuuaitiH7FuU2yszBZtn3Ky
w+2WH82LyZe+WbO6c/CaYe9vY1WTUytveljxTgY8DITlkx3izZXR9IaYhVN+THHiGOK6Di62SayJ
qQfDDIFs0sl4qVg92MiyyQ5DHazisFycmm3Rr9suXN1bcXTfaDPYkvmvFWrh4tVSCLxPLIEFiQVi
gVjAi2LlL6CtHuXp3oQ8bCUfCr//sQtLxsbaLRqJOhrrZzc892p4n3J/Tz4OtX7LlX7FZ4rVvem9
fQmksaO5XrVD58Otp3q1r+llLxN3a8ZLu4v/y/Tvtm5eSuy33+2r6o/iMhxCrmscFozVsJP8YPHb
iVXEQT9/oJztEO/PZ3iSJnM+dqGcNdEsmefocDW76Ba85BMo8o3hQGLdGFKtbXv1b2J++LELVTmP
Il8y3kvX8YJVOQ1j9kQM/IJYc7JoyzUnpiJUdwJ1xuo+sOEIvcIq9lHwuHO4JLSq/uOKJrqGD7p8
5fUZM+3vbKnSc/z9xMo+8aBu20zNdqieNd7vzhuY97ELo3kU+cyFqcjKpziMVzeH4f389juh5xeo
2UuqeR/exnpdqtkNtdlLvvRJDviixMKZGu8AsUAsEAsgFogFYgHEArFALGAlj14rDJdLKq9MLnN9
7HpRX6b6NaJQX/1/b/1Q6pfy+hGxejuyK9PL1L/ScLPVrLas8aqzKjFLKVxA6oVKpW2Ffjh5YoVe
lzlONYHU1bqpSAtOMrEyr5alVXoUWB9EuAjXncRKS85u3bp65JAiqI31yvM8TbXnQxdjz3oAOFev
MIW2N5fuDjek0WhDf5GKhlqY22TD1zAVImsbGs8C6QMCSxvrUKUwz6/Pbm8lXh1QrCfPdn8zYgHE
2rSNZTiXWCAWiAUQC4flxynIMSQisUAsEOvkGMciFogFYgHEwnExjlVgHEtigVgg1skxjkUsEAvE
AoiF42Icq8A4lsQCsUCsk2Mci1ggFogFEAvHxThWgXEsiQVigVgnxzgWsUAsEAsgFo6LcawC41gS
C8QCsU6OcSxigVggFkAsHBfjWAXGsSQWPlasMHS+9cKxWSnMvnf+NF75Tui3lsLgbOPlxArtD5mw
ZWIFgYU9EitNNDQCubBd471w7SReefq8QawUTuBUrDiwT/86nbnPHa+/qPWWxvuZiNnv9jllJJhY
INaRAwvE2hiNK2Lh0zj1fKzqpldoHItYiqFSCGKdHONYxAKxQCyAWDgu3ldYUI9jmUpDrB2I1/+p
pRRu79XF69MSa2OCZ5rEArFALDSNLK0sYm1KVbbiofG+BelqFqUk1i5V0Ckg1q7FEMTaCvOxiLV3
ZAkujXfFUGKBWIBSuBHeVyixQCwQ6+QYxyIWiAViAcTCcTGOVWAcS2KBWN+FiYBK4WKef3eCN0pL
rP3iSmgRC8TSviLWWdG40nhfhXEsifWbkSW4JJZiKLEOgPlYxMLHlsLQNWaDVi22Eyt03zQeTvQ1
9lAK8VmJFdqfIaLSeUqhXN5NrPCgJgKrxUpz5o4A2lhLMI71hl5h27QKKRluwIZitTIlVkEpBLFw
1lJ4QhR9iQViQSk8N/GvYkis7bVyCpTCHbTxXlSJtUor74yXWDvFVVQIifV26jj782eupFAKN3VB
TZVYozSat1ClhS+xttfPdCyJtSKyXq9gokpirSiGMzbDLIkFYp2vpiqF5yLNNAsSC8QCsb4U7ysk
FogFYgHEwnExjlXgrRQSC8QCsU6OcSxigVggFkAsHBfjWAXGsSQWiAVinRzjWMQCsUAsgFg4Lsax
CoxjSSwQC8Q6OcaxiAVigVjA/mKFvuWh6YFl/MzxKjU/X02sP/jKONYbEqt36QRnO8br/9gzsUL7
k0707I1ZaGGfxAqP0+vL0ZjcLbGu7amb4vflXimCb+4VniWvlMDfECtc/1MisN1wQ1MR0wl6hc0X
Tgiud4l1Hqr8qYR3tbEAYoFYx2NeJ8XwhDbWDvjyXom1k1dCi1ibWASlcPeiRzWJtYJiSsdk0dO4
IhaI9UHtK1/eq421nHzGUPXQLEgs/UBiHcGsqOgphbvEVT/3nVMSCxLryIHleSaxdkDpIxaI9UEj
AdXfv4LrbG2sN02DYtXJEss0KGIBHyOWqNLG2qfp8x6zvK9QKQSxtuut6bMphR85DhAUQ6UQxAKx
AGJB4/0z0HSXWCAWiHVyfIgvsUAsEAsgFo6LcawC41gSC8QCsU6OcSxigVggFkAsHBfjWAXGsSQW
Ples0HfC9cKxXSnsvUrf/0X2/T9ZMdw9sQqXnG+8mFih/cm+rygQC6+KFab7SoFZeEmspKGBnRvv
J8Qz6n1ihZS0sbC4f530ubEDRt7L55SRYGKBWCAWQCwcFuNYBbrDEgvEArFOjnEsYoFYIBZALBwX
41gFxrEk1ub4EleJtY9W0dchEmufuIp/FUOlEMTSviLWOdG4IhY03j8psqLgIpZiqBSCWDAfi1gg
FogFEAtHxnBDgZegJRaIBWKdHONYxAKxQCyAWG/B5NJVGMcqSBNaefOOxNoproQWsUCsIzIaxxJV
xNoFjStigVgfF1mCazmGGxRDYu2P+VhKIYgFYp0c87GIBWJ9SYQ4lgXHIrGgFOKDWquT32IPLCFJ
LLyJn7kG/laiOpYPOBZtLGi8g1jAnF4hILHwOb3COsXCUfqG4XKgIzlMvh/orEzb8nOn93hd/CBl
8ih/zAOdkiOdlTun5s/RW10agYc+K3cP5OewT4UjFiBnZbYth5/znqTWR56VnyOng7D6ll5h8rzU
xtrvCA833HCQs3iw4YZ0IINuD0cgYBeMvINYIBaIBbSvzDQ/9du5Qn1leGdXc3+YWDEQC8/l6rt5
198ppeHOkNJkTzSZmozn4wZpcsTg6lX7XxtsbcTdHVUgFu5JNgqmJsNCO5XhmlMhBW0sLA2s0WPt
Q6m+3jTB0oNBWh+8hlmBVTbEng+rSyyUgdVIVTfWx4o1LfiQdSPvT36UWBgyKOU3pqY/XyVKtVzN
lbAm9IAZltx5TCnEjDhbnkwSC7sgsUAsEAvEAogFYoFYALFALBAL2JJ/5VKIFLYnbN8AAAAASUVO
RK5CYII=
</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2008-10-23 13:23:18 +0200" MODIFIED_BY="Gudrun Paletta">
<APPENDIX ID="APP-01" MODIFIED="2008-10-03 12:37:02 +0200" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2008-10-03 11:53:44 +0200" MODIFIED_BY="[Empty name]">Search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2008-10-03 12:37:02 +0200" MODIFIED_BY="[Empty name]">
<TABLE COLS="1" ROWS="2">
<TR>
<TH>
<P>Search terms</P>
</TH>
</TR>
<TR>
<TD>
<P>Unless otherwise stated, search terms are free text terms; MeSH = Medical subject heading (Medline medical index term); exp = exploded MeSH; the dollar sign ($) stands for any character(s); the question mark (?) = to substitute for one or no characters; tw = text word; pt = publication type; sh = MeSH; adj = adjacent.</P>
<P/>
<P>The following Medline search strategy was used and adapted for use with the other databases.<BR/>
<BR/>
<B>MEDLINE:</B>
<BR/>OBESITY OR WEIGHT LOSS<BR/>
<BR/>1 Obesity/ [MeSH term, all sub trees and subheadings included]<BR/>2 Bulimia/ [MeSH term, all subheadings included]<BR/>3 Hyperphagia/ [MeSH term, all subheadings included]<BR/>4 Anti-Obesity-Agents/ [MeSH term, all subheadings included]<BR/>5 Pickwickian syndrome (and) Prader-Willi-syndrome/[MeSH term, all subheadings included]<BR/>6 (obes* or adipos* or overweight* or over weight*) [in abstract or title]<BR/>7 (overeat* or overfeed*) [in abstract or title]<BR/>8 (binge eating disorder* or fat overload syndrom*) [in abstract or title]<BR/>9 Weight-gain/ [MeSH term, all subheadings included]<BR/>10 Weight-loss/ [MeSH term, all subheadings included]<BR/>11 Body-Mass-Index/ [MeSH term]<BR/>12 weight gain [in abstract or title]<BR/>13 weight cycling [in abstract or title]<BR/>14 (weight near (reduc* or loss losing or maint* or decreas* or watch* or diet* or control*)) [in abstract or title]<BR/>15 or/1-14<BR/>
<BR/>This was combined with the following search strategy:<BR/>
<BR/>EXERCISE<BR/>
<BR/>1. exercis* OR (physic* activ*) OR exert* OR (physic* fit*) OR sports (text words)<BR/>2. walk* or jog* or swim* (text words)<BR/>3. (weight lift*) OR (strength train*) OR (resistance train*) OR (circuit weight train*) OR (aerob* train*) (text words)<BR/>4. exercise/ [MeSH term, all subheadings and categories included]<BR/>5. exertion/ [MeSH term, all subheadings and categories included]<BR/>6. physical education/ [MeSH term, all subheadings and categories included]<BR/>7. training/ [MeSH term, all subheadings and categories included]<BR/>8. physical-fitness/ [MeSH term, all subheadings and categories included]<BR/>9. sports/ [MeSH term, all subheadings and categories included]<BR/>10. OR/ 1-9<BR/>
<BR/>This was combined with the following search strategy:<BR/>
<BR/>RANDOMISED CONTROLLED TRIALS<BR/>
<BR/>1 RANDOMISED-CONTROLLED-TRIAL in PT<BR/>2 "RANDOMISED-CONTROLLED-TRIALS"/ all subheadings<BR/>3 "RANDOM-ALLOCATION" in MIME, MJME<BR/>4 random* or alloc* or assign*<BR/>5 (#4 in TI) or (#4 in AB)<BR/>6 #1 or #2 or #3 or #5<BR/>7 CONTROLLED-CLINICAL-TRIAL in PT<BR/>8 CLINICAL-TRIAL in PT<BR/>9 explode "CLINICAL-TRIALS"/ all subheadings<BR/>10 (CLIN* near TRIAL*)<BR/>11 (#10 in TI) or (#10 in AB)<BR/>12 "CROSS-OVER-STUDIES" in MIME, MJME<BR/>13 cross-over near (stud* or trial* or design*)<BR/>14 crossover near (stud* or trial* or design*)<BR/>15 #7 or #8 or #9 or #11 or #12 or #13 or 14<BR/>16 "DOUBLE-BLIND-METHOD" in MIME, MJME<BR/>17 "SINGLE-BLIND-METHOD" in MIME, MJME<BR/>18 (singl* or doubl* or trebl* or tripl*) near (blind* or mask*)<BR/>19 (#18 in TI) or (#18 in AB)<BR/>20 #16 or #17 or #19<BR/>21 "PLACEBOS"/ all subheadings<BR/>22 placebo* in TI<BR/>23 placebo* in AB<BR/>24 #21 or #22 or #23<BR/>25 explode "RESEARCH-DESIGN"/ all subheadings<BR/>26 TG=COMPARATIVE-STUDY<BR/>27 explode "EVALUATION-STUDIES"/ all subheadings<BR/>28 "FOLLOW-UP-STUDIES" in MIME, MJME<BR/>29 "PROSPECTIVE-STUDIES" in MIME, MJME<BR/>30 control* or prospectiv* or volunteer*<BR/>31 (#30 in TI) or (#30 in AB)<BR/>32 #25 or #26 or #27 or #28 or #29 or #31<BR/>33 #6 or #15 or #20 or #24 or #32<BR/>34 (TG=ANIMAL) not ((TG=HUMAN) and (TG=ANIMAL))<BR/>35 #33 not #34<BR/>
<BR/>This was combined with the following search strategy:<BR/>
<BR/>SYSTEMATIC REVIEWS AND META-ANALYSES<BR/>
<BR/>1 "META-ANALYSIS" in MIME,MJME<BR/>2 explode "REVIEW-LITERATURE"/ all subheadings<BR/>3 META-ANALYSIS in PT<BR/>4 REVIEW in PT<BR/>5 REVIEW-ACADEMIC in PT<BR/>6 REVIEW-LITERATURE in PT<BR/>7 REVIEW-TUTORIAL in PT<BR/>8 GUIDELINE in PT<BR/>9 PRACTICE-GUIDELINE in PT<BR/>10 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9<BR/>11 REVIEW-OF-REPORTED-CASES in PT<BR/>12 REVIEW-MULTICASE in PT<BR/>13 LETTER in PT<BR/>14 COMMENT in PT<BR/>15 EDITORIAL in PT<BR/>16 HISTORICAL-ARTICLE in PT<BR/>17 #11 or #12 or #13 or #14 or #15 or #16<BR/>18 #10 not #17<BR/>19 ((systematic* or quantitativ* or methodologic*) near (review* or overview*)) in TI,AB<BR/>20 (meta anal* or metaanal*) in TI,AB<BR/>21 (integrativ* research review* or research integration) in TI,AB<BR/>22 (quantitativ* synthes*) in TI,AB<BR/>23 (pooling* or (pooled analys*) or (mantel* haenszel*)) in TI,AB<BR/>24 (peto* or der simonian* or dersimonian* or fixed effect* or random effect*) in TI,AB<BR/>25 #19 or #20 or #21 or #22 or #23 or #24<BR/>26 #18 or #25<BR/>27 (TG=ANIMAL) not ((TG=HUMAN) and (TG=ANIMAL))<BR/>28 #26 not #27</P>
<P/>
</TD>
</TR>
</TABLE>
<P/>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2008-10-23 13:23:18 +0200" MODIFIED_BY="Gudrun Paletta" NO="2">
<TITLE MODIFIED="2008-10-03 12:52:09 +0200" MODIFIED_BY="[Empty name]">Original data for all outcomes</TITLE>
<APPENDIX_BODY MODIFIED="2008-10-23 13:23:18 +0200" MODIFIED_BY="Gudrun Paletta">
<TABLE COLS="10" ROWS="43">
<TR>
<TH>
<P>Study ID</P>
</TH>
<TH>
<P>Outcome 1</P>
</TH>
<TH>
<P>Outcome 2</P>
</TH>
<TH>
<P>Outcome 3</P>
</TH>
<TH>
<P>Outcome 4</P>
</TH>
<TH>
<P>Outcome 5</P>
</TH>
<TH>
<P>Outcome 6</P>
</TH>
<TH>
<P>Outcome 7</P>
</TH>
<TH>
<P>Outcome 8</P>
</TH>
<TH>
<P>Outcome 9</P>
</TH>
</TR>
<TR>
<TD>
<P>Aggel-Leijssen 2001</P>
</TD>
<TD>
<P>Weight change (kg) at 12 weeks (mean +/- SD): diet = -14.8 +/- 5.3 kg, diet + exercise = -15.2 + / - 6.3 kg</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Aggel-Leijssen 2001b</P>
</TD>
<TD>
<P>Weight change (kg) at 12 weeks (mean +/- SD): exercise = 86.5 +/- 10.2 kg (pre) to 87.1 +/- 10.1 kg (post), control = 94.7 + / - 14.0 kg (pre) to 94.5 +/- 14.5 kg (post)</P>
</TD>
<TD>
<P>Change in BMI at 12 weeks (mean +/- SD): exercise = 32.1 +/- 2.9 (pre) to 32.4 +/- 3.0 (post), control = 33.3 + / - 3.8 (pre) to 33.1 +/- 3.9 (post)</P>
</TD>
<TD>
<P>Change in % body fat at 12 weeks (mean +/- SD): exercise = 42.6 +/- 3.1 (pre) to 42.8 +/- 2.4 (post), control = 44.4 + / - 3.0 (pre) to 44.9 +/- 3.2 (post)</P>
</TD>
<TD>
<P>Change in WHR at 12 weeks (mean +/- SD): exercise = 0.89 +/- 0.04 (pre) to 0.89 +/- 0.05 (post), control = 0.90 + / - 0.03 (pre) to 0.88 +/- 0.03 (post)</P>
</TD>
<TD>
<P>Change in VO2 max (ml/min) at 12 weeks (mean +/- SD): exercise = 2126 +/- 168 (pre) to 2188 +/- 291 (post), control = 1913 + / -460 (pre) to 1966 +/- 359 (post)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Aggel-Leijssen 2002</P>
</TD>
<TD>
<P>Weight change (kg) at 12 weeks (mean +/- SE): vigorous exercise = 105.5 +/- 6.6 kg (pre) to 105.1 +/- 6.2 kg (post), moderate exercise = 102.7 + / - 10.8 kg (pre) to 103.1 +/- 11.4 kg (post), control = 96.5 +/- 10.3 kg (pre) to 95.9 +/- 9.6 kg (post)</P>
</TD>
<TD>
<P>Change in BMI at 12 weeks (mean +/- SE): vigorous exercise = 32.2 +/- 1.6 (pre) to 32.1 +/- 1.3 (post), moderate exercise = 31.6 + / - 3.1 (pre) to 31.7 +/- 3.1 (post), control = 31.5 +/- 2.4 (pre) to 31.4 +/- 2.5 (post)</P>
</TD>
<TD>
<P>Change in % body fat at 12 weeks (mean +/- SE): vigorous exercise = 31.3 +/- 4.3 (pre) to 31.8 +/- 4.4 (post), moderate exercise = 31.9 + / - 2.4 (pre) to 31.5 +/- 2.2 (post), control = 31.6 +/- 5.1 (pre) to 31.7 +/- 5.0 (post)</P>
</TD>
<TD>
<P>Change in VO2 max (ml/min) at 12 weeks (mean +/- SE): vigorous exercise = 3312 +/- 448 (pre) to 3820 +/- 453 (post), moderate exercise = 3191 + / - 532 (pre) to 3556 +/- 542 (post), control = 2944 +/- 443 (pre) to 3019 +/- 557 (post)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Anderson 1999</P>
</TD>
<TD>
<P>Weight change (kg) at 16 weeks (mean +/- SD): diet + exercise = -8.3 +/- 3.8 kg, diet = -7.9 +/- 4.2 kg</P>
</TD>
<TD>
<P>Triglyceride change (%) at 16 weeks (mean +/- SD): diet + exercise = -17.9 +/- 18.2 %, diet = -14.6 +/- 32.4 %</P>
</TD>
<TD>
<P>Cholesterol change (%) at 16 weeks (mean +/- SD): diet + exercise = -10.9 +/- 8.0 %, diet = -9.3 +/- 12.4 %</P>
</TD>
<TD>
<P>Systolic blood pressure change (%) at 16 weeks (mean +/- SD): diet + exercise = -7.0 +/- 7.1 %, diet = -7.9 +/- 11.6 %</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Anderssen 1996</P>
</TD>
<TD>
<P>BMI change at 12 months: exercise = -0.65 (SE=1.5), diet = -1.6 (SE=1.8), diet + exercise = - 2.2 (SE=1.8), control = 0.4 (SE=0.8)</P>
</TD>
<TD>
<P>Fasting serum glucose change at 12 months: exercise = -0.09 (SE=0.4), diet = -0.2 (SE=0.5), diet + exercise = - 0.3 (SE=0.6), control = 0.07 (SE=0.5)</P>
</TD>
<TD>
<P>VO2 max change at 12 months: exercise = 4.0 (SE=0.1), diet = 1.7 (SE=0.1), diet + exercise = 6.7 (SE=0.1)</P>
</TD>
<TD>
<P>Change in total energy intake at 12 months: exercise = 92 (SE=602), diet = -1679 (SE=450), diet + exercise = -1414 (SE=574)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Balkestein 1999</P>
</TD>
<TD>
<P>Weight change (kg) at 12 weeks: diet + exercise = 102 +/- 3 (SEM) (pre) to 87 +/- 2 (SEM) (post), diet = 103 +/- 3 (SEM) (pre) to 88 +/- 2 (SEM) (post)</P>
</TD>
<TD>
<P>Change in BMI at 12 weeks: diet + exercise = 33 +/- 1 (SEM) (pre) to 28 +/- 1 (SEM) (post), diet = 32 +/- 1 (SEM) (pre) to 27 +/- 1 (SEM) (post)</P>
</TD>
<TD>
<P>Change in systolic blood pressure (mmHg) at 12 weeks: diet + exercise = 130 +/- 2 (SEM) (pre) to 122 +/- 2 (SEM) (post), diet = 127+/- 3 (SEM) (pre) to 117 +/- 2 (SEM) (post)</P>
</TD>
<TD>
<P>Change in diastolic blood pressure (mmHg) at 12 weeks: diet + exercise = 82 +/- 2 (SEM) (pre) to 77 +/- 2 (SEM) (post), diet = 80 +/- 2 (SEM) (pre) to 72 +/- 2 (SEM) (post)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Cox 1996</P>
</TD>
<TD>
<P>Weight change (kg) at 16 weeks: Vigorous exercise = -1.43 kg (SEM=0.3), light exercise = -0.35 kg (SEM=0.3)</P>
</TD>
<TD>
<P>Systolic blood pressure change (mmHg) at 16 weeks: vigorous exercise = -3.2 mmHg (95%CI, -5.6 to -0.7), light exercise = -3.6 mmHg (95%CI, -5.6 to -1.6)</P>
</TD>
<TD>
<P>Diastolic blood pressure change (mmHg) at 16 weeks: vigorous exercise = -2.9 mmHg (95%CI, -4.2 to -1.6), light exercise = -3.1 mmHg (95%CI, -4.9 to -1.3)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Cox 2004</P>
</TD>
<TD>
<P>Weight change (kg) at 16 weeks: exercise = -1.55 kg (95%CI, -0.25 to -2.84), diet = -10.88 kg (95%CI, -8.53 to -13.23), diet + exercise = - 11.66 kg (95%CI, -8.32 to -15.01), control = -0.44 kg (95%CI, 0.4 to -1.3)</P>
</TD>
<TD>
<P>Waist-to-hip ratio change at 16 weeks: exercise = 0.00 (95%CI, -0.02 to 0.02), diet = -0.02 (95% CI, -0.01 to -0.03), diet + exercise = - 0.03 (95% CI, -0.01 to -0.05), control = 0.01 (95% CI, 0.01 to -0.01)</P>
</TD>
<TD>
<P>BMI change at 16 weeks: exercise = -0.1 (95% CI, -0.6 to 0.3), diet = -3.1 (95% CI, -4.0 to -2.3), diet + exercise = - 2.9 (95% CI, -4.0 to -1.7), control = 0.1 (95% CI, -0.2 to 0.4)</P>
</TD>
<TD>
<P>Fasting serum glucose change (mmol/L) at 16 weeks: exercise = -0.01 (95% CI, -0.3 to 0.26), diet = 0.03 (95% CI, -0.19 to 0.26), diet + exercise = - 0.09 (95% CI, -0.37 to 0.19), control = 0.51 (95% CI, 0.04 to 0.98)</P>
</TD>
<TD>
<P>Glycated haemoglobin change (%) at 16 weeks: exercise = 0.13 (95% CI, -0.08 to 0.36), diet = 0.14 (95% CI, 0.01 to 0.26), diet + exercise = - 0.03 (95% CI, -0.26 to 0.20), control = 0.21 (95% CI, -0.1 to 0.53)</P>
</TD>
<TD>
<P>VO2 max change (L/min) at 16 weeks: exercise = 0.59 (95% CI, 0.67 to 0.51), diet = 0.01 (95% CI, 0.08 to 0.12), diet + exercise = 0.65 (95% CI, 0.49 to 0.79), control = 0.09 (95% CI, -0.01 to 0.20)</P>
</TD>
<TD>
<P>Change in energy intake (kj/d) at 16 weeks: exercise = 787 (95% CI, -755 to 2330), diet = -4023 (95% CI, -5015 to -3032), diet + exercise = - 4804 (95% CI, -6402 to -3205), control = -802 (95% CI, -3383 to 1780)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Gillett 1987</P>
</TD>
<TD>
<P>Weight change (lb) at 16 weeks (mean +/- SD): exercise = 165.3 +/- 16.9 lb (pre) to 159.8 +/- 15.9 lb (post), control = 166.3 + / - 17.7 lb (pre) to 160.4 +/- 17.7 lb (post)</P>
</TD>
<TD>
<P>Change in % body fat at 16 weeks (mean +/- SD): exercise = 42.3 +/- 6.7 (pre) to 40.6 +/- 4.9 (post), control = 42.8 + / - 6.0 (pre) to 38.8 +/- 6.6 (post)</P>
</TD>
<TD>
<P>Change in total serum cholesterol (mg%) at 16 weeks (mean +/- SD): exercise = 204.9 +/- 45.6 (pre) to 209.7 +/- 45.4 (post), control = 195.1 + / - 36.0 (pre) to 185.4 +/- 56.4 (post)</P>
</TD>
<TD>
<P>Change in total serum triglycerides (mg%) at 16 weeks (mean +/- SD): exercise = 116.3 +/- 64.2 (pre) to 149.1 +/- 85.8 (post), control = 109.3 + / - 53.3 (pre) to 122.0 +/- 74.5 (post)</P>
</TD>
<TD>
<P>Change in total serum glucose (mg%) at 16 weeks (mean +/- SD): exercise = 94.3 +/- 10.0 (pre) to 91.3 +/- 7.6 (post), control = 88.5 + / - 6.2 (pre) to 86.2 +/- 5.7 (post)</P>
</TD>
<TD>
<P>Change in systolic blood pressure (mmHg) at 16 weeks (mean +/- SD): exercise = 115.0 +/- 13.3 (pre) to 110.8 +/- 11.2 (post), control = 109.8 + / - 8.1 (pre) to 103.5 +/- 5.9 (post)</P>
</TD>
<TD>
<P>Change in diastolic blood pressure (mmHg) at 16 weeks (mean +/- SD): exercise = 79.2 +/- 12.2 (pre) to 72.1 +/- 8.7 (post), control = 70.6 + / - 8.3 (pre) to 66.5 +/- 6.2 (post)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Gordon 1997</P>
</TD>
<TD>
<P>Weight change (kg) at 12 weeks (mean +/- SD): exercise = -1.0 +/- 1.8 kg, diet = - 5.8 +/- 3.9 kg, diet + exercise = - 7.1 +/- 2.9 kg</P>
</TD>
<TD>
<P>Body fat (%) change at 12 weeks (mean +/- SD): exercise = -0.5 +/- 1.0 %, diet = - 1.6 +/- 1.3 %, diet + exercise = - 2.4 +/- 1.7 %</P>
</TD>
<TD>
<P>Maximal oxygen uptake change (ml/min) at 12 weeks (mean +/- SD): exercise = -1.0 +/- 1.8 kg, diet = - 5.8 +/- 3.9 kg, diet + exercise = - 7.1 +/- 2.9 kg</P>
</TD>
<TD>
<P>Systolic blood pressure change (mmHg) at 12 weeks (mean +/- SD): exercise = -9.9 +/- 6.4 mmHg , diet = - 11.3 +/- 12.1 mmHg, diet + exercise = - 12.5 +/- 6.3 mmHg</P>
</TD>
<TD>
<P>Diastolic blood pressure change (mmHg) at 12 weeks (mean +/- SD): exercise = -5.9 +/- 4.6 mmHg , diet = - 7.5 +/- 4.3 mmHg, diet + exercise = - 7.9 +/- 4.3 mmHg</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Hays 2004</P>
</TD>
<TD>
<P>Weight change (kg) at 14 weeks (mean +/- SD): diet = -3.2 +/- 1.2 kg, diet + exercise = -4.8 + / - 0.9 kg, control = -0.1 +/- 0.6 kg</P>
</TD>
<TD>
<P>% body fat change at 14 weeks (mean +/- SD): diet = -2.2 +/- 1.2 %, diet + exercise = -3.5 + / - 0.7 %, control = 0.2 +/- 0.6 %</P>
</TD>
<TD>
<P>Physical activity (kcal/wk) from baseline to week 14 (mean and SEM): diet - pre = 3034 (SEM=411) and post = 3495 (SEM=954) kcal/wk; diet + exercise - pre = 4549 (SEM=808) and post = 4988 (SEM=477) kcal/wk, control - pre = 4730 (SEM=679) and post = 5157 (SEM=820) kcal/wk</P>
</TD>
<TD>
<P>Maximal aerobic capacity (mL/kg/minute peak oxygen consumption) from baseline to week 14 (mean and SEM): diet - pre = 17.8 (SEM=0.9) and post = 17.8 (SEM=1.0); diet + exercise - pre = 18.5 (SEM=1.3) and post = 23.1 (SEM=1.3), control - pre = 17.0 (SEM=1.0) and post = 17.0 (SEM=1.0)</P>
</TD>
<TD>
<P>Resting energy expenditure (kcal/d) from baseline to week 14 (mean and SEM): diet - pre = 1356 (SEM=69) and post = 1343 (SEM=68) kcal/d; diet + exercise - pre = 1286 (SEM=53) and post = 1224 (SEM=52) kcal/d, control - pre = 1357 (SEM=92) and post = 1318 (SEM=81) kcal/d</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Hellenius 1993</P>
</TD>
<TD>
<P>BMI at 6 months: exercise = -0.3 (95% CI, -0.5 to -0.01), diet = -0.3 (95% CI, -0.6 to 0.03), diet + exercise = - 0.6 (95% CI, -0.9 to -0.3), control = 0.3 (95% CI, 0.1 to 0.5)</P>
</TD>
<TD>
<P>Waist circumference (cm) at 6 months: exercise = -2.2 (95% CI, -3.2 to -1.3), diet = -1.3 (95% CI, -2.5 to -0.1), diet + exercise = - 3.0 (95% CI, -3.9 to -2.0), control = 0.3 (95% CI, -0.5 to 1.1)</P>
</TD>
<TD>
<P>WHR at 6 months: exercise = -0.06 (95% CI, -0.08 to -0.05), diet = -0.05 (95% CI, -0.07 to -0.02), diet + exercise = - 0.05 (95% CI, -0.06 to -0.03), control = -0.05 (95% CI, -0.07 to -0.04)</P>
</TD>
<TD>
<P>Systolic blood pressure (mmHg) at 6 months: exercise = -5 (95% CI, -9 to -0.3), diet = -7 (95% CI, -10 to -3), diet + exercise = - 4 (95% CI, -7 to -1), control = -1 (95% CI, -3 to 4)</P>
</TD>
<TD>
<P>Diastolic blood pressure (mmHg) at 6 months: exercise = -4 (95% CI, -7 to -2), diet = -6 (95% CI, -8 to -4), diet + exercise = - 2 (95% CI, -4 to 1), control = -1 (95% CI, -3 to 1)</P>
</TD>
<TD>
<P>Total serum cholesterol (mmol/L) at 6 months: exercise = -0.12 (95% CI, -0.35 to 0.11), diet = -0.19 (95% CI, -0.49 to 0.11), diet + exercise = - 0.45 (95% CI, -0.77 to -0.13), control = -0.13 (95% CI, -0.33 to 0.07)</P>
</TD>
<TD>
<P>Total serum triglycerides (mmol/L) at 6 months: exercise = -0.10 (95%CI, -0.34 to 0.13), diet = 0.03 (95%CI, -0.09 to 0.15), diet + exercise = - 0.12 (95%CI, -0.31 to 0.08), control = 0.06 (95%CI, -0.08 to 0.20)</P>
</TD>
<TD>
<P>Change in energy intake (kj/d) at 6 months: exercise = 8928 (SD=1522) pre to 8564 (SD=1494) post, diet = 8160 (SD=1751) pre to 7795 (SD=1506) post, diet + exercise = 8635 (SD=2055) pre to 7705 (SD=1674) post, control = 9391 (SD=2723) pre to 8753 (SD=2387) post</P>
</TD>
<TD>
<P>Change in number of exercise sessions per month at 6 months: exercise = 5.1 (SD=7.3) pre to 11.7 (SD=6.7) post, diet = 5.6 (SD=7.0) pre to 6.1 (SD=7.0) post, diet + exercise = 5.1 (SD=7.3) pre to 9.9 (SD=6.8) post, control = 5.3 (SD=7.1) pre to 5.4 (SD=7.4) post</P>
</TD>
</TR>
<TR>
<TD>
<P>Irwin 2003</P>
</TD>
<TD>
<P>Weight change (kg) at 3 months: Intervention = -0.5 kg (95%CI, -1 to 0.1), control = 0 kg (95%CI, -0.6 to 0.5); Weight change (kg) at 12 months: Intervention = -1.3 kg (95%CI, -2 to -0.5), control = 0.1 kg (95%CI, -0.6 to 0.8)</P>
</TD>
<TD>
<P>BMI change at 3 months: Intervention = -0.2 (95%CI, -0.4 to 0), control = 0 (95%CI, -0.2 to 0.2); BMI change at 12 months: Intervention = -0.3 (95%CI, -0.6 to -0.1), control = 0.3 (95%CI, 0 to 0.6)</P>
</TD>
<TD>
<P>Waist circumference (cm) change at 3 months: Intervention = -0.5 cm (95%CI, -1.2 to 0.2), control = -0.1 cm (95%CI, -0.8 to 0.6); Waist circumference change at 12 months: Intervention = -1.0 cm (95%CI, -1.8 to -0.1), control = 0.1 cm (95%CI, -0.8 to 0.9)</P>
</TD>
<TD>
<P>Hip circumference (cm) change at 3 months: Intervention = -0.1 cm (95%CI, -0.6 to 0.6), control = 0.2 cm (95%CI, -0.4 to 0.9); Hip circumference change at 12 months: Intervention = -1.5 cm (95%CI, -2.3 to -0.7), control = 0.1 cm (95%CI, -0.6 to 0.9)</P>
</TD>
<TD>
<P>DXA total body fat change (kg) at 12 months: Intervention = -1.4 kg (95%CI, -2 to -0.8), control = -0.1 kg (95%CI, -0.6 to 0.6)</P>
</TD>
<TD>
<P>DXA % fat change at 12 months: Intervention = -1.2 % (95%CI, -1.6 to -0.8), control = -0.2 % (-0.6 to 0.2)</P>
</TD>
<TD>
<P>Intra-abdominal fat change (CT - g / cm2) at 12 months: Intervention = -8.5 (95%CI, -15.1 to -2.0), control = 0.1 (95%CI, -6.7 to 6.6)</P>
</TD>
<TD>
<P>Subcutaneous fat change (CT - g / cm2) at 12 months: Intervention = -21.2 (95%CI, -34.4 to -7.9), control = 7.6 (95%CI, -5.8 to 20.9)</P>
</TD>
<TD>
<P>Maximal oxygen consumption, % change at 12 months: Intervention = 11.7 % (95%CI, 8.8 to 14.6), control = 0.7 % (95%CI, -2.2 to 3.6)</P>
</TD>
</TR>
<TR>
<TD>
<P>Jakicic 1995</P>
</TD>
<TD>
<P>Weight change (kg) at 20 weeks (mean +/- SD): Vigorous exercise = -6.4 +/- 4.5 kg, light exercise = -8.9 +/- 5.3 kg</P>
</TD>
<TD>
<P>VO2 max change by 20 weeks (mean +/- SD): Vigorous exercise = 1842.2 +/- 412.5 ml/min pre to 1944.9 +/- 337.3 ml/min post, light exercise = 2030.9 +/- 466.4 ml/min pre to 2132.2 +/- 401.9 ml/min post</P>
</TD>
<TD>
<P>BMI change by 20 weeks (mean +/- SD): Vigorous exercise = 33.7 +/- 4.8 pre to 31.3 +/- 5.0 post, light exercise = 34.2 +/- 3.7 pre to 30.9 +/- 3.8 post</P>
</TD>
<TD>
<P>Systolic blood pressure change by 20 weeks (mean +/- SD): Vigorous exercise = 117.9 +/- 14.9 mmHg pre to 114.0 +/- 16.0 mmHg post, light exercise = 117.0 +/- 10.5 mmHg pre to 114.3 +/- 10.8 mmHg post</P>
</TD>
<TD>
<P>Diastolic blood pressure change by 20 weeks (mean +/- SD): Vigorous exercise = 80.0 +/- 10.1 mmHg pre to 75.9 +/- 9.3 mmHg post, light exercise = 80.6 +/- 7.0 mmHg pre to 75.4 +/- 8.4 mmHg post</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Jakicic 2003</P>
</TD>
<TD>
<P>Weight change (kg) at 12 months (mean +/- SD): Vigorous intensity, high duration exercise = -8.9 +/- 7.3 kg, Moderate intensity, high duration exercise = -8.2 +/- 7.6 kg, Moderate intensity, moderate duration exercise = -6.3 +/- 5.6 kg, Vigorous intensity, moderate duration exercise = -7 +/- 6.4 kg</P>
</TD>
<TD>
<P>BMI change from baseline to 12 months (mean +/- SD): Vigorous intensity, high duration exercise = 32.9 +/- 3.9 (pre) to 29.5 +/- 4.8 (post), Moderate intensity, high duration exercise = 32.3 +/- 3.9 (pre) to 29.2 +/- 4.8 (post), Moderate intensity, moderate duration exercise = 32.7 +/- 4.3 (pre) to 30.3 +/- 4.5 (post), Vigorous intensity, moderate duration exercise = 32.7 +/- 4.6 (pre) to 30.2 +/- 4.6 (post)</P>
</TD>
<TD>
<P>Change in leisure-time physical activity (min/week) from baseline to 12 months (mean +/- SD): Vigorous intensity, high duration exercise = 134.3 +/- 288.8 (pre) to 175.7 +/- 170.3 (post), Moderate intensity, high duration exercise = 160.6 +/- 248.8 (pre) to 189.9 +/- 119.0 (post), Moderate intensity, moderate duration exercise = 108.3 +/- 221.7 (pre) to 206.6 +/- 242.0 (post), Vigorous intensity, moderate duration exercise = 115.2 +/- 245.3 (pre) to 140.1 +/- 115.4 (post)</P>
</TD>
<TD>
<P>Change in energy intake (kcal/day) from baseline to 12 months (mean +/- SD): Vigorous intensity, high duration exercise = 2099 +/- 796 (pre) to 1471 +/- 532 (post), Moderate intensity, high duration exercise = 2116 +/- 981 (pre) to 1557 +/- 531 (post), Moderate intensity, moderate duration exercise = 2027 +/- 743 (pre) to 1350 +/- 422 (post), Vigorous intensity, moderate duration exercise = 2200 +/- 875 (pre) to 1449 +/- 502 (post)</P>
</TD>
<TD>
<P>Change in cardiorespiratory fitness (mL/kg) from baseline to 12 months (mean +/- SD): Vigorous intensity, high duration exercise = 20.2 +/- 2.9 (pre) to 24.5 +/- 4.8 (post), Moderate intensity, high duration exercise = 19.4 +/- 3.2 (pre) to 22.1 +/- 4.0 (post), Moderate intensity, moderate duration exercise = 19.7 +/- 3.7 (pre) to 22.2 +/- 4.6 (post), Vigorous intensity, moderate duration exercise = 19.7 +/- 3.1 (pre) to 23.3 +/- 4.5 (post)</P>
</TD>
<TD>
<P>Change in cardiorespiratory fitness at 12 months (mean +/- SD): Vigorous intensity, high duration exercise = 22 +/- 19.9%, Moderate intensity, high duration exercise = 14.9 +/- 18.6 %, Moderate intensity, moderate duration exercise = 13.5 +/- 16.9 %, Vigorous intensity, moderate duration exercise = 18.9 +/- 16.9 %</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Janssen 2002</P>
</TD>
<TD>
<P>Weight change (kg) at 16 weeks (mean +/- SD): diet = -10 +/- 3.9 kg, diet + aerobic exercise = -11.1 + / - 4.4 kg, diet + resistance exercise = -10 +/- 3 kg</P>
</TD>
<TD>
<P>BMI change at 16 weeks (mean +/- SD): diet = -4 +/-1.4, diet + aerobic exercise = -4.2 + / - 1.2, diet + resistance exercise = 3.9 +/- 1</P>
</TD>
<TD>
<P>Fasting serum glucose change (mmol/L) at 16 weeks (mean +/- SD): diet = -0.1 +/-0.4, diet + aerobic exercise = -0.1 + / - 0.5, diet + resistance exercise = -0.1 +/- 0.4</P>
</TD>
<TD>
<P>Serum triglyceride change (mmol/L) at 16 weeks (mean +/- SD): diet = -0.3 +/-1.6, diet + aerobic exercise = -0.3 + / - 0.5, diet + resistance exercise = -0.4 +/- 0.8</P>
</TD>
<TD>
<P>Fasting serum cholesterol change (mmol/L) at 16 weeks (mean +/- SD): diet = -0.8 +/-0.4, diet + aerobic exercise = -0.4 + / - 0.6, diet + resistance exercise = -0.6 +/- 0.4</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Jeffery 1998</P>
</TD>
<TD>
<P>Weight change (kg) at 12 months: exercise = -6.5 +/- 6.5 kg, control = -8.3 + / - 4.3 kg</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Jeffery 2003</P>
</TD>
<TD>
<P>Weight change (kg) at 6 months (mean +/- SD): Diet = -8.1 +/- 7.4 kg, diet + exercise = -9 +/- 7.1 kg; Weight change (kg) at 12 months: Diet = -6.1 +/- 8.8 kg, Diet + exercise = -8.5 +/- 7.9 kg; Weight change (kg) at 18 months: Diet = -4.1 +/- 7.3 kg, Diet + exercise = -6.7 +/- 8.1 kg</P>
</TD>
<TD>
<P>Energy expenditure (kcal/wk) from baseline to 18 months (mean and SD): diet - pre = 1286 (SD=1258) and post = 1629 (SD=1483) kcal/wk; diet + exercise - pre = 1278 (SD=1369) and post = 2317 (SD=1854) kcal/wk</P>
</TD>
<TD>
<P>Energy intake (kcal/d) from baseline to 18 months (mean and SD): diet - pre = 2071 (SD=1058) and post = 1641 (SD=742) kcal/d; diet + exercise - pre = 2189 (SD=1066) and post = 1631 (SD=670) kcal/d</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Kiernan 2001</P>
</TD>
<TD>
<P>Weight change (kg) at 12 months (mean +/- SD): diet + exercise = -6.9 +/- 5.5 kg, diet = - 4.5 +/- 5.7 kg</P>
</TD>
<TD>
<P>BMI change at 12 months (mean +/- SD): diet + exercise = -2.3 +/- 1.8, diet = - 1.6 +/- 1.8</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Leutholtz 1995</P>
</TD>
<TD>
<P>Weight change (kg) at 12 weeks (mean +/- SD): vigorous exercise = -15.7 +/- 5.3 kg, light exercise = - 15.0 +/- 8.4 kg</P>
</TD>
<TD>
<P>Body fat (%) change at 12 weeks (mean +/- SD): vigorous exercise = -9.6 +/- 3.2 %, light exercise = - 8.3 +/- 2.9 %</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Manning 1991</P>
</TD>
<TD>
<P>Weight change (kg) at 12 weeks (mean +/- SEM): exercise = 84.1 +/- 3.5 kg (pre) to 85.5 +/- 3.6 kg (post), control = 87.0 +/- 4.2 kg (pre) to 87.3 +/- 4.3 kg (post)</P>
</TD>
<TD>
<P>Change in BMI at 12 weeks (mean +/- SEM): exercise = 31.4 +/- 1.3 (pre) to 32.0 +/- 1.4 (post), control = 32.8 +/- 1.4 (pre) to 33.0 +/- 1.4 (post)</P>
</TD>
<TD>
<P>Change in energy intake (kcal/day) at 12 weeks (mean +/- SEM): exercise = 1618 +/- 135 kcal/day (pre) to 1675 +/- 96 kcal/day (post), control = 1658 +/- 144 kcal/day (pre) to 1728 +/- 102 kcal/day (post)</P>
</TD>
<TD>
<P>Change in total serum cholesterol (mg/dl) at 12 weeks (mean +/- SEM): exercise = 200 +/- 10 (pre) to 198 +/- 11 (post), control = 197 +/- 15 (pre) to 205 +/- 15 (post)</P>
</TD>
<TD>
<P>Change in total serum triglycerides (mg/dl) at 12 weeks (mean +/- SEM): exercise = 111 +/- 10 (pre) to 126 +/- 12 (post), control = 106 +/- 20 (pre) to 114 +/- 30 (post)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Neumark 1995</P>
</TD>
<TD>
<P>Weight change (kg) at 3 months (mean +/- SD): exercise = -3.6 +/- 2.6 kg, control = -3.8 +/- 2.0 kg</P>
</TD>
<TD>
<P>Change in waist circumference (cm) at 3 months (mean +/- SD): exercise = -7.4 +/- 7.0 cm, control = -8.5 +/- 8.9 cm</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Nieman 1998</P>
</TD>
<TD>
<P>Weight change (kg) at 3 months (mean +/- SEM): exercise = 88.4 +/- 2.9 (pre) to 87.4 +/- 2.8 (post), diet = 90.6 +/- 3.8 (pre) to 82.8 +/- 3.7 (post), diet+ exercise = 89.9 +/- 2.5 (pre) to 81.8 +/- 2.3 (post), control = 90.5 +/- 2.4 (pre) to 89.7 +/- 2.5 (post)</P>
</TD>
<TD>
<P>Change in BMI at 3 months (mean +/- SEM): exercise = 32.3 +/- 1.1 (pre) to 32.0 +/- 1.1 (post), diet = 34.2 +/- 1.6 (pre) to 31.3 +/- 1.5 (post), diet+ exercise = 32.6 +/- 1.0 (pre) to 29.7 +/- 0.9 (post), control = 32.8 +/- 1.0 (pre) to 32.5 +/- 1.0 (post)</P>
</TD>
<TD>
<P>Change in % body fat at 3 months (mean +/- SEM): exercise = 43.1 +/- 1.3 (pre) to 42.1 +/- 1.5 (post), diet = 44.3 +/- 1.1 (pre) to 40.1 +/- 1.4 (post), diet+ exercise = 43.3 +/- 1.1 (pre) to 39.6 +/- 0.9 (post), control = 43.4 +/- 1.0 (pre) to 42.3 +/- 1.1 (post)</P>
</TD>
<TD>
<P>Change in VO2 max (ml/min) at 3 months (mean +/- SEM): exercise = 2018 +/- 61 (pre) to 2303 +/- 73 (post), diet = 1993 +/- 45 (pre) to 2018 +/- 59 (post), diet+ exercise = 1995 +/- 73 (pre) to 2157 +/- 72 (post), control = 1986 +/- 77 (pre) to 2057 +/- 69 (post)</P>
</TD>
<TD>
<P>Change in serum cholesterol (mmol/L) at 3 months (mean +/- SEM): exercise = 5.6 +/- 0.2 (pre) to 5.7 +/- 0.2 (post), diet = 5.4 +/- 0.2 (pre) to 4.8 +/- 0.2 (post), diet+ exercise = 5.3 +/- 0.2 (pre) to 4.7 +/- 0.2 (post), control = 5.1 +/- 0.2 (pre) to 5.1 +/- 0.2 (post)</P>
</TD>
<TD>
<P>Change in serum triglycerides (mmol/L) at 3 months (mean +/- SEM): exercise = 1.6 +/- 0.2 (pre) to 1.8 +/- 0.2 (post), diet = 1.6 +/- 0.2 (pre) to 1.4 +/- 0.1 (post), diet+ exercise = 1.5 +/- 0.1 (pre) to 1.3 +/- 0.1 (post), control = 1.5 +/- 0.1 (pre) to 1.8 +/- 0.2 (post)</P>
</TD>
<TD>
<P>Change in serum glucose (mmol/L) at 3 months (mean +/- SEM): exercise = 5.1 +/- 0.2 (pre) to 4.9 +/- 0.1 (post), diet = 5.2 +/- 0.2 (pre) to 4.8 +/- 0.1 (post), diet+ exercise = 5.3 +/- 0.2 (pre) to 4.9 +/- 0.1 (post), control = 5.1 +/- 0.2 (pre) to 5.4 +/- 0.2 (post)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Pritchard 1997</P>
</TD>
<TD>
<P>Weight change (%) at 12 months (mean +/- SD): exercise = -3 +/- 0.5%, diet = -7.2 +/- 0.9%, control = 1.0 +/- 0.5%</P>
</TD>
<TD>
<P>BMI change (%) at 12 months (mean +/- SD): exercise = -4.4 +/- 0.7%, diet = -8.2 +/- 0.9%, control = 1.0 +/- 0.7%</P>
</TD>
<TD>
<P>Change in energy intake (%) at 12 months (mean +/- SD): exercise = 3.1 +/- 2.7%, diet = -30.4 +/- 3.8%, control = 5.5 +/- 4.7%</P>
</TD>
<TD>
<P>Change in physical activity (%) at 12 months (mean +/- SD): exercise = 15.6 +/- 0.1%, diet = 3.4 +/- 1.2%, control = 6.4 +/- 1.7%</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Raz 1994</P>
</TD>
<TD>
<P>Change in BMI at 12 weeks (mean +/- SD): exercise = 31.8 +/- 4.6 (pre) to 31.5 +/- 4.3 (post), control = 30.2 + / - 4.7 (pre) to 30.6 +/- 4.2 (post)</P>
</TD>
<TD>
<P>Change in serum glucose (mmol/l) at 12 weeks (mean +/- SD): exercise = 11.4 +/- 2.3 (pre) to 10.2 +/- 3.3 (post), control = 11.8 + / - 4.6 (pre) to 12.3 +/- 4.4 (post)</P>
</TD>
<TD>
<P>Change in serum cholesterol (mmol/l) at 12 weeks (mean +/- SD): exercise = 5.7 +/- 1.0 (pre) to 5.6 +/- 1.0 (post), control = 6.0 + / - 1.1 (pre) to 6.0 +/- 1.0 (post)</P>
</TD>
<TD>
<P>Change in serum triglycerides at 12 weeks (mean +/- SD): exercise = 2.0 +/- 0.7 (pre) to 1.9 +/- 0.7 (post), control = 2.1 + / - 0.6 (pre) to 2.2 +/- 0.1 (post)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Ross 1996</P>
</TD>
<TD>
<P>Weight change (kg) at 16 weeks (mean +/- SD): diet = -11.4 +/- 3.5 kg, diet + aerobic exercise = -11.6 + / - 3.7 kg, diet + resistance exercise = -13.2 +/- 4.1 kg</P>
</TD>
<TD>
<P>Waist circumference change (cm) at 16 weeks (mean +/- SD): diet = -8.5 +/- 4.0 cm, diet + aerobic exercise = -12.9 + / - 4.0 cm, diet + resistance exercise = -11.9 +/- 4.0 cm</P>
</TD>
<TD>
<P>WHR change at 16 weeks (mean +/- SD): diet = -0.03 +/- 0.03, diet + aerobic exercise = -0.05 + / - 0.05, diet + resistance exercise = -0.05 +/- 0.02</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Schwartz 1987</P>
</TD>
<TD>
<P>Weight change (kg) at 3 months (mean +/- SD): exercise = -2.8 +/- 3.6 kg, diet = - 13.1 +/- 6.1 kg</P>
</TD>
<TD>
<P>Change in calorie intake (kcal/day) at 3 months (mean +/- SD): exercise = 174 +/- 187, diet = - 199 +/- 256</P>
</TD>
<TD>
<P>Change in triglycerides (mg/dL) at 3 months (mean +/- SD): exercise = -2 +/- 35, diet = - 54 +/- 67</P>
</TD>
<TD>
<P>Change in cholesterol (mg/dL) at 3 months (mean +/- SD): exercise = 7 +/- 17, diet = - 29 +/- 27</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Schwartz 1990</P>
</TD>
<TD>
<P>Weight change (kg) at 3 months (mean +/- SD): exercise = -2.3 +/- 3.4 kg, diet = - 13.6 +/- 6.7 kg</P>
</TD>
<TD>
<P>Change in % body fat at 3 months (mean +/- SD): exercise = -2.3 +/- 2.3 %, diet = - 5.9 +/- 3.5 %</P>
</TD>
<TD>
<P>Change in calorie intake (kcal/day) at 3 months (mean +/- SD): exercise = 202 +/- 176 kcal/d, diet = - 247 +/- 275 kcal/d</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Stefanick 1998</P>
</TD>
<TD>
<P>Weight change (kg) at 12 months (mean +/- SD): exercise = -0.5 +/- 2.8 kg, diet = - 2.8 +/- 3.5 kg, diet + exercise = - 3.7 +/- 4.0 kg, control = 0.7 +/- 3.5 kg</P>
</TD>
<TD>
<P>Change in serum cholesterol (mmol/L) at 12 months (mean +/- SD): exercise = -5.4 +/- 4.7, diet = - 10.6 +/- 4.5, diet + exercise = - 19.1 +/- 4.5, control = -2.5 +/- 4.5</P>
</TD>
<TD>
<P>Change in serum triglycerides (mmol/L) at 12 months (mean +/- SD): exercise = -12.9 +/- 6.9, diet = - 5.3 +/- 7.9, diet + exercise = - 8.6 +/- 7.2, control = -5.4 +/- 7.9</P>
</TD>
<TD>
<P>Change in serum glucose (mmol/L) at 12 months (mean +/- SD): exercise = -6.7 +/- 3.0, diet = - 7.7 +/- 2.8, diet + exercise = - 7.8 +/- 3.1, control = -3.2 +/- 3.6</P>
</TD>
<TD>
<P>Change in systolic blood pressure (mmHg) at 12 months (mean +/- SD): exercise = -0.8 +/- 2.8, diet = - 2.6 +/- 2.8, diet + exercise = - 3.1 +/- 2.7, control = - 1.0 +/- 2.8</P>
</TD>
<TD>
<P>Change in diastolic blood pressure (mmHg) at 12 months (mean +/- SD): exercise = -1.2 +/- 2.6, diet = - 1.1 +/- 2.3, diet + exercise = - 2.9 +/- 2.4, control = 0.6 +/- 2.4</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Stensel 1994</P>
</TD>
<TD>
<P>Weight change (kg) at 12 months: exercise = 79.3 +/- 1.5 (SEM) (pre) to 79.1 +/- 1.5 (SEM) (post), control = 77.6 + / - 2.5 (SEM) (pre) to 78.3 +/- 2.7 (SEM) (post)</P>
</TD>
<TD>
<P>BMI change at 12 months: exercise = 25.4 +/- 0.4 (SEM) (pre) to 25.4 +/- 0.4 (SEM) (post), control = 24.8 + / - 0.7 (SEM) (pre) to 25.0 +/- 0.7 (SEM) (post)</P>
</TD>
<TD>
<P>Change in % body fat at 12 months: exercise = 28.7 +/- 0.8 (SEM) (pre) to 27.6 +/- 0.7 (SEM) (post), control = 29.5 + / - 1.5 (SEM) (pre) to 29.3 +/- 1.5 (SEM) (post)</P>
</TD>
<TD>
<P>Change in WHR at 12 months: exercise = 0.95 +/- 0.01 (SEM) (pre) to 0.94 +/- 0.01 (SEM) (post), control = 0.95 + / - 0.01 (SEM) (pre) to 0.94 +/- 0.01 (SEM) (post)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Svendsen 1993</P>
</TD>
<TD>
<P>Weight change (kg) at 12 weeks (mean +/- SD): diet = - 9.5 +/- 2.8 kg, diet + exercise = - 10.3 +/- 3.0 kg</P>
</TD>
<TD>
<P>WHR change at 12 weeks (mean +/- SD): diet = - 0.3 +/- 0.3, diet + exercise = - 0.3 +/- 0.4</P>
</TD>
<TD>
<P>VO2 max change at 12 weeks (mean +/- SD): diet = 2.3 +/- 2.2 ml/kg/min, diet + exercise = 6.9 +/- 9.6 ml/kg/min</P>
</TD>
<TD>
<P>Change in serum cholesterol (mmol/L) at 12 weeks (mean +/- SD): diet = - 1.36 +/- 0.84, diet + exercise = - 1.23 +/- 0.67</P>
</TD>
<TD>
<P>Change in serum triglycerides (mmol/L) at 12 weeks (mean +/- SD): diet = - 0.5 +/- 0.69, diet + exercise = - 0.3 +/- 0.46</P>
</TD>
<TD>
<P>Change in energy intake (kj/d) at 12 weeks (mean +/- SD): diet = - 3287 +/- 2076, diet + exercise = - 3526 +/- 2378</P>
</TD>
<TD>
<P>Change in systolic blood pressure (mmHg) at 12 weeks (mean +/- SD): diet = - 13 +/- 12, diet + exercise = - 11 +/- 11</P>
</TD>
<TD>
<P>Change in diastolic blood pressure (mmHg) at 12 weeks (mean +/- SD): diet = - 7 +/- 8, diet + exercise = - 9 +/- 8</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Thong 2000</P>
</TD>
<TD>
<P>Weight change (kg) at 3 months: exercise + diet = -7.6 kg +/- 0.1 (SE), diet = - 7.4 kg +/- 0.2 (SE)</P>
</TD>
<TD>
<P>BMI change at 3 months: exercise + diet = -2.4 +/- 0.1 (SE), diet = - 2.4 +/- 0.1 (SE)</P>
</TD>
<TD>
<P>WHR change at 3 months: exercise + diet = -0.03 +/- 0.01 (SE), diet = - 0.04 +/- 0.01 (SE)</P>
</TD>
<TD>
<P>VO2 max change at 3 months: exercise + diet = 8.8 +/- 0.9 (SE), diet = 0.8 +/- 0.9 (SE)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Utter 2000</P>
</TD>
<TD>
<P>Weight change (kg) at 3 months (mean +/- SE): exercise = 80.5 +/- 2.0 (pre) to 80.7 +/- 2.1 (post), control = 91.8 +/- 6.5 (pre) to 93.3 +/- 6.3 (post)</P>
</TD>
<TD>
<P>Change in % body fat at 3 months (mean +/- SE): exercise = 40.7 +/- 1.1 (pre) to 39.6 +/- 1.2 (post), control = 41.9 +/- 1.3 (pre) to 42.3 +/- 1.3 (post)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Wadden 1997</P>
</TD>
<TD>
<P>Weight change (kg) at 24 weeks (mean +/- SD): diet + exercise = - 16.4 +/- 7.3 kg, diet = - 16.7 +/- 5.5 kg</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Wallace 1997</P>
</TD>
<TD>
<P>Weight change (kg) at 14 weeks (mean +/- SD): vigorous exercise = -4.2 +/- 4.1 kg, moderate exercise = - 1.9 +/- 5.1 kg</P>
</TD>
<TD>
<P>Change in % body fat at 14 weeks (mean +/- SD): vigorous exercise = -6.9 +/- 1.3 %, moderate exercise = - 1.4 +/- 1.4 %</P>
</TD>
<TD>
<P>WHR change at 14 weeks (mean +/- SD): vigorous exercise = -0.06 +/- 0.01, moderate exercise = - 0.04 +/- 0.01</P>
</TD>
<TD>
<P>Change in serum triglycerides (mg/dL) at 14 weeks (mean +/- SD): vigorous exercise = -43.8 +/- 13.6, moderate exercise = - 31.9 +/- 12.2</P>
</TD>
<TD>
<P>Change in blood pressure (mmHg) at 14 weeks (mean +/- SD): vigorous exercise = -14.6 +/- 5.5, moderate exercise = - 8.3 +/- 6.8</P>
</TD>
<TD>
<P>Change in serum glucose (mg/dL) at 14 weeks (mean +/- SD): vigorous exercise = -11.1 +/- 2.9, moderate exercise = - 5.9 +/- 2.6</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Whatley 1994</P>
</TD>
<TD>
<P>Weight change (kg) at 3 months (mean +/- SD): vigorous exercise = -19.6 +/- 4.2 kg, moderate exercise = - 15.8 +/- 4.2 kg</P>
</TD>
<TD>
<P>Change in WHR at 3 months (mean +/- SD): vigorous exercise = -0.02 +/- 0.03, moderate exercise = - 0.04 +/- 0.06</P>
</TD>
<TD>
<P>Change in VO2 max (L/min) at 3 months (mean +/- SD): vigorous exercise = - 0.05 +/- 0.02, moderate exercise = - 0.08 +/- 0.18</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Wing 1988</P>
</TD>
<TD>
<P>Weight change (kg) at 12 months (mean +/- SD): diet + exercise = 104.1 +/- 6.0 kg (pre) to 96.2 +/- 6.5 kg (post), diet = 102.0 +/- 5.0 kg (pre) to 98.2 +/- 4.9 kg (post)</P>
</TD>
<TD>
<P>BMI change at 12 months (mean +/- SD): diet + exercise = 37.5 +/- 1.9 (pre) to 34.6 +/- 2.1 (post), diet = 37.9 +/- 1.7 (pre) to 36.6 +/- 1.8 (post)</P>
</TD>
<TD>
<P>Change in HbA1c at 12 months (mean +/- SD): diet + exercise = 10.6 +/- 0.5 (pre) to 9.2 +/- 0.5 (post), diet = 10.9 +/- 0.5 (pre) to 10.1 +/- 0.4 (post)</P>
</TD>
<TD>
<P>Change in serum cholesterol (mmol/l) at 12 months (mean +/- SD): diet + exercise = 4.9 +/- 0.3 (pre) to 5.2 +/- 0.3 (post), diet = 4.8 +/- 0.2 (pre) to 5.2 +/- 0.2 (post)</P>
</TD>
<TD>
<P>Change in serum triglycerides (mmol/l) at 12 months (mean +/- SD): diet + exercise = 2.5 +/- 0.6 (pre) to 1.9 +/- 0.3 (post), diet = 1.8 +/- 0.3 (pre) to 1.9 +/- 0.2 (post)</P>
</TD>
<TD>
<P>Change in serum glucose (mmol/l) at 12 months (mean +/- SD): diet + exercise = 11.6 +/- 0.6 (pre) to 9.9 +/- 0.8 (post), diet = 12.6 +/- 0.7 (pre) to 11.8 +/- 1.0 (post)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Wing 1998</P>
</TD>
<TD>
<P>Weight change (kg) at 6 months: exercise = -2.1 +/- 4.2 kg, diet = - 9.1 +/- 6.4 kg, diet + exercise = - 10.3 +/- 7.7 kg, control = -1.5 +/- 2.7 kg</P>
</TD>
<TD>
<P>Change in BMI at 6 months: exercise = -0.8 +/- 1.5, diet = - 3.3 +/- 2.2, diet + exercise = - 3.7 +/- 2.6, control = -0.6 +/- 1.0</P>
</TD>
<TD>
<P>Change in fasting plasma glucose (mmol/l) at 6 months: exercise = 0.0 +/- 0.7, diet = - 0.2 +/- 0.4, diet + exercise = - 0.2 +/- 0.4, control = 0.1 +/- 0.5</P>
</TD>
<TD>
<P>Change in fasting plasma cholesterol (mmol/l) at 6 months: exercise = 0.12 +/- 0.72, diet = - 0.49 +/- 0.71, diet + exercise = - 0.33 +/- 0.61, control = 0.12 +/- 0.5</P>
</TD>
<TD>
<P>Change in fasting plasma triglycerides (mmol/l) at 6 months: exercise = 0.1 +/- 1.6, diet = - 0.3 +/- 1.5, diet + exercise = - 0.7 +/- 1.5, control = -0.3 +/- 1.3</P>
</TD>
<TD>
<P>Change in systolic blood pressure (mmHg) at 6 months: exercise = -2.4 +/- 18.9, diet = - 10.2 +/- 9.2, diet + exercise = - 12.3 +/- 9.5, control = -2.0 +/- 10.5</P>
</TD>
<TD>
<P>Change in diastolic blood pressure (mmHg) at 6 months: exercise = -1.7 +/- 12.2, diet = - 6.2 +/- 6.9, diet + exercise = - 6.9 +/- 10.4, control = -2.2 +/- 8.0</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Wirth 1985</P>
</TD>
<TD>
<P>Weight change (kg) at 4 months (mean +/- SD): exercise = 81.9 +/- 10.6 kg (pre) to 81.6 +/- 10.7 kg (post), control = 86.6 +/- 12.9 kg (pre) to 88.2 +/- 14.5 kg (post)</P>
</TD>
<TD>
<P>Change in % body fat at 4 months (mean +/- SD): exercise = 24.0 +/- 4.6 (pre) to 22.1 +/- 3.1 (post), control = 24.7 +/- 3.1 (pre) to 25.6 +/- 2.5 (post)</P>
</TD>
<TD>
<P>Change in resting systolic blood pressure (mmHg) at 4 months (mean +/- SD): exercise = 137 +/- 5.1 (pre) to 123 +/- 5.1 (post), control = 132 +/- 5.6 (pre) to 132 +/- 4.9 (post)</P>
</TD>
<TD>
<P>Change in total serum cholesterol (mg/dL) at 4 months (mean +/- SD): exercise = 273 +/- 57 (pre) to 260 +/- 52 (post), control = 299 +/- 61 (pre) to 294 +/- 58 (post)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Wood 1988</P>
</TD>
<TD>
<P>Weight change (kg) at 12 months (mean +/- SD): exercise = -4.0 +/- 3.9 kg, diet = - 7.2 +/- 3.7 kg, control = 0.6 +/- 3.7 kg</P>
</TD>
<TD>
<P>Change in energy intake (kj/day) at 12 months (mean +/- SD): exercise = -873 +/- 2558 kj/day, diet = -1429 +/- 1887 kj/day, control = -433 +/- 2071 kj/day</P>
</TD>
<TD>
<P>Change in VO2 max (ml/kg/min) at 12 months (mean +/- SD): exercise = 4.1 +/- 5.9, diet = 0.0 +/- 3.2, control = -2.4 +/- 3.2</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Wood 1991</P>
</TD>
<TD>
<P>Weight change (kg) at 12 months (mean +/- SD): diet + exercise = -3.4 +/- 4.9 kg, diet = - 2.3 +/- 6.0 kg</P>
</TD>
<TD>
<P>Change in serum triglycerides (mmol/L) at 12 months (mean +/- SD): diet + exercise = -0.2 +/- 0.6, diet = - 0.03 +/- 0.5</P>
</TD>
<TD>
<P>Change in serum cholesterol (mmol/L) at 12 months (mean +/- SD): diet + exercise = -0.32 +/- 0.70, diet = - 0.4 +/- 0.6</P>
</TD>
<TD>
<P>Change in systolic blood pressure (mmHg) at 12 months (mean +/- SD): diet + exercise = -4.5 +/- 8, diet = - 4.1 +/- 7.3</P>
</TD>
<TD>
<P>Change in diastolic blood pressure (mmHg) at 12 months (mean +/- SD): diet + exercise = -3.5 +/- 4.9, diet = - 2.3 +/- 5.9</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<I>Footnotes</I>
</P>
</TD>
<TD COLSPAN="7">
<P>SD=standard deviation; SE=standard error; SEM=standard error of the mean; CI=confidence interval; kg=kilograms; lb=pounds; BMI=body mass index; WHR=waist-hip ratio; DXA=dual-energy x-ray absorptiometry; mmHg=millimetres of mercury; kcal=kilocalories; VO2max=maximal oxygen uptake; HDL=high-density lipoprotein; LDL=low-density lipoprotein; mmol/L=millimoles per litre</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>